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HC03 dependence of Cl/base exchange in the basolateral membrane
of rabbit proximal tubule S3 segment. G. Seki and E. Frômter, Zentrum
der Physiologie, J. W. Goethe Universität, Frankfurt, Federal Republic
of Germany. SI and S2 segments of mammalian proximal tubule absorb
HCO3 from lumen to blood mainly via the Na (HC03)3 cotrans-
porter in the peritubular membrane. S3 segments, in contrast, which do
not express the Na (HC03)3 cotransporter (Kondo Y, Frömter E,
Pflügers Arch 410, 481, 1987) utilize a C1/base exchanger (Kondo Y,
FrOmter E, Pflugers Arch, in press). We have now investigated the
mechanism of HC03 transport across this exchanger in isolated,
microperfused S3 segments of rabbit proximal tubule. Cell pH was
measured with double-barrelled pH microelectrodes while suddenly all
bath Cl was replaced by gluconate. In presence of HC03 (25
mmol/liter) the cells alkalinized with an initial rate of 0.28 0.08 pH
units/mm (N = 7). In HC03/C02 free solutions this rate fell to 0.07
0.03 (N = 8). After correction for the different buffer capacity of the
cells under both conditions the experiments yielded initial HC03
fluxes of 205 59 pmol/min cm tubule length in the presence and 19
8 in the absence of HC03. The latter data, which may still overesti-
mate the flux since no correlation was made for the fall in cell volume,
indicate that the exchanger requires HC03 to operate and does not
efficiently exchange Cl for 0H. Experiments with cyanide suggest
that the residual flux in HC03/C02 free solutions might have been
even due to recirculation of metabolically generated C02/HC03.
Adaptive changes in kidney morphology induced by chronic inhibition
of carbonic anhydrase with acetazolamide. M. Schmid, S. Bachmann
and W. Kriz, Department of Anatomy and Cell Biology 1, Heidelberg,
Federal Republic of Germany. The effects of chronic administration (7
days) of acetazolamide were studied in the kidneys of female Wistar
rats. The study was focused on possible adaptive changes in collecting
duct morphology. The experimental group (ACET; N = 16) received a
daily dose of 62 mg acetazolamid delivered by i.p. implanted osmotic
minipumps; animals of the control group (CTR; N = 14) were sham
operated. Eight ACET rats and 7 CTR rats were used for morphological
investigation, the other rats were decapitated for recording of plasma
control parameters (pH and aldosterone). Urinary control parameters
were recorded in all animals. A significant diuresis and natriuresis in
ACET persisted during the whole experiment. No differences in plasma
and urine pH were recorded between the groups. Plasma aldosterone
was increased in ACET (P < 0.05) indicating an enhanced sodium
reabsorption in the collecting duct. In ACET, the epithelial volume of
the collecting duct as well as the area of the basolateral membrane per
micrometer tubule length in principal cells significantly increased in all
kidney zones. Because cell volume and membrane area increased in
proportion, the surface density of the basolateral membrane remained
constant except for an increase in the inner medullary collecting duct.
Intercalated cells of the collecting duct in ACET exhibited an increased
number of large clear vesicles equipped with a non-continuous border
of 'studs,' which are regarded as the morphological equivalent of the
H-pump in these cells. The collecting duct hypertrophy in ACET is
thought to represent an adaptive change of the kidney to saluresis and
pH disequilibrium. The increase in intercalated cell vesicles bearing
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'studs' indicates a possible storage mechanism of the proton pumps
induced by carbonic anhydrase inhibition.
Transport of organic bases across the basolateral membrane of rabbit
proximal tubule. F. Braendle and J. Greven, Department of Pharma-
cology, RWTH Aachen, Wendlingweg, 5100 Aachen, Federal Republic
of Germany. In contrast to organic acids very little is known about the
secretion of organic bases in proximal tubules. The present study
examines the basolateral uptake of cimetidine (cim.) in the model of the
isolated non-perfused proximal tubule. S2 segments of the proximal
tubule were incubated in an artificial solution containing 3H-cim. as a
marker for the transport of organic bases and '4C-inulin as a marker of
the extracellular space. Because the tubules were totally collapsed, the
intracellular activity was equal to the uptake across the basolateral
membrane. Time course of cellular cim. uptake: At an incubation
temperature of 37.5°C the cellular uptake reached a steady state after 15
mm. At a bath concentration of 2 x l0— mol/liter the intracellular
concentration during the steady state was 81 times greater than the
extracellular one. At an incubation temperature of 22°C the steady state
was achieved after 25 mm and the intracellular concentration was only
half of that at 37.5°C. Cellular uptake after 30 mm incubation under
increasing cim.-bath concentrations: The cim. uptake was satured at a
concentration of 5 x l0— mol/liter. Effiux-exchange studies: The
tubules were incubated for 25 mm with 2 x l0 mol/liter radiolabeled
cim. Afterwards nonradiolabeled cim. (5 x iO mol/liter) was given to
the bath. After the administration of nonradiolabeled cim. the intracel-
lular concentration of radiolabeled cim. decreased. After 25 mm a new
steady state was achieved with a 75% lesser extent of intracellular
stored radiolabeled cim. Effiux-exchange studies with other organic
bases: Giving procainamide or quinine in a concentration of 5 x iO
mol/liter to the bath, the intracellular amount of radiolabeled cim. also
decreased, while N-methyl-nicotinamide (5 x iO mol/liter) did not
change the intracellular cim. concentration. Conclusions: 1.) The up-
take of cimetidine across the basolateral membrane is an active,
saturable transport process. 2.) Not all organic bases seem to be
transported about the same carrier. 3.) Further studies show a depen-
dence of the uptake from extracellular pH, different transport capacities
of the three segments of the proximal tubule and an inhibition of the
transport process by ouabain.
Localization of mercapturic acid formation in the kidney. A. Heuner,
W. Dekant, J.S. Schwegler, S. Silbernagl, with the technical assistance
of Sigrid Mildenberger, Physiologisches Institut und Institut fur Tox-
ikologie der Universität Wflrzburg, Federal Republic of Germany.
Glutathione S-conjugates released by the liver into the circulation
undergo extracellular hydrolysis in the kidney followed by reabsorption
of the resultant cysteine S-conjugates. In microinfusion and microper-
fusion experiments with S-benzyl-L-cysteine as a model substance, we
investigated in which nephron segment of the rat kidney the last step of
mercapturic acid formation, the acetylation of S-substituted cysteine,
takes place in vivo et situ. Methods: We microinfused 50 pmol/min
('4C]S-benzyl-L-cysteine into early proximal, late proximal and early
distal superficial tubules for 20 minutes. In the final urine, which was
collected in fractions, we determined S-benzyl-L-cysteine (BC) and its
mercapturic acid N-acetyl-S-benzyl-L-cysteine (AcBC) by HPLC and
scintillation spectrometry. In additional experiments, proximal convo-
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luted tubules were microperfused with 100 pmol/min S-benzyl-L-
cysteine. Results (± SEM): S-benzyl-L-cysteine microinfused into early
proximal tubules was reabsorbed completely: BC was not detected in
the urine and 16.3 1.8% (N = 11) of the infused radioactivity was
found as AcBC. Microperfused BC was almost completely reabsorbed
in the proximal convolution. During late proximal microinfusion, urine
contained 13.0 2.3% (N = 6) of the infused radioactivity in the form
of BC and 28.1 2.3% (N = 12) in the form of AcBC. BC microinfused
into early distal tubules was found unchanged at 90.3 2.1% (N = 4) in
the urine. AcBC could not be detected there. Conclusions: S-benzyl-
L-cysteine is reabsorbed, acetylated, and secreted as mercapturic acid
into the tubular lumen by the whole proximal tubule, but not by the
distal tubule. The rate of acetylation and/or secretion in the straight
part of the proximal tubule is almost twice as high as in the convoluted
part. (Supported by the "Wilhelm-Sander-Stiftung")
Role of potassium in proximal renal tubular cell volume regulation. M.
Joannidis, H. Vôlkl, W. Pfaller, and F. Lang, University of A 6010
Innsbruck, Austria. Like cells from a variety of tissues, proximal renal
tubular cells regulate their volume in an isotonic media. Following
sudden exposure to hypotonic extracellular fluid the initial cell swelling
is followed by cell volume regulatory decrease (RVD). The present
study has been performed to test for the role of potassium in RVD. In
a first series of experiments cell volume of isolated perfused tubules of
the mouse kidney was determined by serial microphotographs. Re-
placement of 40 mmol/liter NaCI by 80 mmol/liter mannitol in the bath
was without appreciable effect on cell volume. Reduction of bath
osmolarity by subsequent removal of mannitol lead within 30 seconds to
cell swelling followed by almost complete RVD within 2 minutes.
Increase of bath potassium concentration to 40 mmol/liter (replacing
NaCI) or addition of potassium channel blocker barium (1 mmol/liter)
depolarized the cell membrane below —35 mV and swelled the cells.
Both maneuvers delayed but did not abolish RVD. In a second series of
experiments potassium activity was continuously traced in the venous
effluent of isolated perfused kidneys (Ke). Replacement of 25
mmol/liter NaCI with 50 mmol/liter mannitol in the perfusate did not
appreciably alter Ke. Reduction of perfusate osmolarity by subsequent
removal of mannitol lead to a marked, transient increase of Ke, pointing
to release of cellular potassium. The increase of Ke was completely
abolished by I mmol/liter barium. The present observations indicate
that RVD is accomplished in part by release of cellular potassium via
barium-sensitive potassium channels and that RVD may involve some
additional mechanisms not requiring release of cellular potassium.
Potassium channels in isolated perfused cortical collecting ducts (CCT)
of the rat. E. Schlatter, M. Bleich, and R. Greger, Physiologisches
Institut, Albert-Ludwigs-Universitat, D-7800 Freiburg, Federal Repub-
lic of Germany. Single K4-channels of isolated perfused CCT of the rat
were studied with the patch clamp technique. Tubules were obtained
from rats pretreated with desoxycorticosterone for 3 to 7 days to
stimulate electrolyte transport. Patch pipettes were inserted into the
tubule lumen from the open end and gigaohmseals were obtained at the
luminal membrane. K4-channels were found in the cell attached and
excised configuration. The single channel conductance of this K4-
channel was around 150 pS in both configurations. In excised patches
the K4-channel was inhibited by Ba and lidocaine (I mmol/liter),
quinine and quinidine (0.1 mmol/liter), and the Ca24 antagonists
verapamil and diltiazem (1 mol/liter). TEA (20 mmol/liter) from the
extracellular side also inhibited the channel. This K4 channel was only
poorly conducting Rb4, Cs4, and NH44 (145 mmol/liter); however, the
K4 current was inhibited by these ions. The channel was highly
selective for K4 over Na4 and Li4. Cytosolic AlP (1—3 mmol/liter)
lowered the probability for the channel being open. Decreasing the
cytosolic Ca24 concentration below I mol/liter reduced the open
probability. The K4 channel was insensitive to cytosolic acidification.
This K4 channel probably represents the luminal K4 conductance
responsible for K4 secretion via the principal cells of the CCT.
Mechanisms of AlP and bradykinin induced activation of potassium
channels. E. WO!l, J. Pfeilschfler, M. Paulmichl, A. Jungwirth, F.
Lang, Department of Physiology, University of Innsbruck, Austria and
Ciba Geigy Ltd., Research Department, Base!, Switzerland. Bradyki-
nm (100 nmol/liter) and nucleotides such as adenosine triphosphate
(ATP, 10 mol/liter) hyperpolarize cultured Madin-Darby canine kid-
ney (MDCK-) cells, epithelial cells from dog kidney with properties of
distal nephron cells. The hyperpolarization is the result of enhanced
potassium conductance. The present study was performed to elucidate
the mechanisms of cellular transmission. To this end, we determined
the effect of the hormones on intracellular calcium activity (Ca1, as
evident from fura2 fluorescence), on the potential difference across the
cell membrane and on formation of 1,4,5 inositol triphosphate (1P3). To
elucidate involvement of proteinkinase C and 0 proteins, experiments
have been performed in cells pretreated with either pertussis toxin (PT)
or phorbolester (TPA). In cells without pretreatment ATP lead to
sustained, bradykinin to transient increase of Ca, and hyperpolarization
of the cell membrane. In the nominal absence of extracellular calcium
both hormones lead to transient increase of Ca1 and hyperpolarization.
Both hormones stimulated 1P3 formation in cells without but not with
pretreatment with either PT or TPA. The hyperpolarizing effect of the
hormones was not significantly impaired by pretreatment with PT or
TPA. In cells pretreated with PT, bradykinin still lead to a transient
increase of Ca in the presence and absence of extracellular calcium. In
cells pretreated with TPA the effect of bradykinin on Ca1 was abolished,
but bradykinin still lead to a hyperpolarization in the presence and
absence of extracellular calcium. The observations indicate that ATP
and bradykinin activate, via pertussis toxin sensitive G proteins,
phospholipase C and subsequently release calcium from intracellular
stores. The activation of phospholipase C is sensitive to pretreatment
with TPA. In addition, the hormones increase Ca, by 1P3 independent
recruitment of intracellular calcium. Furthermore, bradykinin hyperpo-
larizes the cell membrane even without an increase of Ca1.
Single channel recordings from the isolated perfused thick ascending
limb (TAL) of rat kidney. M. Bleich, E. Sch!atter, and R. Greger,
Physio!ogisches Institut der Albert Ludwigs Universitdt Freiburg,
Hermann Herder StraJie 7, D-7800 Freiburg, Federal Republic of
Germany. Thick ascending limbs (N = 260) from rat kidneys were
isolated, perfused in vitro and immobilized. In some 465 records from
the luminal and basolateral membrane 96 channels were found. Fifty-
two patches from the luminal membrane contained K channels but no
C1 channels in cell attached and excised mode. The conductance in
excised patches was 72 4 p5 (N = 38). The open probability was
reduced by (all in mol/liter): Ba44 >iO, quinine and quinidine >l0—,
lidocaine > l0, verapamil >106, diltiazem > l0, extracellular TEA
>l02, cytosolic Ca44 >l06, ATP> l0 and acidification by 0.1 to
0.2 units. The channel was highly selective for K4 over Na4 and Li4.
Rb4, Cs4, NH44, and choline4 were all poorly conducted and inhibited
the K4 current. Thirty-four patches from the basolateral membrane
contained only Cl channels in the cell attached and excised configura-
tion with a conductance of 40 3 p5 (N = 30, in excised patches).
These channels were inhibited by 5-nitro-2-(3-phenylpropylamino)-
benzoic acid (NPPB > l0 mol/liter) and insensitive to cytosolic pH
changes. The described K channel is probably responsible for the
luminal K4 recycling and the Cl channel for the conductive basolateral
Cl exit in TAL cells. Supported by DFG Or 480/9.
Eicosanoids may regulate potassium conductance in proximal renal
tubules. F. Lang, W. Rehwald, University of A 6010 Innsbruck, Austria.
Potassium conductance (Ok) in proximal renal tubules maintains the
potential difference across the cell membranes and thus is the driving
force for electrogenic transport processes. Stimulation of sodium-
coupled transport processes depolarizes the cell membrane. Due to its
inwardly rectifying property, Ok is decreased by this depolarization.
However, sustained stimulation of sodium coupled transport leads to a
delayed increase of Gk and repolanzation. The cellular mechanisms
triggering this delayed increase of Ok are not known. The present study
was performed to test for an involvement of eicosanoids. To this end
the potential difference across the basolateral cell membrane (Vm), the
potassium selectivity of the basolateral cell membrane (tk), and the
lumped resistance of the two cell membranes (Rm) have been deter-
mined using microelectrodes, step changes of peritubular potassium
concentration and cellular cable analysis. The effect of stimulated
sodium coupled transport was tested by sudden addition of 10
mmol/liter phenylalanine (Phe) to luminal perfusate. Mepacrine (100
mol/liter), an inhibitor of phospholipase A2, depolarized the cell
membranes, increased Rm, and virtually abolished the delayed repo-
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larization upon Phe. Nordihydroguaiaretic acid (50 zmol/liter), a ii-
poxygenase inhibitor, had no significant influence on Vm and Rm in the
absence of Phe, but reduced Rm and accelerated the delayed repolar-
ization upon Phe. Indomethacin (10 mol/liter), a cycloxygenase
inhibitor, in freshly perfused kidneys, had no effect on Vm or Rm in
presence or absence of Phe. Arachidonic acid (100 mol/liter) added
together with nordihydroguaiaretic acid and indomethacin hyperpolar-
ized the cell membrane, increased tk and decreased the depolarizing
effect of Phe. The observations suggest that arachidonic acid stimulates
Gk in proximal renal tubules.
How is alanine handled by Henle's loops of rats? S. Silbernagl and
W.H. Dantzler (techn. ass.: K. VOlker), Departments of Physiology,
University of Wurzburg, FRG; University of Arizona, Tucson, USA.
Some 3% of filtered alanine (Ala) is recovered from the end of
superficial rat proximal convolutions (LPT), but only 0.1 to 0.3% are
found in the final urine. As ['4C]-L-Ala microinjected into superficial
early distal tubules (EDT) was recovered completely from the final
urine, Ala resorption in Henle's loop has been postulated. However, no
net resorption between LPT and EDT of superficial nephrons has been
found. Thus, deeper nephrons must handle Ala differently. In this in
vivo study, we (1) microperfused ['4C]-L- and -D-Ala-containing solu-
tions (+[3H]-inulin) through short loops of Henle (20 nI/mm), or
microinfused them (2) into the tips of Henle's loops of juxtamedullary
nephrons or (3) into ascending Vasa recta (10 nI/mm). '4C activity was
measured in EDT fluid samples (exp. 1) or in the papillary urine (exps.
2 and 3), and related to the respective 3H activity. Results: (I) Short
loops: At an initial ['4C]-Ala concentration (= [Ala]0) of 0.6 msi,
was resorbed to 97.3% 0.9 (sEM; N = 6) in case of L-Ala and to 86%
3 (N = 17) in case of D-Ala. At [Ala]0 = 50 m, resorption of '4C was
33% 3 (N = 8) in the case of L-Ala, and 77% 4 (N = 15) in that of
D-Ala. If the D-amino acid oxidase (DAAO) inhibitors benzoate and
indole-2-carboxylic acid (5 m each) were added to the perfusate
([Ala]0 = 50 mM), resorption of D-Ala dropped to 48% 8 (N = 8) but
that of L-Ala was unchanged. (2) Distally to the tip of long loops, 31%
5 (N = 7) of ['4C]-L-Ala and 26% 4 (N = 7) of [14C]-D-Ala were
resorbed ([Ala]0 = 2.3 and 10 mrvt, resp.), whereas ['4C]-mannitol (8
mM) was recovered to 100% 7 (N = 10). (3) The '4C activity of Ala
microinfused into ascending Vasa recta was recovered from the papil-
lary urine to 73% 6 (N = 12) in the case of L-Ala and to 51% 8 (N
= 6) in that of D-Ala. Only 1.5% of the radiolabel of L- or D-Ala infused
into the systemic circulation was recovered from the final urine.
Conclusions: (a) In short loops, resorption of ['4C]-L-Ala >> net
resorption of endogenous L-Ala, that is, bidirectional transport takes
place. (b) In short loops, fractional resorption of ['4C]-D-Ala is smaller
at 0.6 m but higher at 50 m than that of ['4C]-L-Ala. As the latter
difference disappears if DAAO is inhibited, DAAO (mainly found in the
pars recta) is accessible for luminal D-Ala and provides a metabolic sink
for D-Ala. (c) Bidirectional transport of the radiolabel of L-Ala exists
between the Vasa recta and the lumen of Henle's loops. Supported by
NATO grant 0104/88.
MDCK-cells as model of intercalated cells of the cortical collecting duct:
HC03 and K channels. W. Steigner, H.-J. Westphale, U. Kersting,
and H. Oberleithner, Department of Physiology, University of
Wurzburg, FederalRepublic of Germany. The cultured MDCK cell line
originally derived from dog kidney resembles properties of intercalated
cells of the cortical collecting duct. The cells are involved in acid-base
transport and can regulate their volume during hypotonic stress by
concomitant net efflux of K and HC03. To test for the presence of
K and HC03 channels, the patch clamp technique was applied in
fused MDCK cells. Due to the special ion composition of bath medium
(146 ms K gluconate, 10 mrvi KHCO3, 5% C02, pH 8.2) and of the
pipette solution (156 msi KHCO3, 5% CO2. pH 7.0) two types of
channels could be detected in the cell attached mode: i) one channel
with a high conductivity of 46 pS, with mean open and closed times of
7 and 0.3 ms, respectively, with an open probability of 0.8 and a
reversal potential near zero; ii) another channel with a low conductivity
of 6 PS, with mean open and closed times of 11 and 25 ms, respectively,
with an open probability of 0.1 and a reversal potential near —70 mV.
Additionally, experiments done in the excised mode (i/o) and with
symmetrical HC03 concentrations in the bath and the pipette also
disclose a low conductance channel. The permeability ratio of HC01
over Cl is estimated to be 6. The experiments suggest K and
HC03 channels in the plasma membrane of MDCK cells, which can
participate in volume and acid-base homeostasis.
Differentiation of MDCK cells: structure-function relationship using
lectin binding. U. Kersting, W. Pfaller, G. Gsraunthaler, W. Steigner,
H. Oberleithner, Departments of Physiology, University Wurzburg,
Federal Republic of Germany and University !nnsbruck, Austria.
MDCK cells originally derived from dog kidney resemble properties of
renal collecting duct cells: principal cells are responsible for sodium
resorption and potassium secretion; intercalated cells secrete acid
(A-cell) or bicarbonate (B-cell) and are rich in carbonic anhydrase. We
addressed the question whether principal cells and the two types of
intercalated cells are separate cell types or manifestations of the same
epithelial cell. From the literature it is known that peanut lectin (PNA)
binds to glycoproteins in the apical membrane of B-cells. Therefore, for
fluorescent microscopy, MDCK layers were treated with FITC-labeled
peanut lectin. Carbonic anhydrase activity was measured histochemi-
cally. pH was measured in dome fluid with ion-selective microelec-
trodes. PNA binding pattern of a confluent monolayer 3 days after
plating in % of total surface was as follows: control, (pH 7.4): PNA 94
1.9, PNA 6 0.9; acidosis, (pH 6.4): PNA 74 2, PNA 26 4.1;
alkalosis, (pH 7.7): PNA 98 1.8, PNA 1.8 1.4. PNA cells were
polymorphic, flat and possessed a light cytoplasm with large vesicles.
PNA cells were small, high and possessed a dark cytoplasm with small
vesicles. PNA cells resembled B-cells. During aging of the confluent
MDCK monolayer the number of PNA cells increased and the number
of PNA cells decreased. PNA cells resembled A-cells and principal
cells. In monolayers incubated in aldosterone supplemented medium
(l0- mol/liter aldosterone for 24 hr) dome formation was enhanced
four times to 436 43 domes/cm2. Aldosterone treatment decreased
dome pH from 7.3 0.04 to 7.15 0.04 in C02/HCO3 medium.
Carbonic anhydrase activity and PNA binding capacity was enhanced
in the MDCK epithelium after incubation in aldosterone supplemented
medium. We conclude: MDCK cells differentiate to intercalated cells
(B-type) dependent on the age of the MDCK monolayer. Alkaline
medium as well as aldosterone accelerate cell differentiation whereas
differentiation is retarded in acidosis. The PNA binding glycoprotein in
the apical membrane could be involved in transepithelial HC03
transport and salt resorption. Supported by DFG (SFB 176/A6).
Specific isolation of collecting duct cells of rat renal papilla by the use
of magnetic beads coated with the lectin dolichos bifiorus agglutinin
(DBA). CT. Grupp, J. Steffgen, D. Cohen, S. Langhans, H.E. Franz,
Sektion Nephrologie, Universitãt Ulm, D-7900 U/rn, Federal Republic
of Germany. Certain lectins exhibit a specific staining pattern in the
kidney. In renal papilla of the rat the lectin dolichos biflorus agglutinin
(DBA) binds exclusively to the papillary collecting duct (PCD) cells
(Am J Physiol 253:F251—F262, 1987). An isolation procedure of PCD-
cells by the use of magnetic beads coated with DBA is described here.
Because the direct binding of the lectin to the beads was insufficient, the
coupling of DBA to the beads was performed via the avidin-biotin
system. Tosyl-activated beads (l08/ml, Dynal Ltd., Norway) were
incubated with Avidin DX (106M) for about 12 hours with tosyl-
activated beads (108/ml, Dynal Ltd.), After washing of the avidin-
coated beads, biotinylated DBA (l06M) was added for 2 hours and
unbound lectin removed by further washing. Blocking with albumin was
not necessary. Cell suspensions of rat papilla, consisting of about 53
2% PCD-cells (identified by staining with FITC-labeled DBA), were
incubated up to 30 mm with DBA-beads (about 30/cell). Isolation of the
bead-loaded cells in a magnetic field resulted in a fraction containing
more than 98% PCD-cells. More than 80% of the cells were recovered.
By addition of the sugar N-acetyl-galactosamine (50 mM), which binds
specifically to DBA, beads could be completely removed in 70 7% of
the cells within one hour. It was possible to cultivate cells isolated by
this method. This technique represents a highly specific, rapid and
preserving procedure for the isolation of one cell type from a heterog-
enous cell population.
Influence of extracellular osmolality on the ion concentration and cell
volume of isolated rat renal inner medullary collecting duct (IMCD) cells.
f.M. Grunewald, R.W. Grunewald, and R.K.H. Kinne, Max-Planck-
Institut fur Systernphysiologie, D-4600 Dortmund, and Sektion Neph-
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rologie, Innere Medizin I, Universitäts-klinik, D-7900 Ulm, Federal
Republic of Germany. In the inner medulla in vivo collecting duct cells
are exposed to rapid and extense changes in extracellular osmolality.
The alterations of intracellular ion content and cell volume under such
conditions are poorly understood. Therefore we studied these parame-
ters on isolated rat IMCD cells in vitro by electron probe microanalysis
and determination of intracellular water by a centrifugation method
using tritiated water and '4C-sucrose. Cells isolated in a 600 mOsm/liter
modified Krebs-Ringer's solution maintained a cell volume of 10.2 2.5
s.d/mg protein (N = 6; mean SD), and intracellular ion concentrations
(X1) of Na 44 15 mM, Cl 93 4 mt,i, and K 144 9 mM (N = 4).
During subsequent incubation in a 300 mOsm/liter buffer (NaCI de-
creased from 270 to 120 mM) cells showed initial swelling (increase of
cell water by 65 15% after 40 seconds), but after 5 mm cell volume
was restored to 24 11% (N = 6) above the initial value. At this time
a decrease in Na1 (15 6 mM) and Cl1 (56 5 mM) was observed,
whereas K1 remained nearly unchanged (N = 6). This regulatory
volume decrease (RVD) was completely inhibited by 1 mt SITS. When
exposed to a 900 mOsm/liter buffer cell volume decreased in the first 5
mm by 33 11% (N = 6) and remained constant for at least one hour,
whereas Na1 increased to 88 22 m and Cl1 to 155 35 mri, K1,
however, remained constant at 152 m. These results show, that
there is a rapid volume regulatory decrease (VRD) under hypoosmotic
conditions, mainly caused by Na and Cl fluxes and probably mediated
by an anion exchanger. In hyperosmotic medium decrease in cell
volume but no regulatory volume increase (RVI) occurred, causing an
increase in Na and Cl concentrations. Interestingly over a wide range of
osmolality K concentration is regulated to remain constant.
Choline transport in isolated rat inner medullary collecting duct
(IMCD) cells. C. Bevan and R.K.H. Kinne, Max-Planck-Institut für
Systemphysiologie, Dortmund, Federal Republic of Germany. Organic
osmolytes, such as glycerophosphorylcholine (GPC), play an important
role in the osmoregulation of cells from the renal inner medulla. Since
organic osmolytes are not transported into LMCD cells, they must be
synthesized from intracellular metabolic pathways. We have studied
choline transport, a precursor of GPC, into isolated rat IMCD cells
using a rapid centrifugation technique. Choline uptake was linear for up
to 10 mm, and the initial rate after 1 mm was inhibited 90% by excess
choline in the incubation medium. The apparent Kmand max for
choline uptake was 80 tM and 120 pmol/.d cell water/mm (approx. 1.4
nmol/mg protein), respectively. Uptake was inhibited, in decreasing
order of potency by: N,N-dimethylethanolamine, ethanolamine, tetra-
ethylammonium Cl, and trimethylammonium Cl. Ethanolamine com-
petitively inhibited choline uptake with a K, of approx. 0.7 mM.
Hemicholinium-3 and thiamine were also potent inhibitors of choline
uptake, but betaine (substitution of the CH2-OH for COOH) had no
effect. Choline transport was unaffected by a sodium gradient, but was
affected by changes in the membrane potential. Preincubation of the
cells with metabolic inhibitors such as iodoacetate and rotenone did not
affect choline uptake. These results indicate that choline uptake into
IMCD cells occurs via a specific Na-independent transport system
similar to what has been reported in other epithelial cells.
Osmotic regulation of intracellular glycerophosphorylcholine (GPC)
and inositol in isolated inner medullary collecting duct cells (IMCD) of
rats. H.G. Bauernschmitt, R.W. Grunewald and R.K.H. Kinne, Max-
Planck-!nstitut für Systemphysiologie, Dortmund and Sektion Nephrol-
ogie, Abt. Innere Med. 1, Universitätsklinik, Ulm, Federal Republic of
Germany. IMCD cells withstand a wide range of urine osmolarities.
Organic osmolytes are at least partly involved in adaptation to these
different conditions. For functional characterization of the organic
osmolytes GPC and inositol, cells were incubated at different osmolar-
ities (adjusted with NaCI) after isolation at 600 mOsm. Intra- and
extracellular GPC and inositol contents were determined enzymati-
cally. After 3 hr of incubation at 300 mOsm, 47 4% of total GPC and
78 14% of total inositol were found in the extracellular medium; at 600
mOsm, the values were 19 7% (GPC) and 55 5% (inositol), and at
900 mOsm, 9 6% (GPC) and 51 11% (inositol). This corresponds to
an osmotically regulated release of 114 smol/g protein for GPC and 59
mol/g protein for inositol (difference 300/900 mOsm). With mannitol
instead of NaC1, the same results were obtained. When urea was used,
no difference in release of the osmolytes depending on the osmolarity
could be detected. When the medium osmolarity was decreased step-
wise (50 mOsm/30 mm), there was a corresponding increase in the
release of GPC and inositol. For GPC this release was significant at a
decrease from 600 to 450 mOsm corresponding to a of 150 mOsm. The
threshold value for inositol corresponded to a of 250 mOsm. These
results indicate that short-term osmoregulation of the intracellular
content of GPC and inositol occurs by selective changes in membrane
permeability, The release of inositol occurs to a lesser extent and at a
higher threshold value than the release of GPC, suggesting different
functions of GPC and inositol in the osmoregulation of IMCD cells.
Oxygen-dependent erythropoietin formation by the isolated perfused
rat kidney. H. Scholz, H.J. Schurek, A. Kurtz, K. U. Eckardt, and C.
Bauer, Physiologisches Institut der Universitat, C'H-8057 Zurich, Swit-
zerland. Erythropoietin (EPO) is produced by the kidneys in an oxygen
dependent fashion. However, it is still a matter of controversy whether
the "oxygen sensor" that controls renal EPO formation is located in the
kidney itself or extrarenally. It was our aim to develop a physiologically
useful in vitro model for studies on the regulation of EPO synthesis:
Isolated rat kidneys were perfused in a recirculating system at constant
pressure of 100 mm Hg. The perfusion medium which was regenerated
by continuous dialysis consisted of a physiologic saline containing 2
g/dl bovine serum albumin and a 10% fraction of human erythrocytes.
EPO was determined by radioimmunoassay. Mean EPO production
rates were inversely related to the P°2 values in the perfusate ranging
from 0.17 U/hr x g (mean 5EM) at arterial P°2 of 500 mm Hg to 1.8
U/hr x g at 30 mm Hg. To test the possibility that hypoxia induced
EPO formation is mediated by the enhanced intracellular release of
second messengers we examined the effect of forskolin (10 SM),
8-bromo-cGMP (100 tM) and calmidazolium (1 SM). Whereas all of
those drugs failed to stimulate EPO formation at P°2 values of 500 mm
Hg, calmidazolium (1 M) regularly prevented hypoxia induced in-
crease of EPO release (p02 120 mm Hg). From our data we conclude:
I. The oxygen sensor that regulates EPO formation is located in-
trarenally. 2. A calcium/calmodulin dependent mechanism is possibly
involved in the cellular signal transduction.
Morphologic alterations In the renal cortex of rats with anti-erythro-
poietin (EPO)-autoantibodies. K.-U. Eckardt, B. Kaissling, M. Le Hir,
R. Neumann, A. Kurtz, Department of Physiology, University of
Zurich, Switzerland, Department of Anatomy and Department of
Internal Medicine, University of Basel, Switzerland. EPO mRNA was
recently detected by in situ hybridization in peritubular cells of renal
cortex and outer medulla. Yet the cellular identity of these cells is still
under debate. To obtain further information on the intrarenal site of
EPO formation, kidneys of 4 rats (Sprague-Dawley) that had been
immunized against recombinant human EPO (2 X 60,000-100,000 IU
rhEPO/kg body wt) were investigated for morphological alterations and
immune deposits. Immunization resulted in variable titers of anti-
human EPO antibodies, that were in part cross reactive with rat EPO.
Depending on the titer of antibodies crossreactive with endogenous rat
EPO, animals developed different degrees of anemia (hct 48, 28, 18, and
16%). Comparison of renal morphology in the two severely anemic
animals with that in the less anemic or non anemic animal showed no
differences in glomeruli, tubuli or endothelial cells. However, in se-
verely anemic animals cortical interstitial fibroblasts showed marked
hypertrophy and an increase in their 5'-ecto-nucleotidase activity. At
the same time extensive IgG deposits were found in the peritubular
space of the cortex, while other regions of the kidney or other organs
showed no immune deposits. The findings confirm the role of the renal
cortical peritubular space as production site for EPO and suggest that
interstitial cortical fibroblasts may be candidates for EPO production.
Anemia increases 5'-nucleotidase (5'-NU) in renal cortical fibroblasts.
M. Le Hir, K.-U. Eckardi, B. Kaissling, Department of Innere Medizin,
Kantospital, CH-4031 Basel, Physiologisches Institut der Universität,
CH-8057 Zurich, Anatomisches Inst itut der Universität, CH-4056
Base!, Switzerland. In the kidney 5'-Nu has been found in the luminal
membrane of tubules and in fibroblasts. It converts 5'-AMP to adeno-
sine, which plays a role in the regulation of renal hemodynamics, of
glomerular filtration rate and of the secretion of renin and of erythro-
poeitin. The production of adenosine is stimulated in periods of
hypoxia, during which concentrations of ATP decrease and those of
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5'-AMP increase. A chronic rise of 5-AMP might provoke an adaptive
increase of 5-Nu. Thus, the sites in the kidney at which the catabolism
of adenine nucleotides, and consequently the production of adenosine,
increase during a chronically lowered oxygen supply might be revealed
by an histochemical study of 5-Nu. In the present study the oxygen
supply was reduced by severe anemia induced by a combined treatment
of the rats with 40 mg/kg phenyihydrazine and a 500-Rad irradiation
(group 1). The hematocnt was less than 10% after 7 days. Irradiation
alone (group 2) or phenylhydrazine alone (group 3) provoked only a
slight decrease of hematocrit. Erythropoietin levels in plasma were
strongly elevated in group 1 (>200-fold) and only moderately elevated
in groups 2 and 3 (2.7-fold and 4.3-fold) compared to untreated rats,
demonstrating that an oxygen deficiency due to anemia has been sensed
by the renal cortex in group I. The distribution of 5'-Nu was studied by
enzyme histochemistry and by immunohistochemistry. 5'-Nu in the
fibroblasts of the cortical labyrinth was markedly enhanced in group I
as compared to the groups 2 and 3. There was no visible effect of anemia
in fibroblasts in other regions of the kidney or in tubular cells. The
increase of 5'-Nu might be due to elevated concentrations of its
substrate 5'-AMP as a consequence of decreased levels of ATP. Such
an explanation is supported by experiments in vitro in which daily
addition of 160 M 5'-AMP for 8 days to renal fibroblasts in culture
provoked a 55% increase of 5'-Nu. These observations suggest that a
decrease of oxygen delivery affects the metabolism of nucleotides in the
cortical labyrinth.
Measurement of renm secretion in isolated perfused rabbit glomeruli.
H.A. Bock, M. Hermie, F.P. Brunner, G. Thie!, Division of Nephrol-
ogy, Kantonsspital Basel, Switzerland. We present a technique which
allows to measure the renin secretion rate of a single glomerulus during
in vitro perfusion through the afferent arteriole. Rabbit glomeruli with
intact Bowman's capsule and afferent arteriole are obtained by micro-
dissection. The afferent arteriole is cannulated with concentric micropi-
pets and perfused with an electrolyte solution (+ 3.4% albumin); pres-
sure in the afferent arteriolar lumen (Paff) can be measured and set to the
desired level at any time. Fluid in the perfusion chamber is assayed for
renin using a micro-RIA. In 10 initial experiments, renin secretion rate
was measured both absolute (RSR) and relative to total renin content
(RSR%) at 40 mm Hg aff After three 15 mm control collection periods,
isoproterenol iO M was added to the perfusion chamber in the 4th
period, and norepinephrine i0 M in the 5th. (x SEM, ap < 0.05 vs.
controls):
Contr.
1
Contr
2
. Contr.
3 Isoprot Noradr
RSR 18±6 12± 3 15 43÷9a 27±6
pgAI/hr2
RSR% 1.9 1 1.4 1 1.7 1 4.7 ia 2.2 1
%/hr
All 10 afferent arterioles contracted to norepinephrine. In a further
series, aff was systematically decreased (55->40->25 mm Hg; N = 4)
or increased (25->40->55 mm Hg; N = 3) in 30 mm intervals. This was
associated with opposite changes in RSR: On average, RSR was 6 times
(±3, P <0.05) higher at 'aff25 mm Hg than at 55 mm Hg. Conclusions:
1. The system is characterized by low renin secretion rates relative to
renin content, intact contractility and responsiveness to a- and /3-
adrenergic stimuli, all of which are criteria of tissue viability. 2. The
preliminary data are consistent with the existence of a "renin-barocep-
tor" mechanism. 3. The system could prove useful to directly study the
regulation of renin secretion at the level of the afferent arteriole.
Mechanisms of a.adrenergic hyperpolarization in cultured renal epi-
theloid cells. F. Friedrich, M. Paulmichl, J. Pfeilsch,fter, E. WOll, H.
Weiss, W. Schobersberger, F. Lang, Department of Physiology, Uni-
versity of Innsbruck, Austria, Ciba Geigy Ltd., Research Department,
Base!, Switzerland. Epinephrine (EN) hyperpolarizes the cell mem-
brane of Madin-Darby canine kidney cells (MDCK-cells), a permanent
cell line displaying properties of distal nephron segments. This hyper-
polarization is mediated by a-adrenergic receptors and is due to an
increase of cell membrane potassium conductance. The present study
was performed to elucidate the cellular mechanisms of EN induced
hyperpolarization. The involvement of protein kinase C and G-proteins
were tested for by pretreatment of cells with pertussis toxin (PT) or
phorbolester (TPA), respectively. EN lead to an increase of intracellu-
lar calcium activity (Ca), which was partially transient in the presence
and fully transient in the absence of extracellular calcium (Cae). EN
activated inwardly-rectifying potassium channels (single channel slope
conductance of some 80 pS). The same channels were activated in
inside-out patches by increase of Ca,. The EN induced activation of
potassium channels and hyperpolanzation were sustained in the pres-
ence and only transient in the nominal absence of Cae. EN stimulated
the formation of 1,4,5 inositol triphosphate (1P3) in cells with and
without pretreatment with PT, but not in cells pretreated with TPA. In
cells pretreated with TPA the effect of EN on Ca was completely
abolished, but EN still lead to a transient hyperpolarization of the cell
membrane. In conclusion, EN releases—via 1P3—calcium from intrac-
ellular stores. The activation of phospholipase C does not require
PT-sensitive G-proteins but is probably inhibited by activation of
protein kinase C. In addition EN is able to hyperpolarize the cell
membrane without increase of Ca.
Physiological role of renal kallikrein. M. Marin-Grez and P. Odigie,
Department of Physiology, University of Munich, Federal Republic of
Germany. The physiological role of renal kallikrein (K) has remained
unknown for more than half a century after its discovery. To clarify the
regulation of kallikrein release and the physiological role of this enzyme
we investigated changes of renal kallikrein activity (RK) and of urinary
kallikrein excretion rate (UK) in rats by means of metabolic, clearance
and in vitro experiments. Desoxycorticosterone (15 mg/kg day) in-
creased UK without affecting RK. Trichlormethiazide (0.25 mg/kg
mm), a blocker of connecting tubule cell NaCI cotransport, reversibly
reduced UK. Inhibition of distal NaCI reabsorption by acute expansion
of the extracellular space also lowered UK. Thus, kallikrein secretion
into the tubular fluid depends on NaCI reabsorption. Kallikrein release
from rat kidney slices was decreased by dihydro-ouabain (10—i M). This
suggests that the parameter that regulates renal kallikrein secretion is
[CI]1. Multivariate analysis showed that in anesthetized normal rats,
the excretion of kallikrein correlates to filtered chloride (r:0.62, P <
0.0007) but not to filtered sodium or potassium. The excretion of these
ions and kallikrein was not correlated. An inverse multiplicative rela-
tionship between kallikrein and bicarbonate excretion (r: —0.72, P <
0.002) was found in anesthetized normal and sodium depleted rats.
These parameters were also correlated in awake animals (r: —0.99, P <
0.0002). To study whether this is a causative relationship, we added
purified kallikrein to the perfusate of isolated perfused rat kidneys. To
that effect kallikrein was purified from rat urine by gel filtration and
affinity chromatography. There was a highly significant inverse relation-
ship between kallikrein and bicarbonate excretion in these isolated
perfused kidneys (r = —0.78, P < 0.00001). We conclude that kallikrein
release, which depends on the rate of sodium chloride reabsorbed by
the connecting tubules cells, is probably regulated by intracellular
chloride concentration, and that the physiological role of this enzyme is
to regulate bicarbonate excretion.
Effect of 1,25(OH)D on renal compensatory growth after uninephrec-
tomy. R. Busch, S. Matthias, J. Merke, G. Mall, E. Ritz, Department of
Internal Medicine and Pathology, University of Heidelberg, Heidel-
berg, Federal Republic of Germany. The antiproliferative action of
l,25(OH)D has been demonstrated in several in vitro systems. In
cultures of renal cell carcinoma, dose dependent diminution of clono-
genicity and proliferation rate was demonstrated by Nagakura (Kidney
mt 29:834, 1986). In the past we demonstrated specific binding of
1 ,25(OH)D in rat kidney which depended on growth phase. It was the
aim of the present study to examine the effect of low-dose (20
pmol/day; s.c.) 1 ,25(OH)D on renal weight, morphometry and mitosis
at various times after uninephrectomy. Male SD rats 130 g body wt, fed
ad libitum, uni-Nx or sham OP. measurements after 2 and 8 days:
kidney dry-weight, mitoses (800 g Demecolcin 8/hr prior to the end of
the experiment). With I ,25(OH)D 5c rose within the normocalcemic
range (2.22 + 0.18 mmol/liter(sD), vs. 2.02 + 0.16; 10 animals/group).
In 1,25(OH)D uni-Nx animals body weight after 2 days (116 + 9.4 vs.
119 + 10.4 g on day 0) was comparable to uni-Nx solvent controls (122
+ 11.3 vs. 121.4 + 9.4 g). Mitoses per mm area were significantly
reduced in cortex on day 2 (197 + 45 vs. 344 + 74), and in proximal and
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distal tubules similar differences on day 8 (118 ÷ 23 vs. 225 + 57). In
parallel on days 2 and 8 kidney dry weight and ratio kidney dry
weight/body wt were significantly reduced. The results document that
I ,25(OH)D has direct or indirect inhibitory effects on renal compensa-
tory growth after uni-Nx.
Characterization of the renal effects of xipamide by clearance and
micropuncture experiments in rats. J. Greven, A. Farjam, Department
ofPharmacology, RWTH Aachen, Wendlingweg, 5100 Aachen, Fed-
eral Republic of Germany. Xipamide is a sulfonamide diuretic which
has certain structural similarities to the thiazide diuretics as well as the
loop diuretics. The diuretic profile of xipamide in man has been
reported to resemble that of the loop diuretics (Knauf and Mutschler,
Eur J Cliii Pharm 26:5 13, 1984). The purpose of the present study was
to clarify the mode and tubular site of action of xipamide by means of
clearance and micropuncture experiments in rats. The peak diuresis
induced by the drug at a maximal effective dose (20 mg/kg i.v.) was
found to be comparable to that observed with classical thiazide diuret-
ics. The drug did not affect GFR and renal plasma flow. Microperfusion
experiments on single loops of Henle in vivo failed to show an inhibition
of the 1oops' NaCI transport when the loops were perfused with
xipamide (10—a M) or urine of a xipamide treated rat. Thus, these data
provide no evidence that xipamide or an urinary metabolite of xipamide
affect the loop's function. The results of free flow micropuncture
experiments performed at late proximal, early distal and late distal
tubular sites suggest an action of xipamide in the early distal tubule.
Probenecid, which is known to attenuate the diuretic effect of thiazides
and 1oop diuretics by inhibition of their proximal tubular secretion, did
not affect the diuretic, natriuretic and chloruretic effects of xipamide. A
comparison of the xipamide effects after intravenous and intratubular
application provides indirect evidence that xipamide may reach its site
of action in the early distal tubule from the peritubular cell side.
Localization of the site of diuretic action of a novel calcium antagonist
in the rat nephron by micropuncture experiments. J. Greven and A.
Farfam, Department of Pharmacology, RWTH Aachen, Wendlingweg,
5100 Aachen, Federal Republic of Germany. The I ,4-dihydronaphthy-
ridine derivative Goe 5584 is a novel calcium antagonist with high
affinity for the L-type calcium channels. In contrast to the calcium
antagonists of the 1 ,4-dihydropyndine type (e.g. nifedipine, nitren-
dipine) the drug is soluble in water. Therefore, unspecific solvent
effects, which hampered all previous renal micropuncture studies with
1 ,4-dihydropyridines, could be avoided. Previous studies have estab-
lished that Goe 5584 exerts diuretic and natriuretic effects in rats. The
drug's effects were stereospecific: The effective doses of the (+) isomer
(Goe 6070) were 4Ofold smaller than those of the (—) isomer (Greven
and Farjam, Naunyn-Schmiedebergs Arch Pharm 318:R 87, 1988). The
purpose of the present study was to clarify the site of action of the (+)
isomer in the rat nephron by micropuncture experiments. Whole kidney
glomerular filtration rate, measured during the micropuncture experi-
ments, did not significantly change after the drug (4 jig/kg i.v.),
whereas urine flow and urinary NaCI excretion significantly increased.
Fractional tubular fluid, sodium and chloride reabsorption remained
unchanged in the proximal tubules. In vivo microperfusion experiments
revealed that the drug (10-s M, added to the perfusion fluid) did also not
affect NaCl transport in the loop of Henle. The drug, however,
significantly decreased fractional tubular fluid, sodium and chloride
reabsorption in the distal tubules. The results provide evidence for a
direct action of Goe 6070 on the distal tubular epithelium.
Synthesis of leukotriene B4 in glomeruli from rats with nephrotoxic
serum nephritis. J. Fauler, A. Wiemeyer, and J.C. FrOlich, Department
of Clinical Pharmacology and Department of Nephrology, Hannover
Medical School, Hannover, Federal Republic of Germany. Leuko-
trienes are putative mediators of inflammation. Peptidoleukotrienes are
potent vasoconstrictors and augment vascular permeability. LTB4 is
one of the most potent endogenous chemotactic substances. We there-
fore investigated the synthesis of leukotrienes in rats with nephrotoxic
serum nephritis. Glomeruli were isolated 1, 2, 4, 6, 8, 12, 14, 48 and 72
hours after induction of the disease and subsequently stimulated either
with A23l87 or fMLP (receptor mediated). LTB4 was isolated and
quantitated by RP-HPLC-U V-detection. For unequivocal identification
of LTB4 we used GC-MS. Mass fragments of synthetic LTB4 and LTB4
from stimulated glomeruli were identical in negative ion chemical
ionization mode. Daily urinary albumin excretion increased from a
control of 0.76 mg to 76 mg and 277 mg 24 and 72 hours after
administration of the nephrotoxic serum, respectively. After 72 hours
albuminuria was 277 mg/24 hours. Stimulation of LTB4 synthesis was
maximal after 6 hours of induction of the disease and reached 5.52 or
2.21 ng LTB4/mg protein (N = 6) after stimulation with A23187 or
fMLP, respectively. To determine whether rapid metabolism of LTB4
by glomeruli underestimates LTB4 production, glomeruli were incu-
bated with 3HLTB4. LTB4 was metabolized by less than 5% to the
omega oxidation products 20-OH- and 20-COOH-LTB4 during 60 mm of
incubation. After 6 hours LTB4 was completely metabolized to two new
biologically-inactive dihydro-LTB4 metabolites. Glomeruli from control
rats metabolized LTB4 5 times slower than glomeruli from rats with
serum nephritis. Glomeruli from untreated animals did not synthesize
any leukotrienes after stimulation with A23 187. Our result suggests an
involvement of LTB4 in the initial phase of nephrotoxic serum glomer-
ulonephritis.
Pathogenesis of in situ immune complex glomerulonephritis (ICGN):
Cellular glomerular infiltrates are formed in situ. A. Radounikli, R.A.K.
Stahl, L. Bergmann, W. Schoeppe, F, Thaiss, University of Frankfurt,
Divisions of Nephrology and Hematology, Frankfurt, Federal Republic
of Germany. Glomerular immune deposits are formed in situ. Immuno-
competent Ia positive cells have been localized in the glomerular tuft (J
Cell Biol 94:483, 0000). We examined whether cellular infiltrates after
induction of an ICGN are regulated locally in the glomerulus. Nephritis
was induced in Lewis rats by selective perfusion of the left kidney with
cationized human IgG followed by an intravenous injection of the
antibody. Twenty-four hours and 10 days after induction of ICGN and
in controls glomeruli were isolated. Single cell suspensions were
prepared by digestion of the glomerular tuft with collagenase, trypsin
and DNAse, followed by mechanical disruption. Cells were cytocentri-
fuged and stained with monoclonal antibodies using immunohistochem-
ical techniques. Additionally peripheral blood mononuclear cells were
stained with the same monoclonal antibodies and separated in a
fluorescein-activated cell sorter. The relative pattern of cells in periph-
eral blood after induction of ICGN did not change. The total number of
glomerular cells was significantly increased at 24 hours and slightly
increased 10 days after induction of LCGN. Glomerular single cell
suspensions showed a significant increase in OxI (common leukocyte;
24 hr ÷ 10 days), ED1 (monocytes/macrophages; 24 hr + 10 days), 0x6
(Ia — 10 days), W3/25 (CD4 — 24 hr + 10 days), Ox33 (B cells — 10
days) positive cells after induction of nephritis. We conclude: (1) the
cellular infiltrate in LCGN is regulated locally in the glomerulus; (2)
examination of peripheral mononuclear cells might not reflect local
inflammatory events and cannot be used as a measure of disease
activity.
Thromboxane B2 mediates hemodynamic changes in rats with chronic
experimental glomerulonephritis. F. Thaiss, W. Schoeppe, R.A.K.
Stahl, University of Frankfurt, Division of Nephrology, Frankfurt,
Federal Republic of Germany. We induced a model of chronic glomer-
ulonephritis and evaluated proteinuria, glomerular eicosanoid synthe-
sis, and the role of thromboxane on the regulation of glomerular
hemodynamics. Nephritis was induced by selective perfusion of the left
kidney with cationized human LgG in uninephrectomized rats, followed
by an intravenous injection of the antibody. Rats were fed a protein rich
diet (42% protein) and were followed for eight weeks after induction of
nephritis. Proteinuria, inulin clearance and glomerular thromboxane B2
(TxB2) and prostaglandin E2 (PGE2) were determined at 2, 4 and 8
weeks after induction of nephritis. Additional animals were fed either a
cyclooxygenase inhibitor (indomethacin 5 mg/kg) or a thromboxane
receptor blocker (daltroban 50 mg/kg) during the last three days after an
eight-week observation period. After 8 weeks proteinuria averaged 320
65 mg/day. Inulin clearance in nephritic rats was significantly lower
when compared to non-nephritic controls (425 35 vs. 1027 197
.tl/min/l00 g). Glomerular TxB2 formation was significantly higher
after induction of nephritis when compared to controls, and further
increased from 2 to 8 weeks in nephritic animals. Glomerular PGE2
formation was not different from non-nephritic controls at 2 and 4
weeks; however, PGE2 biosynthesis was significantly stimulated in
nephritic rats at 8 weeks. Indomethacin treatment further reduced (295
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54 d/min/1OO g) and daltroban significantly increased GFR (795 83
l/min/100 g). We conclude: (I) after induction of chronic glomerular
immune injury glomerular TxB2 formation is significantly stimulated;(2) application of a thromboxane receptor blocker increased GFR
significantly; (3) TxB2 might be of significant relevance in the progres-
sion of experimental glomerular immune injury.
Biochemistry of IF-antineutrophil.cytoplasm antibodies (ANCA/
ACPA) in patients with systemic necrotizing vasculitis. J. Koderisch, K.
Andrassy, A. Erb, Departments of Medicine and Pathology, University
of Heidelberg, Heidelberg, Federal Republic of Germany. The diagno-
sis of Wegener's granulomatosis (WG) and related disorders (micro-
scopic polyarteritis (MP), rapid progressive glomerulonephritis (RPGN)
and some forms of overlap-vasculitis was hitherto based on histological
proof of the disease. Introduction of the IF-ANCA test has revolution-
ized this field. The If-patterns, however, differed. Besides the classical,
diffuse fine granular cytoplasmic WG pattern, a focal rosette-like
cytoplasm staining, a perinuclear and a nuclear staining (granulocyte
specific ANA, Gs-ANA) could be seen in MP. To define these patterns
more explicitly an ANCA- and a myeloperoxidase (MPOX)-ELISA was
established. Thirty-one patients with WG and 13 patients with MP were
analyzed. There was a close correlation between the classical pattern in
ANCA-IF and ANCA ELISA (31/31 +) but MPOX were positive
(borderline) in only 1 of 31. Patients with the more rosette-like IF-
staining were positive with ANCA-ELISA (6/6) but 3 of 6 had MPOX
also (low titer). In patients with the IF nuclear staining (Gs-ANA)
MPOX were clearly positive in 7 of 7, whereas ANCA-ELISA remained
negative in all. Since the IF GS-ANA was still present after institution
of therapy, whereas MPOX had become negative, additional antibodies
might be responsible for this peculiar nuclear staining. In conclusion,
various antibodies against neutrophil constituents do exist in patients
with systemic necrotizing vasculitis.
Neutrophil cytoplasm IgA antibodies (ANCA-IgA) in patients with IgA
nephritis (IgAN) Ilenoch-SchOnlein purpura (HSP) and other forms of
glomerulonephritis (GN). A. Erb, K. Andrassy, J. Koderisch, R. Wald-
herr, E. Ritz, Departments of Medicine and Pathology, University of
Heidelberg, Federal Republic of Germany. The diagnosis of IgA
nephropathy is based on the presence of IgA deposits in the kidney. In
the present investigation we tried to answer the question whether a
differentiation is possible between IgAN/HSP and other forms of GN
by means of the ANCA-IgA test. Sixty-three patients were examined:
24 patients with IgAN and S with HSP (group 1), 8 patients with
epimembranous GN (group 2), 8 with focal sclerosis (group 3), and 18
patients with various forms of renal disease (group 4) other than groups
1 to 3. Forty healthy male adults (aged 20 to 40) served as the control
(group 5). Methods: The presence of IgA in neutrophil granulocytes was
investigated by means of direct (dilution of patient serum 1:20) and
indirect (dilution of patient serum from I : I to 1: 16) fluorescence
techniques. The classical ANCA IgG was performed simultaneously.
Results: None of the controls turned positive with ANCA-IgA. With the
direct immunofluorescence test only IgAN and HSP reacted positively
(13 of 24 with IgAN, 2 of 5 with HSP; Table 1). In contrast the indirect
ANCA-IgA test revealed a positive reaction not only in patients with
IgAN and HSP but also in some patients with epimembranous Gn and
focal sclerosis (Table 1).
Pos.
ANCA-
IgA:
Group
1
Group
2
Group
3
Group
4
Group
5
Direct IF 15/29 0/8 0/8 0/18 0/40
(1:20)
Indirect IF 22/29 2/8 4/8 0/18 0/40
(1:4)
Conclusion: A positive ANCA-IgA points to the presence of lgAN. The
direct If-test is more specific but less sensitive than the indirect test.
Therapy of idiopathic membranous glomerulonephritis with nephrotic
syndrome. M. Przechera, E. Mündlein, Anette Weber, P. Heering, G.
Muller, B. Grabensee, P. Schollmeyer, T. Risler, Med Klinik III
Nephrologie 7400 Tubingen, Abt. Nephrologie Med. Klinik 4000 Düs-
seldorf, Med. Klinik IV 7800, Freiberg, Federal Republic of Germany.
In spite of several publications about new treatments of MGN with
nephrotic syndrome there is still no agreement on the best form of
therapy. We therefore observed the history of 28 patients with MGN,
divided into 3 groups, comparing 24 hr proteinuria, serum creatinine
and side effects. Results: Group 1 (8 patients with a natural history;
mean follow-up of 8 years) complete remission: 4; terminal renal failure:
2; persistent proteinuria without nephrotic syndrome and normal serum
creatinine (partial remission): 1; persistent nephrotic syndrome: 1
patient. Group 2: (combination of prednisone/cyclosponne A as De-
Santo; 9 patients over a period of 16 months) complete remission: 1;
partial remission: 2; persistent nephrotic syndrome: 6. Group 3: (com-
bination of prednisone/chlorambucil as Ponticelli, 11 patients over a
period of 35 months) complete remission: 6; partial remission: 2;
persistent nephrotic syndrome: 3. Conclusion: Regarding the high
incidence of spontaneous remissions in MGN, each treatment has to be
evaluated in controlled studies. In our patients we observed a high rate
of relapse in nephrotic syndrome after the end of therapy with cyclos-
porine A. So far best results have been achieved combining steroids and
chlorambucil.
High frequency of relapse after discontinuation of cyclosporine A (CsA)
and prednisolone (PRED) in nephrotic syndrome (NS). G.J. Dobos, H.B.
Steinhauer, J. Bohler, P. Schollmeyer, Department of Nephrology,
University of Freiburg, Freiburg, Federal Republic of Germany. To test
the efficiency of CsA + PRED in NS of different pathogenesis, resistant
to steroids (S) alone (N = 2), or in combination with chlorambucil (CC)
according to Grupe (N EngI J Med 295:745, 1976; N = 5), or to
Ponticelli (N = 2), 9 patients (pts, age 32 16) were treated according
to DeSanto (Am J Nephrol 7:74, 1987). Pts were suffering from
membranous GN (2 >' MGN), focal segmental (2 x FSGS), minimal
change (1 x MChN) and IgA nephritis (1 x IgAN). Initial proteinuria
(PROT) ranged from 4.2 to 14.4 g/day (mean 8.1 3.5). Pts responded
within one week to 6 months to treatment. Three pts (MGN, IgA,
MChN) showed total remission (PROT below 0.6). Two pts (2 x FSGS)
had partial remission with PROT below 2 g and in 3 pts (3 x MGN),
PROT was reduced from 10 4.4 to 6.2 2.6 g/day. The PROT of 6
pts, whose therapy was discontinued after 6 months, reincreased from
3.6 1.5 to 10.6 3.0 g/day (4 x GN, I x FSGS, I x MChN) within
1 to 10 months. Two of them had initially shown complete remission
(MGN, MChN). Conclusion: NS in various types of primary GN
responded even after former failure to therapy with CS and CC.
Discontinuation of therapy resulted in a relapse of NS in all pts within
10 months. Successful treatment of NS with CsA requires long-term
therapy.
Long-term prognosis of measngioproliferative glomerulonephritis in
relation to histological and clinical parameters. A study of 455 immuno-
histologically examined cases. 0. Bogenschutz, M. Wehrmann, C. Batz,
H.V. Gartner, A. Bohle, Institute of Pathology of the University of
Tubingen, Federal Republic of Germany. As shown by our co-workers,
the prognosis of various different types of glomerulonephritis (membra-
noproliferative glomerulonephritis type I, chronic idiopathic membra-
nous glomerulonephritis and focal sclerosing glomerulonephritis) de-
pends on the severity of the accompanying tubulointerstitial changes
but not on the severity of the glomerular lesions. This study was
undertaken to determine the relationship of histological and clinical
parameters to kidney survival rates (KSRs) in mesangioproliferative
glomerulonephritis (mesGN). Four hundred and fifty-five cases were
examined and the following results were obtained: (I) Patients with
immunologically negative mesGN (N = 132) have higher 5 and 10 year
KSRs and thus a much more favorable prognosis than patients with IgA
nephritis (N = 239) or non-IgA nephritis (N = 84). The KSRs of patients
with IgA nephritis and non-IgA nephritis did not differ significantly. (2)
Female patients (N = 150) have a better prognosis than male patients (N
= 304). (3) Patients with minimal proliferating intercapillary glomeru-
lonephritis (MPI GN) (N = 105) or mild mesGN (N = 250) have higher
5 and 10 year KSRs than patients with moderate or severe mesGN (N
= 100). (4) Patients without tubulointerstitial lesions (N = 332) have a
much better prognosis than patients with tubulointerstitial changes such
as interstitial fibrosis, acute renal failure or a combination of both
interstitial fibrosis and acute renal failure. There is a highly significant
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correlation (P < 0.0001) between the severity of the glomerulonephritis
and the severity of tubulointerstitial changes. (5) Patients whose serum
creatinine concentration is 1.2 mg% or less at the time of biopsy (N =
317) have a much more favorable prognosis than patients with higher
serum creatinine concentrations (N = 136). It was shown that the serum
creatinine concentration and the severity of the tubulointerstitial lesions
are strongly correlated (P < 0.0001). (6) Patients with proteinuria of 1.0
g/day or less at the time of biopsy (N = 155) have higher 5 and 10 year
KSRs than patients with more severe proteinuria (N = 300). (7) Patients
with normal blood pressure at the time of biopsy (N = 300) have a much
better prognosis than patients with hypertension (N = 155). (8) Patients
whose first symptom is microscopic or gross hematuria (N = 335) have
a significantly better prognosis than patients without hematuria (N =
95). (9) Taking all histological and clinical parameters into consider-
ation, multivariate analysis shows that the interstitial fibrosis is the
most important histological parameter and the serum creatinine con-
centration at the time of biopsy is the most important clinical parameter
for assessment of the prognosis of patients with mesGN. To sum up the
results of our investigations: Apart from the serum creatinine concen-
tration, which reflects the current state of the disease, the presence or
absence of interstitial fibrosis is the most important parameter available
for assessment of the prognosis. Its presence is a reliable indicator of a
poor prognosis. Thus, it is possible to predict the prognosis for patients
with mesGN from the morphological features noted during histological
examination of the renal biopsy specimen.
Wegener's granulomatosis (WG) with kidney Involvement: Correlation
between initial renal insufficiency, renal histology, duration of therapy
and renal course. K. Andrassy, A. Erb, J. Koderisch, R. Waldherr, E.
Ritz, Departments of Medicine and Pathology, University of Heidel-
berg, Federal Republic of Germany. Up to now there is a lack of
information about the renal course of WG with a large number of
patients. In the following we demonstrate our observations in 25
patients (12 m, 13 f, median age 52 years (range 17 to 70) suffering from
WG and renal involvement (median observation time: 29 months, range
5 to 100). Renal biopsy was performed in 17 of 25 patients (16/17 with
crescentic necrotizing glomerulonephritis (GN), 1/17 mesangial prolif-
erative GN); no renal vasculitis, immune histology negative. All pa-
tients had a positive ANCA-test (median 1:160—320; range 1:20—
1: 1280). Twenty-two of 25 patients were treated according to the
FAUCI-scheme. Renal course: 14 of 25 patients were initially put on
hemodialysis (HD) (group I; median duration 14 days, range 2 to 60), 2
of 14 remained on HD (initial median Scr 9.5 mg/dl (6.2 to 16.8; after 6
month 1.85, after 1 year 1.5, after 3 years 1.85 mg/dl. Eleven of 25
patients not requiring HD (group 2 had a median initial Scr of 3.1 mg/dl
(range 1.3 to 5.2), after 6 months 1.4, after 1 year 1.2, after 3 years 1.5
mg/dl. Upon presentation all patients had hematuria (which disap-
peared I year after initiation of therapy) and moderate proteinuria
which turned into the nephrotic range (3 to 6 months in group 1/group
2) after onset of therapy. Even after 3 years proteinuria persisted in
group 2. Five of 14 patients of group I first had hypertension, 2 in the
further course. Three of 11 of group 2 had a hypertension only at the
beginning. Conclusion: The prognosis of the renal course of WG is by
no means that disadvantageous as it is generally held hitherto, even in
patients requiring HD at presentation.
Hemolytic-uremic syndrome (HUS) and thrombotic thrombocytopenic
purpura (TTP): A comparison of morphological features. V.C. Oliveira,
R. Inniger, A. Bohle, M. Wehrmann, Institute of Pathology, University
of Tubingen, Liebermeisterstrasse 8, 7400 Tubingen, Federal Republic
of Germany. Because there are conflicting accounts in the literature
concerning renal and extrarenal vascular changes in HUS and TTP, we
have undertaken systematic morphological investigations on tissue
obtained at autopsy from 28 cases of HUS and 8 cases of TFP. In 13 of
the cases of HUS we found, in addition to the typical glomerular and
vascular changes of primary malignant nephrosclerosis, scattered intra-
vascular fibrin thrombi (FTh) in the lungs, pancreas, adrenals, myocar-
dium, intestine and pituitary gland. These Fl'h showed no signs of
organization. The other cases of HUS exhibited only renal involvement
represented by primary malignant nephrosclerosis. None of the eight
cases of TTP exhibited the renal lesions of primary malignant nephro-
sclerosis, but multiple FTh, some in the process of organization, were
found in the vessels of the kidneys, lungs, myocardium, pancreas,
adrenals, intestine, liver and brain. Although the clinical features of
HUS and TTP are similar, it is significant that the patients with HUS,
unlike those with TTP, had developed severe hypertension early in the
course of the disease. From these findings it is concluded that HUS and
TTP are not variants of the same disorder, but are two distinct diseases
of different aetiology and pathogenesis, which exhibit different morpho-
logical changes,
Relationship of morphological and clinical parameters to the long-term
prognosis of hemolytic-uremic syndrome. V.C. Oliveira, M. Wehrmann,
R. Inniger, A. Bohle, Institute of Pathology, University of Tubingen,
Liebermeisterstrasse 8, 7400 Tubingen, Federal Republic of Germany.
As has already been demonstrated by our research group, various
morphological changes may appear in the kidney in HUS: primary
malignant nephrosclerosis (PMN), thrombotic microangiopathy (TM)
and the signs of acute renal failure (ARF) without glomerular or
vascular changes. We have performed a retrospective study of 189
cases of HUS to investigate the influence of morphological and clinical
parameters on the prognosis of this condition. The results can be
summarized thus: 1.) In HUS with PMN the renal survival rate (RSR)
is 14% at 5 years and 6% at 10 years. 2.) In HUS with TM the RSR is
47% at 5 years. 3.) In HUS with ARF but no glomerular or vascular
changes, the RSR is 91% at 5 years. 4.) The clinical parameters sex,
platelet count and maximal serum creatinine concentration have no
influence on the prognosis. Although younger patients (under 15 years
at the time of biopsy) appear to have a better prognosis, the difference
is not statistically significant. We conclude that the prognosis of HUS is
significantly affected only by extent of vascular involvement. In other
words, HUS cases with PMN have a significantly poorer prognosis than
those with TM or ARF without glomerular or vascular changes.
New diagnostic aspects by analysis of urinary proteins using a rapid two
dimensional electrophoresis with computed evaluation. A. Lapin, H.
Kopsa, W. Wutzl, J. Hirschmann, F. Gab!, I/Allg.Poliklin. Wien,
2/I.Med. Univ.Klin., 3/Inst.f.Klin.Chem.u.Lab.Diagn.; Univ. Wien,
4/Hirschmann Gerdtebau,Munchen, Federal Republic of Germany.
Non-invasive diagnostic techniques are of increasing interest in
nephrology. The relative composition of urinary proteins depends from
various pathophysiological factors. Thus, the pattern of urinary pro-
teins is highly variable in turn, can be considered as an abundant source
of clinical information. We developed a rapid two dimensional electro-
phoretic technique useful for routine analyses of proteins in urinary
samples. The proteins are separated in a two dimensional pattern of
spots: according to "5 zones" (Albumin, alpha-l, alpha-2, beta,
gamma) evaluation, most relevant urinary proteins are recognized by
their relative position within the pattern and estimated semi-quantita-
tively. Moreover, typical formations of spots, indicating specific patho-
logical changes can be recognized and evaluated in view of the entire
pattern of urinary proteins. For example, we could differentiate in case
of tubular proteinuria between "functional" and degenerative lesions,
"overflow" dysfunction and tubulointerstitial disturbances. In cases of
glomerular proteinuria, glomerular selectivity, severity of the glomeru-
lar disease as well as involvement of specific groups of proteins. A
noninvasive monitoring of the kidney in renal transplant patients by this
method was of special interest. By sequencial analysis of the pattern of
urinary proteins, newly developed disturbances of the kidney graft
could be better recognized. The present noninvasive diagnostic proce-
dure represents a valuable diagnostic tool in a specialized nephrologic
department.
Prospective study for early detection of renal disease and urinary tract
infection in children—An approach to prevention in nephrology. C.
Kaufmann, E. Meyer, A.E. Lison, Med. Poliklinik, University of
MOnster, MOnster, Federal Republic of Germany. In more than 2700
children, age 3 to 12 years, the diagnostic validity of urine screening
methods was investigated. Leucocyte-sensitive test strips, standardized
urinary sediment analysis (MD-Kova5), dipslides, quantitative mea-
surement of proteinuria in single voided urine samples, N-acetyl-
/3-D-glucosaminidase, SDS-polyacrylamidgel electrophoresis, and uri-
nary cytology were performed. In this ongoing trial the children will be
tested three times/year. This report gives the data of the first two
investigations. Pathological findings in 351 children prompted for med-
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ical examination. In 99 of these the results of clinical investigation are
available (diseases known before investigation are excluded) N = 99.
Renal disease 10%
Urinary tract infection 18%
Affection of genitalia 15%
Hematuria, parainfectious 6%
Cardiopathy 1%
Pathological urinary findings 18%
(etiology not yet known)
Most of these children had none or only discrete uncharacteristic
symptoms. The diagnosed serious diseases and active infections defi-
nitely show the necessity of controlled use of such screening programs
in preventive medicine.
Hantavirus and hemorrhagic fever with renal syndrome epidemiologi-
cal studies in southwest Germany. M. Zeier, J. Clement, A. Lefevre, K.
Den gler, K. Andrassy, E. Ritz, Department of Internal Medicine,
University of Heidelberg, Federal Republic of Germany; Military
Hospital Brussels, Belgium. Since our initial report (DMW 111:207—210,
1986) hantavirus infection has recently been recognized as a cause of
nontraumatic ARF in Germany. In our unit we counted for 6.25% of
consecutive ARF in 1985/88. Hantavirus infection was diagnosed
serologically by indirect immunofluorescence. Temporary hemodialysis
was necessary 3 of 5 patients. Renal function normalized in all patients
after the acute episode. To examine the prevalence of hantavirus
infection we examined 2609 sera of healthy probands from rural and
urban areas of southwest Germany, using indirect immunofluorescence
and testing the following hantavirus subtypes, CGI8-20, NE, Puumula,
TCH and 13091. Antibodies were detected in 28 samples with titers
from 1:64 to 1:4096; 1:64 was considered to be significant. In contrast
to past studies where only Nephropathia epidemica strains (NE, CG
18-20) were found, we found titers against the Apodemus mouse
transmitted hantastrain with titers up to 1:512. Seroprevalence varied
geographically and forest workers were identified as a high risk group.
Seroprevalence of 1.7% and 2.2%, respectively, were found in villages
where we observed HFRS cases. We conclude that (i) HFRS is a cause
of nontraumatic ARF in Germany. (ii) Seroprevalence is a function of
profession and geography. (iii) infection with hantastrain with a more
adverse clinical prognosis was demonstrated.
Chronic renal magnesium loss with reduced calciuria and tendency to
hypokalemia and metabolic alkalosis after treatment with cisplatin in
childhood. M.G. Bianchetti, C. Kanaka, A. Ridolfi-Luthy, HP Wagner,
A. Hirt, L. Paunier, OH. Oetliker, University Children's Hospital
Berne and Geneva, Switzerland. Three children (age 8, 9 and 11 years)
with renal tubular hypomagnesemia of <0.75 mmol/liter were studied
more than one year after discontinuating treatment with cisplatin
because of neuroblastoma. The renal handling of electrolytes, glucose
and protein was assessed on the basis of timed urine specimens and
corresponding blood values. Urinary concentrating ability was esti-
mated in the first morning urine. Besides renal magnesium wasting, a
clear cut tendency to reduced calciuria (expressed as fractional excre-
tion, calcium to creatinine ratio or calciuria corrected for glomerular
filtration rate) was observed. Plasma potassium tended to be low (3.4 to
3.7 mmol/liter), plasma chloride was normal (>95 mmol/liter), while
plasma bicarbonate was sometimes slightly increased (24.9 to 27.8
mmol/liter) and the urinary pH always <6.00, thereby indicating a renal
bicarbonate threshold >24.9 mmol/liter in all patients. The glomerular
filtration rate estimated from plasma creatinine and height, the renotu-
bular handling of glucose and inorganic phosphorus, and the urinary
concentration ability were always unaltered. Very comparable features
were found in three newly re-evaluated children (age 3½, 8 and 13
years) with history of rare tetanic crises of febrile fits, who suffered
from primary renotubular hypomagnesemia-hypokalemia with hypocal-
ciuria, a benign and perhaps not rare primary tubulopathy, first de-
scribed by Gitelman. The latter disorder simulates the effects of
prolonged treatment with thiazide diuretics. Conclusion: The chronic
cisplatin nephropathy includes, apart from magnesium wasting, re-
duced calciuria, and tendency to hypokaliemia and metabolic alcalosis.
The renotubular dysfunction of cisplatin nephropathy is strikingly
reminiscent of Gitelman's syndrome and chronic medication with
thiazide diuretics.
Glucose-6-phosphate (G6P) content and metabolism in renal inner
medulla (IM) of diabetic (D) rats. R. W. Grunewald, I. Inka, Weber, and
R.K.H. Kinne, Sektion Nephrologie, Abt. Innere Med. I, Universitäisk-
linik, Ulm and Max-Planck-Institut für Systemphysiologie, Dortmund,
Federal Republic of Germany. As part of glycolysis, gluconeogenesis
and pentosephosphate shunt G6P plays an important function in me-
tabolism. G6P may influence sorbitol synthesis and is thought to be
responsible for some of the complications in diabetes mellitus. There-
fore the G6P content and its main metabolic pathways were studied in
vitro in homogenates of the IM of streptozotocin treated rats. The G6P
content in the IM of diabetic rats was found to be significantly increased
from 1.53 0.40 (control (C)) to 2.76 0.55 (diabetes (D)) mol/g
protein (prot). The hexokinase activity (21 11(C) vs. 18 8(D) U/g
prot), the glucose-6-phosphase activity (24 3 (C) vs. 24 2 (D) U/g
prot), and the 6-phosphogluconate-dehydrogenase activity (8 6 (C)
vs. 10 6 (D) U/g prot) in the IM of diabetic and control rats were
unaltered indicating that neither alterations in enzymatic activity for
G6P synthesis nor G6P degradation via the pentosephosphate shunt and
the last step of gluconeogenesis were responsible for the higher G6P
content in the IM of diabetic rats. The gluconeogenic pathway, how-
ever, seemed to be partially activated (fructose-I ,6-biphosphatase was
48% increased to 3.7 1.1 U/g prot (D)), but the influence of this
pathway on the G6P content remained speculative. Therefore in vivo
the elevated blood glucose concentration together with the high capac-
ity of the glucose transport in the collecting duct cells (Plügers Arch
414:346, 1989) seemed to be the main reason for the higher G6P content.
This increase in G6P may inhibit the hexokinase by a negative feedback
mechanism leading to an even higher intracellular glucose concentra-
tion, so that more glucose is available for the sorbitol pathway. In
contrast to other tissues (aorta and brain) there is no evidence for a
direct influence of G6P on the sorbitol metabolism, since the in vitro
activity of aldose reductase remained unchanged after preincubation
with G6P.
Urinary excretion of the extracellular matrix proteins laininin and
fibronectin and of the Tamm-Horsfall protein in diabetes mellitus (DM).
I. JackIe-Meyer, V. Metze, B. Szukics, R. Petzoldt, H. Stolte, Medical
School Hannover, Department of Internal Medicine, Division of
Nephrology; Diabetesklinik Bad Oeynhausen, Federal Republic of
Germany. The early stage of diabetic nephropathy (DN) is character-
ized by microalbuminuria and morphological alterations of the extra-
cellular matrix in the glomeruli. In the present study, the excretion of
proteins of renal origin, as the Tamm-Horsfall protein (THP), laminin
and fibronectin (FN), was studied in comparison to other functional
parameters as creatinine clearance and proteinuria (qualitative and
quantitative). The diabetic patients were classified according to their
albumin excretion (group 1: <30 mg/l2 hr, GFR = 111,5; group 2:
30—144 mg/12 hr, GFR = 93; group 3: >144 mg/12 hr, GFR ii = 60,5).
Results: I.) THP excretion (ELISA) was not significantly changed in
any of the groups (controls it = 8.25 mg/12 hr, diabetics it = 8.9 mg/12
hr). 2.) As an intrinsic component of the glomerular basement mem-
brane the laminin-P1-fragment was determined (RIA). In diabetics the
urinary excretion of this protein as well as the serum concentration was
not altered in comparison to the controls (serum: controls it = 1.2
U/mI, diabetics it = 1.24 U/mI; urine: controls it = 165 U/12 hr,
diabetics it = 260 U/12 hr). 3.) Fibronectin (ELISA) mainly localized in
the mesangial matrix showed a significantly higher excretion rate in all
diabetic groups than in controls (controls it = 30 .tg/l2 hr, group 1 it =
170 g/l2 hr, group 2 it = 110 g/12 hr, group 3 it = 230 tg/l2 hr).
Serum concentration of fibronectin increased from 240 mg/liter in
controls to 2500 mg/liter in group 3. Itcould be shown that fibronectin
excreted in urine is of renal origin. Conclusion: 1.) THP excretion does
not reflect the stage of DN, so it is not a suitable marker to judge the
stage of DN. 2.) The alterations of the glomerular basement membrane
in DM are not reflected by the concentration of laminin in serum or
urine, respectively. 3.) The urinary fibronectin excretion is increased
before other parameters as the albumin excretion are increased. This
finding could reflect very early changes in the mesangial matrix in DM.
Supported by DFG (Sto 71/6-I)
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Renal functional reserve in type I diabetics: Influence of ACE-inhibi-
tion. T. Eisenhauer, E. Jungmann, D. Warneboldi, G. Ansorge, E.
Schifferdecker, J. Talartschik, F. Scheler, Department of Nephrology,
University Gottingen, Department of Endocrinology, University Frank-
furt, Federal Republic of Germany. In 19 type I diabetics (9 women, 10
men, age 21 to 51 years) renal functional reserve was evaluated by
parenteral infusion of 250 ml amino acid (AA) solution (Aminosterol®
10%) during 2 hours. All patients had normal albumin excretion (<20
sg/min), were normotensive (RR <140/90 mm Hg) and had glycosi-
lated hemoglobin levels less than 9.5%. After an equilibration period of
30 minutes, inulin, creatinine and PAH clearances were carried out I
hour before, during and I hour after the AA infusion. The identical
protocol was repeated one week later after pretreatment with 25 mg
captopril (Lopirin®) orally. Two groups of patients were found: During
AA infusion inulin clearance in group A (N = 10, responders) increased
from 118 27 ml/min to 140 46 mI/mm (P < 0.02) as did PAH
clearance from 501 mI/mm to 723 182 mI/mm (P < 0.04). In
group B (N = 9, non-responders) an insignificant decrease of inulin
clearance from 169 54 mI/mm to 145 36 mI/mm and of PAH
clearance from 842 449 mI/mm to 796 564 mI/mm was observed.
Both groups were comparable in ages, duration of diabetes, glycosilated
hemoglobin as well as in plasma levels of glucagon, renin activity,
aldosterone and growth hormone. Group B, however, had a signifi-
cantly higher basal inulin clearance of 169 54 mI/mm compared to
group A (118 27mI/mm; P < 0.02). Pretreatment with 25 mg captopril
decreased the elevated basal inulin clearance in group B. ACE inhibi-
tion completely abolished the increase of inulin and PAH clearances
during AA infusion in group A. In summary we conclude that some type
I diabetics still have a renal functional reserve in contrast to those who
are mainly hyperfiltrating. Since ACE inhibition abolished hyperfiltra-
tion during AA infusion in diabetics with normal baseline GFR and
reduced GFR in those patients with persisting hyperfiltration, it is
tempting to speculate that ACE inhibition might be beneficial in
preventing diabetic nephropathy.
Renal and metabolic effects of antihypertensive therapy with verapamil
or enalapril in diabetic patients. C. Ferrier, P. Ferrari, P. Weidmann, U.
Keller, W. Riesen and all Collaborators of the Swiss Hypertension
Treatment Program in Diabetes. Med. Poliklinik, University of Berne,
Switzerland. In patients with diabetes mellitus, arterial hypertension
and poor glycemic control may accelerate the development of diabetic
nephropathy. Therefore, controlling arterial blood pressure (BP) with-
out adversely affecting glucose metabolism or renal function is partic-
ularly important. We assessed the antihypertensive efficacy, the meta-
bolic and renal effects of verapamil (V) and enalapril (E), administered
in randomized order alone or combined over 30 weeks, in 42 hyperten-
sive (>140/90 mm Hg) patients with diabetes mellitus type I (N = 6) or
II (N = 36) and normal serum creatinine (82 6 mol/Iiter). Mono-
therapy with V (240 to 480 mg/day) or E (20 to 40 mg/day) normalized
BP (to <90 mm Hg diastolic) in 27 patients; compared with placebo, V
decreased BP from 157/97 4/1 to 149/87 3/2 mm Hg (N = 14, P <
0.01), while E reduced BP from 163/99 4/2 to 144/85 3/2 mm Hg(N = 13, P < 0.001). In the 15 patients who were still hypertensive after
10 weeks of monotherapy, a combination of both drugs decreased BP
from 165/103 2/1 to 148/90 5/2 mm Hg (P < 0.001). Urinary
albumin (by radioimmunoassay) as related to creatinine excretion
(UAE, g albumin/mg creatinine) was on average unchanged after V or
E, alone or combined. Considering different categories of pre-treatment
UAE, the administration of V and E alone or combined did not modify
microalbuminuria in patients with normal UAE (20 pg/mg creatinine,
N = 17) or UAE >70 pg/mg creatinine ("late incipient diabetic
nephropathy," N = 14). However, in the patients with pre-treatment
UAE between 20 and 70 sg/mg creatinine ("early incipient diabetic
nephropathy," N = II), UAE decreased from 36 5 to 19 3 pg/mg
creatinine (P < 0.005); this improvement was observed primarily in
patients treated with E or E + V. Serum glucose, glycosylated
hemoglobin, fructosamine, total lipids, HDL- and LDL-cholesterol,
potassium or creatinine were not modified by V, E or V + E. These
findings indicate that in diabetic patients, antihypertensive treatment
with the calcium antagonist verapamil or the ACE inhibitor enalapril
alone or combined can effectively lower BP without adversely affecting
carbohydrate and lipid metabolism. In some but not all patients with
early incipient nephropathy, antihypertensive treatment tended to
decrease microalbuminuria.
Structural adaptation of remnant nephrons in human chronic and
end-stage renal insufficiency. fE. Scherberich, Chr. Albers, A. Nowack,
G. Wolf, H. Schmidt, A. MattheJi, W. Schoeppe, Department Nephrol-
ogy, University Hospital, Frankfurt am Main, Federal Republic of
Germany. To elucidate the structural adaptation of nephrons in pro-
gressive renal insufficiency, the expression as well as the distribution
patterns of glomerular and tubular cell markers were assessed in
kidneys of 27 RCDT patients (20 men, 7 women; 0.5 to 14 years on
dialysis treatment), and in 38 patients with various kidney diseases
applying specific (immuno-)histochemical techniques. In addition, ex-
cretion of the markers angiotensininase A (ATA; glomerular endothe-
ha), brush border-GGT, aminopeptidase-M, and serum protein profiles(SDS-PAGE) was studied in 24 patients with chronic GN (serum
creatinine 1.6 to 7.8 mg/dl), and 30 RCDT patients (i treatment 8
months) with rest diuresis (0.05 to 2 liter/24 hrs). Histuria was com-
pared with that from 68 (34 men, 34 women) controls. A decrease in the
tissue concentration of marker proteins compared to normal controls (N
10) was found by quantitative image analysis with progressive loss of
renal function (2P < 106); this was positively correlated with a drop of
GGT but with a significant rise of ATA excretion. Kidney sections of
RCDT patients revealed the presence of clusters of hypertrophic and
well-shaped remnant nephrons exhibiting high glomerular ATA and
tubular GOT activities, normal concentrations of distal tubule cell
markers (1 2H 1 2-epitope), and normal architecture of the glomerular tuft
without segmental sclerosis. All RCDT patients showed heavy com-
plete form of tubular proteinuria, thus indicating disturbance in tubular
rather than in glomerular handling of serum proteins in remaining
nephrons. Loss of functioning renal mass apparently leads to compen-
satory rise in the expression of glomerular and tubular marker antigens
in a selected, highly resistent population of nephrons escaping further
destruction. The structural integrity of glomeruli was independent from
that of the tubule segments. Hyperperfusion per se might not constitute
a main causative factor for progressive nephron damage in pts. with
renal diseases.
Reduced progression of renal insufficiency by control of blood pressure.
H.G. Mühlbauer, H.J. Deuber, W. Schulz, III .Med.Clinics and Insti-
tute of Nephrology, Bamberg, Federal Republic of Germany. Renal
diseases are commonly associated with a raised blood pressure (BP).
On the other hand elevated BP can produce severe glomerular damage.
By that a vicious circle might be started. As animal studies yet have
shown control of blood pressure can lengthen time in progression of
renal failure. This retrospective study was done to investigate the effect
of BP control on development of renal insufficiency. Sixty-seven of our
out-patients with pyelonephritis, glomerulonephritis, polycystic kid-
neys, diabetes mellitus or interstitial nephritis, aged 45 12.5 years
were included in this study. Evaluated were BP, drug therapy, creati-
nine and proteinuria during a study period of 88 months. Starting with
BP of 170 to 250/95 to 115 mm Hg BP could be lowered by therapy with
calcium channel blockers, beta-receptor antagonists, vasodilating sub-
stances and diuretics to 120 to 160/80 to 95 mm Hg. Concomitantly
proteinuria could be reduced from up to 10 g/day to approximately 0.6
to 2.0 g/day, regardless of underlying renal disease. After start of
antihypertensive therapy there was a short rise of serum creatinine. In
the long run serum creatinine remained stable at about 2 mg/dl, if BP
was controlled strictly enough. This pure clinical study clearly demon-
strated that regardless of pharmacological group of antihypertensive
drugs, a stabilization of renal impairment can be achieved if BP control
is strictly enough. Therefore time of compensated renal insufficiency
can be prolonged.
Lack of a protective effect of a chronic captopril (CAP) administration
on the development of glomeruloscierosis (GS) and protelnuria (PU) In
Milan normotensive rats (MR). R. Brunkhorst, K.W. Kuhn, V. Kliem,
K.H. Neumann, H. Claus, K.M. Koch, Hannover Medical School,
Hannover, Federal Republic of Germany. MR are characterized by the
spontaneous development of a glomerular PU during the 3 month of life
(MO) and by a progressive GS, starting in the 6 MO. The pathogenetic
mechanisms of these strain specific changes have not yet been ex-
plained. In order to investigate the possible role of angiotensin II
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regulated glomerular hemodynamics, we studied the effects of a chronic
angiotensin converting enzyme inhibition by CAP on the development
of GS and PU in MR. Nine male MR received a daily dose of 5mg CAP
per kg body weight with the drinking water starting the 2 MO.
Creatinine clearance (CCL) and PU (Biuret) were measured monthly,
mean arterial blood pressure and the incidence of GS (% G.S.) were
investigated at the end of MO 8. Nine age-, sex- and weight-matched
MR served as controls. Results: Mean weight gain during the study was
comparable between both groups (MR + CAP: 103 19 g, MR: 111.4
23 g). There were no significant differences in PU and CCL at any
time point of the investigation. Results of 8 MO are listed in the table.
CCL
mI/minig
P
mg/2
U
4 hr
SI.
%
MAP
mm Hg
MR + CAP 0.53 0.09
NS
356 121
NS
16 6
NS
91.4 8
NS
MR 0.58 0.14 286 133 10 2 97.3 6
5D, NS = non significant
Chronic administration of CAP had no protective effect on the devel-
opment of GS and PU in MR. Conclusions: In contrast to experimental
models as diabetic GS and the remnant kidney, a mechanism indepen-
dent of glomerular angiotensin II actions seems to be responsible for
progressive GS and PU in MR.
Hormone levels during glomerular hyperfiltration opposite effects of
calcium-antagonist and ACE-inhibitor on GFR. J. BOhler, E. Keller,
R.P. Woitas, K.G. Petersen, P.J. Schollmeyer, Departments of
Nephrology and Endocrinology, University of Freiburg, D-7800
Freiburg, Federal Republic of Germany. After loss of renal tissue
hyperfiltration of remnant nephrons develops. This mechanism has
been suspected to accelerate progression of chronic renal failure to
end-stage renal disease. Intravenous infusion of amino acids (AA) also
induces hyperfiltration, thus mimics the hemodynamic changes seen in
renal disease. The mechanism by which amino acids induce hyperfil-
tration is not known, but hormones such as glucagon, atrial natriuretic
factor (ANF), and growth hormone (STH) have been implicated. In this
investigation stimulation of glomerular filtration rate (GFR) by AA was
used as a model to study drug effects on hyperfiltration and selected
hormones. Effects of the calcium antagonist nifedipine and the ACE-
inhibitor Captopril on GFR at rest and on AA-induced hyperfiltration
was studied in 13 healthy volunteers. On three separate days, GFR
(inulin clearance method) was measured, first at rest and afterwards
after stimulation by AA. During both phases samples for glucagon,
STH, and ANF were also obtained. Day A served as control where no
medication was given. On day B 10 mg nifedipine and on day C 25 mg
of Captopril were given orally prior to study. Without medication (day
A) GFR at rest was 120.6 (±8.2) mI/mm and increased to 147.6 (±9.1)
mI/mm after stimulation by AA (P < 0.01). On day B (nifedipine) GFR
was already elevated before AA infusion to 135.9 (±5.7) mI/mm (P <
0.05 compared to baseline on day A) and increased after stimulation by
AA to 147.6 (±7.0) mI/mm (P < 0.001 compared to day A). On day C
(Captopril) GFR at rest or after stimulation did not significantly increase
when compared to baseline on day A (129.5 9.2 [at rest] vs. 131.9
8.9 ml/min [after AA]). After infusion of AA, glucagon increased
significantly and to the same level on all three days (day A: 84.3->
128.4*; B: 82.l>l33,3*; C: 84.4>l50.6* (pg/mi); *= p < 0.05
compared to baseline), while STH and ANF levels did not show
significant changes. Amino acid induced hyperfiltration is associated
with a sharp rise in glucagon levels, while ANF or STH levels are not
affected. However, induction of hyperfiltration by nifedipine, indepen-
dently of AA infusion, is not accompanied by an increased glucagon
level. Moreover, AA-induced hyperfiltration can be prevented by
Captopril despite elevated glucagon levels. We conclude that antihy-
pertensive agents modify GFR and hyperfiltration independently of the
hormones measured.
Effect of two different calcium antagonists on glomerular hemodynam-
ics in the dog. J. Hel!er, V. Horác'ek, Inst.f. Clin. and Exp. Med. Prague,
CSSR. During an intrarenal infusion of calcium antagonists verapamil
(VER, 4 pg/kg body wt/min) and nifedipine (NIF, 0.3 pg/kg body
wt/min), the renal hemodynamics in pentobarbitol anesthetized dogs
was studied using clearance and micropunction techniques. The drugs
did not affect the mean arterial pressure. Apart from natriuresis and
diuresis, which were significantly greater with NIF than with VER, the
response to both preparations was very similar, We observed a rise in
the renal blood flow (RBF; VER: 17%, NIF: 20%), the glomerular
filtration rate (GFR; VER: 34%, NIF: 39%) and the filtration fraction
(VER: 12%, NIF: 14%); at the single nephron level the results were
similar. The glomerular capillary pressure, measured directly after
ablation of a thin layer of cortex corticis, was elevated (VER: 11%,
NIF: 10%); the proximal tubular and peritubular capillary pressures
displayed no changes. The glomerular ultrafiltration coefficient (Kr) did
not change either. The total arteriolar resistance was lowered (VER:
20%, NIF: 15%) as a result of an afferent resistance drop (VER: 31%,
NIF: 27%). The efferent resistance did not change, the reason for which
is not known. Summary: In acute experiments with intrarenal admin-
istration both drugs elevated the RBF and GFR with mainly afferent
dilation without any change in the Kf.
Growth hormone induced rise in GFR is not obliterated by converting
enzyme inhibitors. D. Haffner, E. Ritz, 0. Mehls, J. Rosman, Depart-
ments of Internal Medicine and Pediatrics University Heidelberg,
Federal Republic of Germany. In 8 healthy normotensive probands
with normal GFR, the effect of recombinant human growth hormone
(rhGH) on inulin clearance (C1) was examined in an open study with
intraindividual cross-over with or without enalapril pretreatment (20
mg/day). Recombinant hGH was administered by s.c. injection 4.5 U
bid for three days. On the following day, inulin clearance was measured
with an enzymatic steady state infusion technique. Systemic hemody-
namics and potential metabolic effects of rhGH, i.e. IGF I, IGF H,
somatomedin binding protein, glucagon, C-peptide, amino acid pattern,
etc., were monitored. On controlled dietary intake of protein, median
rose 72 h after start of rhGH administration from 114 mI/mm x 1.73
m2 (range 19 to 158) to 135 (108 to 167) without enalapril pretreatment
(P < 0.001) and from Ill (range 88 to 153) to 131 (100 to 173) with
enalapril pretreatment (P < 0.02). The results confirm that (i) rhGH
increases C to a similar extent as extractive GH and (ii) further
demonstrate that this action is not obliterated by blocking the circulat-
ing converting enzyme.
Pathophysiological importance of renal kallikrein in experimental renal
hypertension. M. Marin-Grez and P. Odigie, Department of Physiology,
University of Munich, Munich, Federal Republic of Germany. Kal-
likrein excretion is reduced in established experimental and clinical
hypertension. The cause and the consequence of this change has
remained unknown. Results from normal rats indicate that the release
of renal kallikrein depends on NaCI reabsorption, and that the physio-
logical role of this enzyme is to regulate bicarbonate excretion (see
accompanying abstract by Marin-Grez and Odigie). Therefore, we
investigated whether kallikrein release correlates to filtered NaCI in
hypertensive rats. The probable existance of an acid-base derangement
was also investigated. Hypertension was induced by constricting one
renal artery of male Sprague-Dawley rats (2K-IC). Clearance experi-
ments were performed under barbiturate anesthesia 8 to 11 weeks later.
Sham operated rats served as controls (C). 2K-iC rats had high blood
pressure (154 + 6 mm Hg) compared to C (102 + 3). Renal kallikrein
activity was lower in the clipped kidney (42 + 7 mU/g), than in the
contralateral (72 + 3), this being not different from C (right: 70 + 2; left:
71 + 1). Kallikremn excretion from the clipped kidney was reduced (0.21
+ 0.07 mU/mm), whereas that from the contralateral was normal (0.61
+ 0.07); (C right: 0.66 + 0.06, C left: 0.62 + 0.03). Hypertensive rats
had higher plasma aldosterone concentration (2H-1C: 1.70 + 0.14 nM
vs. C: 1.21 + 0.16, P < 0.05). The glomerular filtration rate of the
clipped kidney was reduced (0.76 0.17 mI/mm vs. 2.96 + 0.68). C
right: 2.74 + 0.25, C left: 2.58 + 0.23). Renal kallikrein release
correlated significantly with filtered NaCI (Na: r = 0.62, P < 0.0005;
C1: r = 0.43, P < 0.02). Blood pH of hypertensive rats did not differ
from that of controls (7.475 + 0.038 vs. 7,447 + 0.027). However, a
reduced pCO2 (32.6 + 3.2 mm Hg vs. 38.9 + 4.4, P < 0.01) and a lower
blood bicarbonate (23.1 + 0.9 mri vs. 25.9 + 0.6, P < 0.02) was found.
Thus, 2K-IC rats secrete less kallikrein than C. This is probably due a
lower distal NaCI delivery. Reduced kallikrein may cause metabolic
acidosis in hypertension.
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Insulin sensitivity and lipoproteins in hypertension-prone man. P.
Ferrari, D. Giachino, P. Weidmann, U. Keller, W. Riesen, and S.
Shaw, Medizinische Poliklinik, University of Berne, and Stoffwechsel-
labor, University of Basel, Switzerland. Essential hypertension (EH)
has been reported to be often accompanied by decreased insulin
sensitivity (S1) of peripheral tissue. Whether the latter represents a
consequence of, or a primary and perhaps even pathogenic event in,
hypertension has been unknown. To elucidate this aspect, S1 (deter-
mined by the minimal model method of Bergman), serum lipoprotein
cholesterol (C) and triglyceride (Tg) fractions and blood pressure (BP)
were assessed in 10 normotensive Sons of hypertensive parents (SEH)
as compared to 10 normotensive sons of normotensive parents (SN).
None of the subjects had first-degree relatives with diabetes mellitus.
Measurements were performed after 3 days of fixed diet (2200 Kcal,
45% carbohydrates, 40% fat, 15% proteins, 160 mmol sodium) and after
an overnight fast. Age, body mass index, BP and 24-hr urinary sodium
excretion were similar in SEH and SN, respectively. The two groups
did not differ with regard to fasting plasma glucose (4.76 0.08 vs. 4.76
0.11 mmol/liter; mean sEM), insulin (10.0 2.7 vs. 7.2 0.8
U/ml) levels, and serum HDL-C/LDL-C ratios (0.43 0.04 vs. 0.46
0.05). Total-Tg (1.15 0.08 vs. 0.72 0.05 mmol/liter, P <0.01) and
VLDL-Tg (0.27 0.1 vs. 0.12 0.06 mmol/liter; P < 0.001) were
higher in SEH S (5.9 1.2 vs. 6.9 1.4 min '/sU/ml) was similar in
SEH and SN. The finding of normal S1 in an unselected group of SEH
suggests that insulin resistance in patients with established EH usually
represents a secondary event. However, altered lipoprotein metabolism
may occur as familial disturbance in hypertension-prone man.
Effect of sodum citrate on blood pressure, acid-base status and electro-
lyte balance in salt-sensitive normotensive subjects. AM. Sharma, S.
Schattenfroh, A. Kribben, A. Distler, Department of Medicine, K/mi-
kum Steglitz, Free University of Berlin, Berlin, Federal Republic of
Germany. The finding that sodium citrate (NaCt) in contrast to sodium
chloride does not raise blood pressure in patients with essential
hypertension has led to the assumption that chloride is important for the
pressor effect of NaCI [1]. We therefore studied the effect of NaCt and
NaCI on blood pressure (BP), acid-base status and electrolyte balance
in previously characterized normotensive, salt-sensitive (SS, N = 7)
and salt-resistant (SR, N = 8) subjects. We administered a low salt diet
(20 mmol/day) for 3 weeks, adding either placebo, NaCI (200
mmol/day) or NaCt (200 mmol/day) for 1 week each in a randomized
single-blind crossover study. NaCI led to an increase in BP only in SS
(P < 0.002). NaCt did not affect BP in either SS or SR. Whereas NaCI led
to a rise in calcium excretion in all subjects (P < 0.01), calcium excretion
was reduced by NaCt (P < 0.01). Arterial pH was lower in SS than SR
under both the low (P < 0.05) and high NaCI (P < 0.01) diets. During
NaCt, arterial pH (P < 0.02) and HCO3 (P < 0.005) were higher compared
to NaCI in all subjects. The urine and plasma levels of other electrolytes
were unchanged. We therefore conclude that apart from the chloride
content, diverging effects of the two sodium salts on acid-base status and
calcium homeostasis may be responsible for their differing effects on BP.
The presence of relative acidosis in SS compared to SR suggests a role for
acid-base homeostasis in the pathogenesis of salt sensitivity.
1. KURTZ ET AL, N EngI J Med 3 17:1043, 1987
Importance of chloride for the changes in renal and vascular response
to angiotensin II induced by variations of sodium chloride intake in
normotensive salt-sensitive men. AM. Sharma, S. Schattenfroh, A.
Kribben, W. Oelkers, A. Distler, Department of Medicine, Klinikum
Steglitz, Free University of Berlin, Berlin, Federal Republic of Ger-
many. To study the role of chloride in the NaCI induced changes in
renal and vascular response to exogenous angiotensin 11 (Ang II), we
performed Ang II infusions in previously characterized normotensive
salt-sensitive (SS, N = 7) and salt-resistant (SR, N = 8) subjects
ingesting 220 mmol Na/day either as NaCl or Na-citrate (NaCt) for 1
week each in a placebo-controlled, single blind crossover study.
Changes in mean arterial pressure (MAP), renal plasma flow (RPF =
CIpAH) and plasma aldosterone were measured during iv. Ang II
infusion (2, 4, 8 ng/kg/min). Under both NaCI and NaCt, there was a
similar increase in the Ang II induced rise in MAP (P < 0.01) compared
to placebo (20 mmol Na/day), whereby the increase in pressor response
was greater in SS than SR under the high Na regimens (P < 0.05). Both
Na salts led to an augmented Ang II induced fall in RPF (P < 0.05) in
SS but not in SR. Ang II induced aldosterone secretion was not
significantly affected by the regimens in both groups. We therefore
conclude that chloride is not important for the NaCI induced changes in
renal and vascular response to Ang II. The enhanced vascular and renal
responsiveness to Ang IL under the high Na diet in SS may be of
importance for the salt sensitivity of the subjects.
Captopril test versus renal sequential scintigraphy as screening tests for
renovascular hypertension. C.M.M. Erley, T. Risler, Medical University
Clinics, Department III, Tubingen, Federal Republic of Germany.
Since the report of Muller et al. (AJM, 1986) the assessment of venous
plasma renin activity (VPRA) before and after administration of capto-
pril is considered a simple test to discriminate between patients with
renovascular hypertension (RVH) and those with essential hyperten-
sion (EH). Other studies demonstrated renal scintigraphy before and
after administration of captopril to be a helpful method in the differen-
tial diagnosis of arterial hypertension. We compared both methods
employing a prospective study design. Referring to the conditions
demanded by Muller et al, we were able to show a threefold increase of
VPRA 90 minutes after oral administration of 25 mg captopril in 6 of the
10 untreated patients with arterial hypertension. All patients had a renal
function scintigraphy using ii 3 1-hippuran before and after use of 25 mg
captopril. All 10 nuclear medicine examinations showed no changes in
parameters suggestive of renal artery stenosis, Angiography of the renal
arteries revealed no stenoses in the patients. One of the 4 patients
without a rise of VPRA after captopril had a fibromuscular dysplasia of
the right renal artery, but without a stenosis. In conclusion, the
captopril test alone showed no sufficient specificity for the differentia-
tion of essential and renovascular hypertension as compared to renal
function scintigraphy before and after captopril.
Evaluation of renal artery stenosis by color coded duplex sonography.
K-P. Spies, K.-L. Schulte, D. van Gemmeren, M. El-Bedewi, F.
Fobbe, R. Gotzen, A. Distler, Departments of Medicine and Radiology,
Klinikum Steglitz, Free University of Berlin, Berlin, Federal Republic of
Germany. Forprecise evaluation of renal artery stenosis (RAS) angiogra-
phy is still the method of choice. However it is an invasive and expensive
procedure with potential hazard of complications. The newly available
color coded duplex sonography (CCDS) allows the simultaneous demon-
stration of soft tissue and blood movement over the entire image. In a
prospective study we examined the sensitivity and specificity of this new
method in detecting RAS. In 37 patients (aged 53.5 years) 71 renal
arteries were studied and the results were compared with subsequent
conventional angiography. The criteria we used to diagnose RAS by
CCDS were high Doppler frequency shift, closure of the systolic window,
and following flow turbulances in the renal artery. Eighty-four and one-half
percent of all renal arteries could be visualized both distally and proxi-
mally. The causes of technical inadequate imaging were obesity and
abdominal intestinal gasous distension. Seventeen of the imaginable 60
renal arteries were stenosed according to angiography. Three of 17 RAS
were not detected by CCDS, but these were mild and hemodynamically
not effective stenoses. Including these RAS the sensitivity of CCDS was
82.4%, the specificity was 97.7%. CCDS is a suitable non-invasive method
in the diagnosis of RAS. We conclude that in case of good imaging of renal
arteries by CCDS hemodynamically effective RAS can be excluded with
high probability.
Distribution of substance P (SP) in rat renal tissue and effects of SQ
14,225 (Captopril) on its plasma concentration and renal clearance. M.
Mohaupt, C. Walz, A. Backer, H. Meyer-Lehnert, H.G. Predel, H.J.
Kramer, Med. Poliklinik, University of Bonn, Bonn, Federal Republic
of Germany. SP is a potent diuretic, natriuretic, vasodilatory and
renin-suppressing undecapeptide which is extensively metabolized in
liver and kidney. In the present study we investigated renal distribution
and metabolism of SP and the effects of SQ 14,225 on plasma and
urinary SP. In 20 Sprague-Dawley rats, concentrations of endogenous
SP in renal cortex, medulla and papilla determined by a specific RIA
were 0.51 0.03, 1.23 0.19 and 3.33 0.20 pmol/g wet weight,
respectively. A similar distribution was observed after ia. administra-
tion of '251-SP. Urinary excretion rate and renal clearance of SP in 8
control rats averaged 11.6 2.2 fmol/min/kg and 0.37 0.17
mI/mm/kg, respectively. In 8 rats pretreated with oral SQ 14,225 (50
mg/kg body wt) 30 mm before the experiments urinary excretion and
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clearance of SP were increased to 26.6 3.9 fmol/min/kg and 1.22
0.36 mI/mm/kg, respectively (P = 0.02 and < 0.05) in the absence of
changes in inulin clearance or urine volume. SQ 14,225 had no effect on
plasma SP (51.0 15.4 vs. 68.6 18.3 pmol/liter). The high concen-
tration of this vasoactive peptide in renal papilla and medulla is
compatible with the high density of SP-receptors in the renal pelvis and
its vicinity. SP has not only modulating effects on renal nerve activity
but our data also suggest an effect on intrarenal blood flow which may
contribute to the rise in sodium and free-water clearances (Kramer et al,
Renal Physiol 6:10—18, 1983). Degradation of SP by peptidases can be
blocked by ACE inhibitors. Thus, SP may contribute to the blood
pressure lowering and renal effects but may also relate to potential
side-effects, e.g. cough, of ACE inhibitors.
Digoxin-like factor in normal and hypertension-prone man. S. Shaw,
S. Schwenk, P. Ferrari, and P. Weidmann, Medizinische Poliklinik,
University of Berne, Berne, Switzerland. The pathogenesis of essential
hypertension (EH) may involve disturbance(s) in endogenous natri-
uretic systems. Previously, we described in normotensive sons of
essential hypertensive parents (SEH) an impaired response of circulat-
ing atrial natriuretic factor to high sodium intake. Others have hypoth-
esized that EH could result from renal sodium retention which, in turn,
would activate a digoxin-like circulating inhibitor of Na/K ATPase.
Using a goat anti-digoxin antibody (Mallinckrodt, Inc., St. Louis, MO,
USA), we have developed a radioimmunoassay for detection of digox-
in-like immunoreactivity. Moreover, this digoxin-like factor (DLF) was
measured in plasma and urine of 25 normotensive Sons of normotensive
parents (SN) and 34 SEH on a free diet. Mean blood pressure (93 I
vs. 92 1 mm Hg, mean SEM) and 24-hr urinary sodium excretion
(166 18 vs. 151 12 mmol/day) did not differ significantly between
SN and SEH. DLF was detected in plasma as well as in urine. Plasma
DLF (12.2 0.8 vs. 12.4 0.7 pg/mI) and urinary DLF excretion (100
5 vs. 82 5 ng/24 hr) also did not differ significantly between SN and
SEH. However, 24-hr urinary DLF (UDLF) correlated positively in both
groups with sodium excretion (UNa) (r = 0.49 and 0.65; P < 0.05 and
<0.001, respectively). Conclusions: In normal man, a DLF exists in
both plasma and urine. DLF may be involved in sodium homeostasis,
modulating and/or reflecting variations in renal sodium excretion. The
UDLF/UNa relationship, as well as plasma DLF seem to be often normal
in hypertension-prone individuals.
Comparative effects of urodilatin and atrial natriuretic factor on renal
function in the rat. S.G. Shaw, P. Weidmann, Medizinische Universi-
täts-Poliklinik Bern, Switzerland. Urodilatin (UD) an N-terminally
extended analogue of alpha human atrial natriuretic factor (ANF) has
recently been isolated from human urine. Speculation that it is pro-
duced in the kidneys has lead to suggestions that its renal effects may be
more pronounced than those of ANF. To test this hypothesis, compar-
ative effects of bolus intravenous injection of the two peptides were
evaluated in Sprague-Dawley rats under nembutal anaesthesia. Follow-
ing surgery for implantation of carotid, jugular vein and bladder
catheters, an equilibration period of 2 hr was allowed before the start of
each experiment. Effects of ANF or UD on glomerular filtration (GFR),
fractional excretion of sodium (FENa) and potassium (FEK), and urine
volume (UV) were monitored for 60 mm following injection of 1, 2, or
3.5 pg/kg of the peptides in separate animals. Values presented are the
maximum responses obtained approximately 10 mm after injection.
Mean arterial pressure (MAP) and hematocrit (Hct) were unchanged at
all doses. Results, mean SE (N = 6).
Dose
glkg
GFR
mi/mini
JOOg
FEN FEK UV
mi/hr%
ANF 0
1.0
2.0
3.5
0.97 0.1
1.6 0.1
1.7 0.2
2.0 0.2
0.18 0.07
0.8 0.2
1.5 0.3
2.0 0.5
21 2
17 1
26 1
25 3
0.7 0.2
2.6 0.7
2.7 0.54
4.0 0.93
UD 0
1.0
2.0
3.5
0.96 0.04
1.7 0.1
1.7 0.2
1.8 0.2
0.18 0.05
0.6 0.1
1.1 0.3
1.6 0.3
20 2
21 2
24 1
24 3
0.6 0.1
1.4 0.15
2.0 0.35
3.9 0.9
The results show that in the rat, injections of UD can dose-dependently
and with similar potency as ANF increase GFR, FENa, FEK and UV
without affecting MAP or Hct.
Renal effects of urodilatin in man. H. Saxenhofer, A. Raselli, P.
Ferrari, S.G. Shaw, and P. Weidmann, Medizinische Universitatspo-
liklinik, Bern, Switzerland. Urodilatin (UD) is a recently identified
analogue of alpha human atrial natriuretic factor (aANF, ANF98-125).
It probably originates in the kidneys and has 33 amino acid residues
(ANF93-l25). To investigate the effects of UD in man, we assessed
effective renal plasma flow (ERPF) and glomerular filtration rate (GFR)
by PAH and 51Cr-EDTA-clearance technique, urine volume (UV),
fractional excretion of sodium (FENa), chloride (FEe,) and potassium
(FEK), blood pressure (BP) and heart rate (HR) after administration of
UD as compared with placebo (P) and aANF as a standard. Eight
subjects received single-blind at a randomized sequence iv. bolus
injections of 25, 50 and 100 g UD, P. and 50 sg aANF (N = 5),
respectively. Results mean SEM.
Doseg Placebo UD 25
ERPF ml/minil.73 m2 566 47 494 98
GFR mi/min/1.73 m2 126 5 130 6
UVmI/min 13±1 l9±la
FENa% 0.77 0.12 1.88 0.4l
FEE, % 1.48 0.60 3.09 0.63
FEK % 12.8 4.6 13.4 2.4
CM2O ml/min/l.73 m2
Hematocrit %
121 5
40.9 0.7
126 6
43.3 l.la
MeanBP,mmHg 85±3 82±3
HRbpm 64±3 71±4
UD 50 (JD 100 cxANF 50
596 41 662 79 533 71
149±13 156±7a 117±4
27± 1' 31±2" l7±2a
4.48 0.48" 4.53 0.66" 2.16 Ø49
5.66 0.89a 5.77 0.83a 2.94 0.92
16.0 2.9 18.4 4.3 13.8 2.9
131 10 145 7 113 4
44.0 o.sa 43.9 0.8a 41.5 0.3
82±2 76±3a 77±4
71±4 78±3a 64±6
a p < 0.05
b p < 0.001 compared to P by ANOVA
Conclusions: In man, UD is biologically active and seems to exert more
potent renal effects than aANF. UD given as a bolus can dose-
dependently increase GFR and enhance diuresis and natriuresis partly
through diminished tubular absorption.
Atrial natriuretic peptide (ANP) and glomerular hemodynamics in
experimental high-output heart failure in rats. U. Frei, Ulrike Rother, R.
Raab, S. Graf, and K.M. Koch, Abi. Nephrologie, Medizinische
Hochschule Hannover, Federal Republic of Germany. In chronic heart
failure (CHF) ANP plasma levels are found to be increased without any
significant influence on renal volume and sodium excretion. In addition
therapeutic application of ANP remained without pronounced effect on
renal function. To examine the ability of atrial natriuretic peptide to
induce diuresis and natriuresis in chronic high output, HF experiments
were performed in 15 Munich-Wistar-FrOmter rats with aortocavale
fistula (ACA), 10 rats served as controls (C). After intravenously
injection of 2 pg/kg body wt a-hANaP as a priming dose and 0.5 tg/kg
mm as constant infusion mean arterial blood pressure (MAP), GFR,
urine flow (U0,) and percentage of sodium excreted (FENa%) were
measured. Micropuncture technique was used to study SNGFR and
SNFF of cortical nephrons. SNFF was determined by measuring the
systemic protein concentration and the concentration in vas efferens.
SNGFR was calculated by urine flow and TF/P1 ratio. Statistical
significance(s) was determined asP < 0.05. MAP decreased slightly but
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not significantly (NS) in both groups (C: 107 2 to 103 2 vs. ACA 100
2 to 96 3 mm Hg; mean SuM). Significant differences between the
groups were only found before ANP infusion. GFR increased signifi-
cantly in both groups (C: 0.99 0.1 to 1.39 0.1 vs. ACA: 0.81 0.1
to 1.04 0.1 mI/mm g kidney). GFR of both groups differed signifi-
cantly before and during ANP infusion. FENa% increased significantly(C: 0.38 0.1 to 1.93 0.4 vs. ACA: 0.27 0.1 to 0.48 0.1%). With
ANP both groups differed significantly. U01 increased significantly in
both groups (C: 4.98 0.3 to 28.3 4.3 vs. ACA: 4.26 0.4 to 6.44
1.1 jl/min g kidney). With ANP both groups differed significantly.
SNGFR increased from C: 60.1 4.5 to 74.4 1.6 (s) and ACA: 50.5
3.6 to 54.7 5.1 nI/mm (ns). Values were significantly different with
ANP. SNFF did not show any significances. In experimental CHF
application of ANP resulted in a significant increase of GFR, while
diuretic and natriuretic response was blunted, But the ANP induced
increase of GFR took place without increasing cortical SNGFR. Al-
tered renal hemodynamics especially a shift of blood flow towards
juxtamedullary nephrons as well as a receptor down regulation might be
responsible for the blunted natriuresis. ANP does not seem to be of
value as a diuretic in chronic heart failure.
ANP, cGMP and RAA.system during dynamic exercise in patients with
essential hypertension treated with /3-blocker or ACE-inhibitor. J. Plum,
J. Willert, M. Reuter, B. Grabenese, Department of Nephro/ogy,
Heinrich-Heine-University, Düsseldorf, Federal Republic of Germany.
The behavior of atrial natriuretic peptide (ANP) and cyclic guanosine
monophosphate (cGMP) regarding essential hypertension (EH) is still
controversial. Methods: Ten normal volunteers (NP) and 20 patients
with EH (WHO I-Il) without medication were studied during graded
exercise on bicycle ergometer workload in the supine position. Blood
samples were taken before exercise and every 4 mm increasing the
workload from 25 watt to 125 watt in steps of 25 watt. A recovery phase
of 12 mm followed, again taking blood samples every 4 mm, We
measured heart rate, blood pressure, ANP, cGMP and plasma renin
activity (PRA). In a second phase, these 20 patients with EH were
divided into two groups of 10 patients each, One group was treated with
betaxolol (EH B: 14.5 6mg) for two weeks, the other group was given
captopril (EH C: 43.8 21.5 mg) for the same period. After that the
exercise test was repeated with both groups. Results: The concentra-
tions of ANP and cGMP in NP (17.3 9,6/5.3 1.2 pmol/ml) did not
differ significantly from patients with EH (16.3 10,3/6.6 3.4
pmol/ml). NP and EH had a comparable exercise dependent regulation
profile with a peak level of ANP/cGMP of 49.6 22.4/7.5 1.7
pmol/ml (NP) and 53.6 42.5/9.8 3.5 pmol/mI (EH). The degree of
ANP decrease after 12 mm of recovery was similar in NP and EH (NP:
—31% and EH: —38%). After giving betaxolol or captopril the systolic
and diastolic blood pressure decreased by 13/16mm Hg and 17/19 mm
Hg, respectively. With betaxolol there was a significant increase of
ANP at all workload levels (76 26%, P < 0,01). With captopril
medication however, the ANP response was smaller at all workload
levels (—16 8%, P < 0.05). PRA also revealed a slight exercise
dependent increase. Plasma levels at rest and during stimulation were
not different comparing NP and EH (at rest: NP 2.0 0.8 EH 2.2 1.2
ng/ml hr). Conclusions: 1.) ANP and cGMP-concentrations were not
different between healthy subjects and patients with a slight to moder-
ate EH at rest and during dynamic exercise. 2.) Under medication with
betaxolol the plasma levels of ANP were significantly elevated, while
captopnl had a lowering effect. 3.) During exercise ANP and PRA did
not show an inverse regulation profile as it was found under acute
volume loading.
ANP, cGMP and renin-angiotensin-aldosterone-system (RAA-system)
after allogene renal transplantation. J. Plum, W. Scholtz, F. Kemmer, B.
Grabensee, Department of Nephrology, Heinrich-Heine-University,
Düsseldorf, Federal Republic of Germany. Up to now, there is little
information about the behavior of ANP/cGMP and its interactions with
the RAA-system after renal transplantation. Methods: Consecutive to
allograft renal transplantation, the following parameters were registered
(day 1—14: daily; 15—21: every 48 hr) in Ii patients (age: 39.5 10.4
years): ANP, cGMP, plasma renin activity, aldosterone, plasma and
urinary sodium, potassium, creatinine and clinical values like body
weight, central venous pressure, blood pressure. According to the
transplant function the patients could be divided into two groups: 7
patients with primary function (PF) and 4 patients with acute renal
failure (ARF). Results: The PF-group had high ANP values immediately
after transplantation with a maximum on the third postoperative day
(1048 490 pg/mi), At this time concentrations were significantly
higher (790 602 pg/mI; P < 0.05) than in the ARF-group. ANP in the
PF-group then fell steadily until the 21st day to 335 144 pg/mI. After
3 weeks, 6 of 7 patients in this group had a normal serum creatinine
(1.18 0.12 mg/dl). Nevertheless, ANP values were still higher (325
155 pg/mI, P < 0.001) than those in normal man (62 27 pg/mI; N =
60). In the ARF-group ANP levels remained on a high level without a
tendency to decline (21st day: ANP 601 476 pg/mI). ANP was
correlated in all patients (PF + ARF) with the following parameters:
central venous pressure (r = 0,57; P < 0.001), difference from the body
dry weight (r = 0.36; P < 0.001) and cGMP (r = 0.29; P < 0.001). In the
PF-group PRA (1.3 1.1 ng/ml x hr) and aldosterone (124 149
pg/mI) were lower than in the ARF-group (PRA 3.7 3.0 ng/ml x hr;
aldosterone 484 482 pg/mI). As reported in normal man ANP and
PRA revealed an inverse correlation (PF =
—0.13, NS; ARF = —0.21,
P < 0.05). During acute rejection in the PF-group we found a distinct
increase of ANP, which did not appear in the early phase of rejection
but after decrease of urinary flow. We could not detect a correlation
between ANP and rejection in the ARF-group. Conclusion: 1.) ANP
and cGMP concentrations are markedly elevated in the early period
after transplantation. Values decline in patients with primary function
and remain on high levels in acute renal failure. 2.) There is a close
relation between ANP and cGMP and a negative correlation between
ANP and PRA/aldosterone in the posttransplant period. 3.) ANP
appears to be a sensitive parameter for body fluid state (central venous
pressure, difference from dry weight) but is not an early indicator of
rejection. 4.) High ANP values after transplantation seem to be useful
to stimulate the transplant function.
Differences in ischemic energy metabolism between cortex and medulla
of protected sheep kidneys. G. Kehrer, A. Aminalai, M. Blech, H.
Kleinert, M. Langheinrich, T. T. Chang, U. Helmchen, and H.J.
Bretschneider, Zentrum Physiologie und Pathophysiologie, Universität
of GOttingen, Federal Republic of Germany, Individual nephron sec-
tions not only differ functionally but also with regard to metabolism
(Guder WG, Ross BD: Kidney mt 26:101—111, 1984). Differences in
metabolism are likely to be responsible for different ischemia tolerance
(Brezis M et al: J C/in Invest 76:1796—1807, 1985). Therefore, in a
clinically relevant model, we investigated energy metabolism of pro-
tected sheep kidneys separately in cortical and outer medullary tissue
and explored to what extent glucose as an additive to protective
solutions is metabolized glycolytically in renal cortex. For it sheep
kidneys were perfused either with Bretschneider's HTK solution (N =
6) or with HTK + 10 m glucose (N = 12). Afterwards the kidneys
were incubated at 25°C. Individually for cortex and outer medulla either
metabolites or tissue pH were analyzed continuously. The results after
5/180 mm are as follows:
HTK solution HTK + 10 mri glucose
Cortex Medulla Cortex Medulla
ATP 12.2/0.4 11.3/1.1 14.2/1,1 14.9/1.8
Lactate 5/39 12/134 4/102 15/191
Glucose 9/2 15/1 66/23 61/15
pH 7.62/7.14 7.36/6,88 7.34/6.96 7.30/6.68
Conclusions: I) Probably mainly in virtue of a different substrate
provision, under HTK protection lactate formation in cortical tissue
(with 5- and S-sections of the proximal tubule) is lower than in the Outer
renal medulla. 2) With 10 m glucose in the solution glucose utilization
and additional lactate formation are comparable in cortex and medulla.
3) Hence, in the condition of adequate substrate supply also the
proximal tubule is able to provide energy glycolytically during isch-
emia. Supported by the DFG, SFB 330-Organprotektion, GOttingen
Aminoglycoside-antibiotic drugs have no influence on Na/H-an-
tiporter at the brush border membrane of human proximal tubulus. W.
Grotz, K. Haag, M. Sellinger, P. Schollmeyer, H. Knauf, Department
of Medicine University Freiburg and St. Bernward Krankenhaus,
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Hildesheim, Federal Republic of Germany. A study was performed on
the influence of aminoglycoside-antibiotic drug (AG) on cation trans-
port at the human brush border of the proximal tubulus. Membrane
vesicles (BBV) were prepared with a Mg-EGTA preparation from
normal renal cortex tissue (after tumor nephrectomy). This preparation
resulted in a 10-fold enrichment of BBM-marker (AAP and AP),
whereas intracellular markers decreased to 0 to 0.3-fold activity in the
homogenate (NAC-glucosaminidase, cytochrom c-oxidase). Preloading
with an outside directed Na-gradient of 65: 1 caused an intravesicular
acidification measured by a pH-sensitive dye (Acridinorange AO 30
yM). In controls calibration of the absorption signal was possible by a
monotone relation between pH-gradient and extinction. Measurement
under voltage clamp conditions a 50% acidification was preserved
indicating an electroneutral Na/H antiport. K loading of the
vesicles resulted only in a small pH-gradient. Administration of AG
induced an increase of acidification (30 to 90%) in Na-preloaded
vesicles in dependency of concentration (10—6 to l0 M AG), however,
not in K-preloaded vesicles. Under voltage clamp conditions no
change of acidification was seen under AG. An influence of AG on the
Na/H-antiporter could be excluded so far. The results might indicate
an altered ion permeability by AG.
Atrial natriuretic factor attenuates oxygen metabolite-induced suppres-
sion of prostaglandin production by rat mesangial cells. S.G. Shaw, A.
Kurtz, P. Weidmann, Medizinische Universitdts-Poliklinik Bern, Phys-
iologisches Institut Universität Zurich, Zurich, Switzerland. Suppres-
sion of glomerular PGE2 production by reperfusion-induced formation
of reactive oxygen metabolites (ROM) may exacerbate acute renal
failure (ARF) following renal ischemia. Previously we have shown that
human-atrial natriuretic factor (ANF) protects agasinst ischemic ARF.
To investigate cellular mechanisms of action, effects of ANF on
ROM-induced suppression of ionomycin-stimulated PGE2 formation
were assessed in rat mesangial cell cultures (MCC). MCC were estab-
lished from isolated rat glomeruli and plated into 24-well culture plates
in RPMI-1640 medium. MCC were washed twice with a HEPES-
buffered salt solution (BSS) then incubated in 0.5 ml of the same
medium with or without H202 (5 x l0 M for 30 mm at 37°C. After
exposure to H202 or control solutions, cells were incubated under the
same conditions in 0.5 ml of BSS plus the calcium ionophore ionomycin
(5 fsM). After addition of indomethacin (2 x j—5 M) all supernatants
were frozen at —70°C until assay. Cells were dissolved in 0.2 ml of 1 N
NaOH for protein estimation. ANF (0.1, 1.0, 1000 ng/ml) was added
during or after H202 treatment. lonomycin-stimulated PGE2 formation
by MCC in the presence of ANF was reduced from a control value of
106 6 (N = 8) to 92 5, 80 4 and 68 7 ng/mg protein at ANF
doses of 0.1, 1.0 and 1000 ng/ml, respectively (N = 4). H202 treatment
without ANF reduced stimulated PGE2 production to 35% (37 2
ng/mg protein, N = 8). At the optimum dose (0.1 ng/ml), ANF given at
the same time as H202 preserved the ability of H202-treated MCC to
respond to ionomycin and maintained stimulated PGE2 production at
60% of control (64 10 ng/mg protein, N = 6, 2P < 0.05). ANF was
similarly effective when given after H202 treatment and maintained
PGE2 production at 54% (50 2 ng/mg protein) of the respective
control (2P < 0.05). The results show that ANF administration during
or after exposure to H202 can protect cultured mesangial cells at the
cellular level against the consequences of exposure to ROM. This
suggests that part of ANF's protective action in ischemic ARF may
involve attenuation of ROM-induced damage on reperfusion.
Renal tissue and circulating catecholamine abnormalities during gen-
tamycin-induced acute renal failure. 5G. Shaw and P. Weidmann,
Medizinische Poliklinik, University of Berne, Berne, Switzerland. The
decrease in glomerular filtration rate (GFR) which often accompanies
aminoglycoside antibiotic administration is suggested to initially result
from a reduced filtration coefficient combined with vasoconstriction.
Catecholamines and angiotensin have been considered as potential
mediators of these effects, but evidence is lacking. To investigate the
possible role of catecholamines (CA), single kidney Cl4-inulin clear-
ance (GFR) and arterial and renal tissue concentrations of free norep-
inephrine (NE), epinephrine (E) and dopamine (DA) (by HPLC with
electrochemical detection) were measured in 6 groups of Sprague-
Dawley rats before and for 9 days during the course of acute renal
failure induced by 3 initial daily intraperitoneal injections of 200 mg/kg
gentamycin sulphate. All samples were taken under pentobarbital
anaesthesia. Results are shown for the first 5 days (mean SCM, N =
8). ap < 0.05 vs. normal controls.
Day 0 Day I Day 2 Day 3 Day 5
GFR 0.5 0.01 0.47 0.02 0.35 0.01 0.3 0.01 0.14 0.02
rn/I
mini
100 g
Plasma ngidl
NE 30±3 31±4 l08±3la l26±20a 30±3
E 5 1 10 3 106 25 84 l7 30 10
DA 43±12 45±6 58±11 60±23 30±7
Cortex ngiprotein
NE 1350 120 1400 140 1000 98 486 28 1500 201
E 20 4 30 7 80 12 100 35 135 l2
DA 28±6 32±4 76±10 38±8 48±9
Medulla nglg proteinNE 778 79 807 147 693 38 340 69 850 98
E 21 7 31 11 128 l8 209 154 24
DA 26±7 27±5 71±8 48±9 44±11
Conclusion: The early phase of gentamycin-induced acute renal failure
in the rat is associated with abnormalities in circulating and renal tissue
CA which have the potential to contribute to the initial loss of normal
renal function.
Continuous hemofiltration in cases of acute renal failure (ARF) with
double-lumen Shaldon catheters. H. Kierdorf, J, Kind/er, B. Heintz, N.
Maurin, HG. Sieberth, Department of Internal Medicine II, RWTH
Aachen, Federal Republic of Germany. The treatment of ARF by
continuous pump-assisted venovenous hemofiltration (CVVH) repre-
sents a further development of the continuous arteriovenous hemofil-
tration technique (CAVH) described by Kramer in 1977. CVVH is
performed with the aid of a blood pump installed in the extracorporal
circulation, enabling any desired hemofiltrate rate to be attained.
Arterial puncture is unnecessary, treatment usually being carried out
via two central vein Shaldon catheters. Double-lumen Shaldon cathe-
ters for acute dialysis have been available for several years. The study
seeks to determine whether an effective CVVH can be performed using
such double lumen Shaldon catheters. A double-lumen Shaldon cathe-
ter (Quinton Co., Seattle, WA, USA) was placed in the Vena jugularis
of 15 patients with oliguric/anuric ARF of varying etiologies. The
external diameter of the catheter was 3,8 mm. Continuous filtration was
carried out with all patients as previously described using an electronic
balancing device. Results: The average daily filtration rate was 19.5 liter
over an average treatment period of 14.3 day and an average blood flow
of95 mI/mm. Retention values were improved in all cases: the average
serum urea concentration fell from 38.2 to 21.2 mmol/liter and the
serum creatinine concentration from 472 to 285 smol/liter after 72
hours of treatment. No additional intermittent hemodialysis treatments
were necessary. Clinically, there were no additional complications in
connection with the inserted catheters. Catheters were changed at an
average interval of 10.4 days, staphylococcal sepsis occurring in two
cases. Autopsies (8 patients) revealed a complete, collateralized throm-
bosis of the Vena jugularis in two cases. Conclusion: Continuous
hemofiltration using double-lumen Shaldon catheters proved an effec-
tive form of treatment for ARF. Unlike other hemofiltration methods, it
requires puncture of only a single large lumen vessel. Despite the 3.8
mm external diameter of the catheter employed for the treatment, no
increase in catheter related complications was observed in the patient
group under examination.
Influence of metyrapone on carbohydrate metabolism of isolated rat
hepatocytes in bilateral nephrectomized rats W. Riegel, M. Kuhlmann,
P. Schollmeyer, WH. Härl, Medizinische Universitdtsk/inik, 7800
Freiburg, German Democratic Republic. Glucocorticoids stimulate
liver gluconeogenesis (GNG). Bilateral nephrectomized rats show ele-
vated levels of corticosterone after 24 hours. Metyrapone inhibits
biosynthesis of corticosteroids. The present study demonstrate GNG of
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isolated hepatocytes and the time course of blood sugar in acutely
uremic and sham operated rats treated with metyrapone or vehicle.
Twelve-hour starved, female Sprague-Dawley rats were sham operated
or bilateral nephrectomized. Immediately after operation metyrapone (5
mg/l00 g body weight) was i.p. injected in the half of animals in each
experimental group (SOMP, BNMP). The others were i.p. injected with
0.9% NaCI(SO, BN). The injection of metyrapone and 0.9% NaCI was
repeated 24 hours later. Blood sugar was assayed 0, 1,24,6, 12, 24, 26,
28, 30 hours after the operation. GNU was defined as production of
glucose from Na-pyruvate, 1-serine or dihydroxy-acetone (each 10 mM)
within 30 minutes of incubation. SOMP rats showed significantly
elevated blood sugar levels compared with SO rats 2 and 4 hours after
application of metyrapone (that is, 2, 4, 26 and 28 hours after opera-
tion). Two and 4 hours after operation BNMP animals also had elevated
blood sugar levels compared with BN group (2 hr: 268 13 vs. 125
4; 4 hr: 230 10 vs. 121 3 mg/dl). In contrast, 26 and 28 hours after
operation glucose levels in BNMP animals were significantly lower
compared with BN (26 hr: 89 11 vs. 135 8; 28 hr: 90 12 vs. 170
15). Two hours after operation hepatocyte GNG from all substrates did
not differ between BNMP and BN. In contrast, after 26 hours liver cells
from BNMP rats showed significantly lowered GNU compared with BN
(such as, pyruvate: 48.4 5.6 vs. 86.6 12.9 nmol/mg protein/30 mm).
Acute uremia seems to evoke a fast exhaustion of carbohydrate stores.
The compensatory enhanced gluconeogenesis can be inhibited by
blocking of glucocorticoid synthesis. Our data show that glucocorti-
coids play a key role for the regulation of gluconeogenesis in acute
uremia.
Uremic peptides and middle-molecules—Do they really exist? D. Mai-
wald, F. Bliiker, and W. Thorn, Abteilung für Biochemie der Univer-
sität Hamburg. The middle-molecule hypothesis holds substances in
the mol mass region between 500 and 2.000 Dalton responsible for
uremic toxicity, in addition to almost known low molecular metabolites.
If this is correct, it should be possible to detect increased amounts of
peptides in serum or hemofiltrate during uremic diseases. Investigations
were done by two different methods: 1.) Pre-separation of an ultrafil-
trated dialysate (10.000 D exclusion size) by gel filtration chromatogra-
phy and isotachophoretic analysis of the native and fluorescence
marked fractions separated by gel filtration. 2.) Separation of amino
acids and peptides by copper chelat chromatography, followed by
two-dimensional thin-layer chromatography of the dabsylated peptide
fraction before and after acid hydrolysis. Analysis of the acid hydro-
lyzed peptide fraction on an amino acid analyzer. No significant
accumulation of uremic peptides could be detected neither in serum nor
in dialysate. Preparative isolations from dialysate yielded not more than
3 mg of peptides compared to a 24-hour urine volume.
Left ventricular diastolic function in patients on maintenance hemodi-
alysis—A dopplerechocardiographic study. W. Josephs, P. Lenga, H.J.
Odenthal, H. W. Wiechmann and Med. Klinik, University of Bochum,
Marienhospital Herne 1, Federal Republic of Germany. For description
of hemodynamic changes in patients on maintenance hemodialysis up to
now parameters of systolic LV-function have been used. Systematic
investigations about the incidence and determinants of a reduced
diastolic LV-function, however, are missing. By doppler echocardiog-
raphy recently a non invasive method for characterization of diastolic
LV-function is available. In 50 patients (22 & 28 9) on maintenance
hemodialysis—mean age 52.7 16.3 years, mean duration of dialysis
treatment 4.2 16.3 years—therefore by continuous wave doppler
echocardiography from apical position the transmitral diastolic inflow
was recorded, As parameter of diastolic LV-function the relation of
peak early (YE) and late (VA) diastolic filling velocity was calculated
and correlated with age, duration of dialysis treatment, systolic LV-
function, degree of LV-hypertrophy, renal hypertension, renal anaemia
and interdialytic fluid overload. Compared with normal patients VE/VA
was found reduced (0.98 0.31) in 78%. In patients with YE/VA < 1.0
the thickness of the interventriculár septum was found significantly
higher—16.2 2.2 mm vs. 14.5 3.4 mm—and the demand for
antihypertensive drug treatment was significantly higher—I .6 0.6 vs.
1.2 0,8 substances—compared with patients with VE/VA> 1.0. No
difference was found regarding age, duration of dialysis treatment and
systolic LV-function, Correspondingly VE/VA was found significantly
reduced—0.87 0.22 vs. 1.10 0.36—in patients with severe renal
hypertension, markedly reduced—0.95 0.31 vs. 1.10 0.32—in
patients with LV-hypertrophy, however, without significant difference
regarding degree of renal anaemia and interdialytic fluid overload.
Conclusion: In most patients on maintenance dialysis a restriction of
diastolic LV-function can be demonstrated. The reduction of passive
early diastolic filling fraction and increasing contribution of active late
diastolic atrial contraction is correlated with the extent of LV-hyper-
trophy and the degree of renal hypertension, not, however, with
duration of dialysis treatment, systolic LY-function and degree of renal
anaemia and interdialytic volume overload.
Ionized and total blood calcium in patients with normal and impaired
renal function. H. Freudiger, Z. Glück, Ch. Haldemann, Division of
Nephrology, Regionaispital Biel, CH-2502, Switzerland. Hypocalcemia
is a frequent feature of advanced, but not of early and moderate renal
failure. Whereas PTH elevations are already found in the latter condi-
tions, it is still a matter of debate whether hypocalcemia is an obligatory
factor in the initiation of parathyroid hyperfunction in renal failure.
Whereas in most studies total calcium (Ca tot) was measured, only
limited data is available as to the ionized blood calcium levels (Ca ion)
at different degrees of renal function, Therefore, we measured Ca tot
and Ca ion in 152 non-selected patients, most of which were electively
admitted to a surgical ward. Patients with acute renal failure, or those
whose diet was supplemented by vitamin D or calcium were excluded.
Blood samples were drawn after an overnight fasting period and Ca ion
was measured within 2 hs by an ion selective electrode (AVL Schaff-
hausen). Serum creatinine, Ca tot and proteins were measured by
standard methods. Serum creatinine levels ranged from 54 to 1128
mol/liter. Ca ion and Ca tot for normal renal function, slight,
moderate and severe renal impairment were (results 1 SD):
5Cr jmol/ 120 121—240 241—360 36l
liter
N 104 27 10 11
Ca tot 2.35 0.16 2.36 0.20 2.26 0.34 2.12 0.23
mmol/
liter
P vs. — 0.701 0.149 0.001
creat
120
Ca ion 1.25 0.06 1.25 0.06 1.18 0.11 1.09 0.15
mmol/
liter
P vs. — 0.996 0.002 0.001
creat
 120
Using a multiple regression analysis creatinine correlated with Ca ion (P
z 0.007), but not with Ca tot (P 0.647), age (P 0.117), or serum
protein (P  0.267). Conclusion: Ca ion, but not Ca tot is significantly
depressed in moderate renal failure and serum creatinine correlates
significantly only with Ca ion. Therefore, Ca ion may be a more
sensitive indicator than Ca tot for beginning renal osteopathy.
Effects of piretanide on calcium and phosphate-excretion In patients
with chronic renal failure. A. Dorfler, W. Schulz, II! .Med.Clinics and
Institute of Nephrology, Bamberg, Federal Republic of Germany.
Hyperphosphatemia and hypocalcemia are important factors in devel-
opment of renal osteopathy. This study investigated the influence of the
loop diuretic piretanide (PN) on excretion of Ca and P in patients with
chronic renal failure (CRF). Twelve patients with CRF (group I: crea
less than 350, group 11 crea above 700 Mmol/liter) were treated with 60
mg PN i.v. and after a wash-out period of 2 days orally. Urine was
collected hourly until 6 hr after medication, thereafter in 6 and 12 hr
fractions and electrolyte content was measured. Twenty-four hour
Ca-excretion rose by 170 to 230% in group I and by 100 to 130% in group
II. Phosphate remained unchanged in group 1 and increased slightly in
group II.
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Day Day Day
1 2 3
Day Day Day
4 5 6
60 mgPN i.v. 60 mgPN p.o.
Calcium 1 0.85 284b 0.51 0.87 2.29a 057
mmol/24 hr
II
1.06 1.94 0.49
049 099b 0.45
0.45 0.42 0.37
0.82 2.02 0.63
0.40 1.12c 0.40
0.42 0.47 0.34
Phosphate I 27.9 27.8 27.7 25.0 26.3 32.8
mmolI24 hr
II
24.0 27.3 22.0
11.7 16.3 14.1
4.9 9.6 9.5
25.6 32.4 40.9
14.0 19.3 14.5
7.2 11.2 6.5
a P 0.05; b P 0.01; C P 0.001 (paired t-test)
Data given as mean and standard deviation PN has high calciuric effect
even in patients with CRF. Hyperphosphatemia is not influenced suffi-
ciently. This fact has to be considered for development of osteopathy.
Differential effect of steroids and chloroquine on the intestinal absorption
of aluminum and calcium. T.H. Ittel, A. GrieJiner, B. KOppe, and H.G.
Sieberth, Medizinische Klinik II, RWTH, Aachen, Federal Republic of
Germany. In rats with normal renal function the intestinal absorption of
aluminum appears to be partly vitamin D dependent. To further charac-
terize the similarities between the absorption of aluminum and calcium we
investigated the effect of prednisolone and chloroquine (CQ) in Sprague-
Dawley rats with normal or reduced renal function. Both agents interfere
with lysosomal function and have been reported to reduce the intestinal
absorption of calcium. To assess the intestinal absorption of aluminum we
monitored urinary aluminum excretion and serum aluminum concentra-
tions following an oral load of 11 mg aluminum. Calcium absorption was
calculated from the differences between an orally administered dose of
45calcium and faecal excretion. CQ (225 mg/kg i.p.; 3 day) as well as
prednisolone (25 mg/kg) significantly reduced calcium absorption (% dose)
in vitamin D-replete rats with normal renal function (CQ: 39 5%,
prednisolone: 42 3%, control: 58 11%). In contrast neither drug
reduced urinary aluminum excretion (CQ: 16.2 5.5 tg/5 day, pred-
nisolone: 13.4 3.7 tg/5 day, control: 12.3 3.2 g/5 day) or the
post-load rise in serum aluminum following oral exposure. When alumi-
num was administered intravenously recovery of aluminum was compa-
rable between treatment groups and controls. In uremic rats (subtotal
nephrectomy) urinary excretion rates of aluminum were larger after an oral
load compared to controls and administration of prednisolone or CQ had
no effect on the pattern or amount of urinary aluminum excretion. In
conclusion: (a) the divergent effects of prednisolone or CQ on the
absorption of aluminum and calcium may relate to different mechanisms of
intestinal uptake and transfer of both cations. (b) Inhibition of lysosomal
function does not appear to affect renal excretion of aluminum. (c) The
enhancement of intestinal aluminum absorption in uremia does not involve
pertubation of lysosomes.
Serum parathyroid hormone concentration after intravenous
1,25(011)21)3 treatment in hemodialysis patients. W. Probst, J.A. Fischer,
U. Binswanger, Nephrologische Station und Forschungslabor für Calci-
umstoffiechsel, Dept. für Innere Medizin, Universitiit Zurich, Switzer-
land. Eleven patients on chronic hemodialysis treatment 3 times weekly
2.5 to 4 hours using high flux polysulfon filters F 60 and acetate dialysate
with calcium of 1.5 mmol/liter received I sg of I ,25(OH)2D3 i.v. (Calci-
ject, courtesy of Abbott Comp.) after each dialysis for 3 weeks. Phosphate
binders were CaCO3 mainly, in a few patients supplemented by moderate
amounts of Al(OH)3. Ionized calcium was measured by ISE (AVL),
normal values being 1.28 to 1.42 mmol/liter. PTH was estimated by a
N-terminal sensitive assay; normal values are <0.25 ng/ml. Results were
as follows (mean + /—sD; I before, H after 1 ,25(OH)2D3):
I II
Ionized calcium before HD 1.19 0.12 1.17 0.14
Ionized calcium after HD 1.33 0.07 1.30 0.09
PTHbeforeHD 1.39± 0.71 1.38
PTH after HD 0.64 0.22 0.60 0.17
Phosphate before HD 1.85 0.48 2.18 043b
a Corrected for hemoconcentrationb vs. II: P < 0.05
No change of PTH concentrations and ionized calcium before and after
hemodialysis treatment could be documented after i.v. l,25(OH)2D3
treatment. Mild and severe hyperparathyroidism reacted not differ-
ently. These data are in contrast to recently published work and
question a short time effect of 1 ,25(OH)2D3 at stable serum ionized
calcium.
Lovastatin and gemfibrozil in nephrology. H. Kopsa, A. Lapin, 0.
Janata, R. Osterode, First Medical Clinic, Institute of Clinical Chem-
istry and Laboratory Diagnosis, Chemotherapeutic University Clinic,
University of Vienna, Austria. Influence of lovastatin and gemfibrozil
on lipid metabolism was studied in 32 renal patients. In group 1 were 8
cases with chronic renal insufficiency and nephrotic syndrome, in group
2 were 4 cases with nephrotic syndrome and normal kidney function, in
group 3 were 12 patients with diabetic nephropathy and in group 4 were
8 renal transplant recipients with proteinuria more than 3 g/liter.
Parameters of lipid metabolism were cholesterol, HDL, LDL, VLDL,
triglycerides, apolipoprotein A and B, lipoproteinlipase activity and
lipid electrophoresis. Therapy of basic renal disease and concomitant
medication remained unchanged in all cases. Lovastatin was used in
hypercholesterinemia, Gemfibrozil in elevated cholesterol and triglyc-
eride levels. In group I mean serum cholesterol decreased from 310
mg/dl to 265 mg/dl, mean serum triglycerides decreased from 520
mg/dl to 290 mg/dl. In group 2 lowering of lipid metabolism parameters
was poor and did not differ significantly between lovastatin, gemfibrozil
and conventional fibrate therapy. In group 3, however, therapeutic
results with the new substances were excellent, in 9 patients with
diabetic nephropathy normal lipid status could be achieved. Improved
compliance and information of diabetics as well as successful antidia-
betic therapy influenced metabolic condition too. In group 4 elevated
serum lipids are a consequence of basic immunosuppression with
corticosteroids and cyclosporin A and use of methylprednisolone for
acute graft rejection. Serum cholesterol levels decreased from 285 mg/dl
to 225 mg/dl, serum triglycerides decreased from 330 mg/dl to 240
mg/dl. The risk of atherosclerosis in renal patients with lipid metabo-
lism disturbances can be significantly reduced by use of lovastatin and
gemfibrozil.
Erythropoietin (EPO) in polycystic kidneys. K.-U, Eckardt, M. Mo/i-
mann, R. Neumann, R. Brunkhorst, H.-U. Burger, G. Lonnemann, H.
Schoiz, G. Keusch, B. Buchholz, U. Frei, A. Kurtz, Department of
Physiology, University of Zurich, Switzerland; Departments of Anaes-
thesiology and Transplant Surgery, University of Münster, FRG;
Department of Nephrology, Medical School Hannover, FRG; Depart-
ments of Pathology and Internal Medicine, University of Zurich,
Switzerland. The moderate degree of renal anemia in patients with
autosomal dominant polycystic kidney disease (ADPKD) is generally
attributed to serum EPO levels that are about twofold higher than in
patients with renal failure of other etiologies. Eighteen patients with
ADPKD were therefore studied to obtain information about the capa-
bility of polycystic kidneys to produce EPO, the intrarenal site of EPO
formation, and the regulation of EPO formation in ADPKD. Arterio-
venous concentration differences for EPO (RIA) in 5 kidneys were 3 to
33 mU/ml. EPO levels in cyst fluid from 357 renal cysts (RIA and in
vivo bioassay; 13 cysts from 6 patients punctured in vivo, 344 cysts
from 12 patients punctured immediately after nephrectomy) ranged
from <5 to 3200 mU/mI. Average amount of EPO in cysts was
positively correlated with serum EPO concentrations. High EPO con-
centrations were preferentially found in small cysts and cysts with
sodium concentrations >100 mmol/liter. This preferential enrichment
of EPO in proximal cysts may either result from higher permeability of
these cysts as compared to distal cysts or indicate a role of proximal
tubular function in EPO formation. Protein concentrations and oxygen
tension (12 cysts) in cysts were not correlated with EPO levels. mRNA
for EPO was detected by in situ hybridization (human cDNA probe) in
stroma cells of cyst walls. Serial sections revealed no evidence for
colocalization of EPO mRNA and factor VIII antigen, suggesting EPO
production outside endothelial cells. The results indicate that single
interstitial cells in polycystic kidneys produce EPO independent of
oxygen tensions in the cysts, which may ameliorate renal anemia in
ADPKD. EPO in cysts could result from 'overflow" of EPO produced
in the interstitium and appears to reflect production capacity of the
kidney.
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Recombinant human erythropoietin (rhEPO) in patients with chronic
renal insufficiency in the predialysis period. 0. Traindl, M. Franz, J.
Kovarik, 2nd Department of Internal Medicine, University of Vienna,
Austria. Worsening kidney function is often associated with the devel-
opment of renal anemia. To investigate the effect of rhEPO in such
patients we treated 19 patients (12 kidney graft recipients, 4 pts. with
chronic glomerulonephritis, 1 with polycystic kidney disease, I with
amyloidosis and 1 with an analgesic nephropathy) with rhEPO. The
mean serum creatinine was 4.9 mg/dl (range from 2.4 mg/dl to 9.7
mg/dO. A dose of 75 U per kilogram of body weight was given twice a
week subcutaneously, The average application duration to date was 9
weeks (from minimum 5 weeks up to 20 weeks). Mean hemoglobin
increased from 6.6 g/dl, +1— 1.74 to 8.74 g/dI, +/— 2.86, P < 0.05.
Only one kidney transplanted patient did not respond to rhEPO-therapy
because of azathioprine-induced bone marrow depression. Renal func-
tion did not alter significantly. Before rhEPO-therapy, mean serum
creatinine was 4.9 mg/dl and 5.4 mg/dl (NS) at the end of the
observation period. Our initial findings show a positive effect of rhEPO
on the erythropoiesis in patients developing renal anemia and were
accompanied by an increase in life quality parameters (P < 0.05). We
conclude that rhEPO-treatment in patients with chronic renal insuffi-
ciency has many beneficial effects and prevents frequent blood trans-
fusions in the predialysis period.
Ilemorheological changes after correction of renal anemia by erythro.
poletin (EPO). M. Pot/ok, R. Brunner, H.M. Steffen, C.A. Baldamus,
Departments of Medicine and Ophthalmology, University of Cologne,
Federal Republic of Germany. Hypertension after correction of renal
anemia by EPO has beefi attributed to changes in blood rheology. The
following rheological parameters were determined in stable, chronic
hemodialysis patients: hematocrit (Hct; vol%), apparent whole blood
viscosity (Vis; mPas), plasma viscosity (PV; mPas), erythrocyte aggre-
gation (Agg; rel. U.), and erythrocyte filterability (Fil; rel. U.).
Patients:
I. pre and under (8 (N 10)
w.)EPO(N=9), 4-
II. long-term EPO,
>12 mo. (N = 10),
III. high Hct, no
EPO (N = 10),
IV. low Hct, no
EPO (N = 9).
Groups I II III IV
EPO 0 short long 0 0
Hct 25 36 30 39 23
PV 1.6 1.5 1.4 1.5 1.6
Vis 2.5a 2.9 2.7a 34 2.6
Agg 4.8a 3.6 5.3 4.8 4.6
Fil — — 15.9 15.4a 13.0
ap < 0.05, t-test
At constant PV Vis increases with rising hematocrit but not as expected
from the initial Vis/Hct correlation (fig.) This is explained by improved
erythrocyte filterability. This effect is not EPO but Hct dependent (H,
III, IV). The decrease of Agg is due to younger erythrocytes and
disappears under long-term EPO (II).
Influence of therapy with erythropoietin on the physical and psycho-
logical fitness in end-stage renal failure patients. H.J. Muller, D.
Abitzsch, J. Niemann, F. Scheler, Department of Nephrology, Univ.
Hospital, GOttingen, Federal Republic of Germany. A variety of
psychological tests and a spiroergometric examination were performed
in 10 patients with end-stage renal failure (aged 30 to 63 years) before
(Hb = 6.8 0.4 g/dl) and after successful treatment with erythropoietin
(Erypo, Cilag) (Hb = 10.5 0.5 g/dl). Treatment after each dialysis
began with a weekly dose of 150 U/kg erythropoietin. Within 6 to 12
weeks all patients reached Hb-concentrations above 10 g/dl and had
stable blood values with a reduced dose between 50 to 100 U/kg per
week thereafter. One patient with secondary hyperparathyroidism
needed a dose of 300 U/kg per week. All patients with initially normal
serum ferritin levels developed iron deficiency. The maximal work
capacity increased from 70 16 to 90 13 watt, the endurance rose
significantly by 25 5% and the maximal O2-uptake by 15 6%.
Concentration, endurance and mood were influenced positively by
treatment with erythropoietin, as was shown by psychological tests.
Cardiovascular complaints and cold intolerance were significantly im-
proved. Therapy with erythropoietin can therefore correct the reduced
physical and psychological fitness in patients with end-stage renal
failure.
Changes in the adrenergic system during therapy of renal anemia with
recombinant human erythropoietin (rhEPO). R. Muller, H.M. Steffen,
R. Brunner, M. Pollok, J. Saric, R. Lang, C.A, Baldamus, Med. Klinik
II, Augenklinik, Med. K/ink I, Universität KOln, Federal Republic of
Germany. With our study we wanted to clear up if the increase in blood
pressure during therapy of renal anemia with rhEPO can be explained
by changes in the adrenergic system. Ten patients on chronic hemodi-
alysis requiring repeated transfusions were examined before and after
therapy with rhEPO (120 U/kg/HD over 2 to 4 months). The following
parameters were determined: mean arterial blood pressure (MAP),
regional peripheral resistance on the right lower leg (W:mm
Hg/ml/min/lOO ml tissue), RIA for the determination of plasma cate-
cholamines was carried out after the COMT-methode, alpha2- and
beta2-receptor density on thrombocytes and lymphocytes were deter-
mined after the specific binding of H3-Yohimbine and J'25-Cyanopin-
dolol, respectively.
Results:
before
rhEPO
after
rhEPO (MW sEM)
Hb 7.2 0.9 10.4 08b
MAP 88 15.5 101
W 25.8 9.1 32.4 13.4a
alpha2 574 76 384 49 (fmol/mg protein)
beta2 28.4 1.5 24.0 2.5 (mol/mg protein)
NA 498 100 383 75 (pg/mi)
A 44 7.6 54 9.2 (pg/ml)
Patients with renal anemia requiring blood transfusions showed unex-
pected high receptor densities. Increase in hemoglobin after rhEPO was
accompanied by increase in MAP and decrease in NA and alpha2
receptor density. We suppose a disturbance in receptor-hormone-
interaction that is diminished after correction of anemia resulting in an
increase in vasoconstriction due to a better vascular response to
adrenergic stimulus.
Improved exercise capacity of dialysis patients after rH-EPO therapy.
H. Jedicke, A. Voigt, R. Meierhenrich, H. Lange, Center of Internal
Medicine, Department of Nephrology, University of Marburg, Federal
Republic of Germany. In dialysis patients exercise capacity is reduced
to about 50% of normal values. Under rH-EPO administration an
increase of physical performance has been observed that was objecti-
fled by computer ergospirometry. As parameters relative exercise
capacity, heart rate, breathing volume and breathing frequency were
chosen. Investigations were performed in 9 patients each time before
dialysis at a defined hemoglobin level:
(A) Before rh-EPO administration: Hb (g/dl) 6.5—9.1
(B) Under rh-EPO therapy: Hb (gJdl) 9.7—10.7
(C) Under rh-EPO therapy: Hb (g/dl) 11.2—12.5
pre
Post>
2
10 20 30 40 50
Hematocrit 1%)
a P:0.05
b P:0.0l
Abstracts 1179
To test the maximum exercise capacity, work load was increased by
steps of 10 or 20 W/min. Results are presented as mean performance
during the last 2 minutes before stopping work load. Relative exercise
capacity increased by 18.2% in trial B and by 26% in trial C, compared
with initial performance, whereas heart rate decreased to 93.7% (B) and
92.1% (C), respectively. Changes in the same direction were ascer-
tained for breathing volume with a reduction to 91.4% (B) and 92.1%
(C), respectively as well as for breathing frequency with 84.7% (B) and
86.9% (C). The results show that exercise capacity is increased due to
correction of renal anemia. However, raising hemoglobin levels above
11 g/dl does not lead to an appropriate further increase of exercise
capacity or change of cardiopulmonary parameters.
Clinical experience with subcutaneous recombinant human erythropoi-
etin (rHuEPO) therapy in CAPD patients. I. Lubrich-Birkner, P. Scholl-
meyer, H.B. Steinhauer, Department of Internal Medicine, Division of
Nephrology, University of Freiburg, Freiburg, Federal Republic of
Germany. The rHuEPO-induced correction of renal anemia influences
blood viscosity and tissue oxygen supply. The aim of the present study
was to investigate the effects of long-term subcutaneous (SC) rHuEPO
treatment on dialysis efficiency in patients with chronic renal failure
undergoing CAPD. Eleven patients (8 female, 3 male; 43 6 years,
SD) with renal anemia (HKT < 28%) took part in the study. All patients
were stable on CAPD and free from peritonitis. The CAPD regime
remained unchanged in all patients during the study. Twice weekly the
patients underwent a study dialysate exchange in the morning with I .51,
1.5% dextrose monohydrate and a dwell time of 4 hours. rHuEPO was
administered SC twice weekly in an initial dose of 50 U/kg. This dose
was increased for 25 U/kg every 4 weeks until the target HKT of 35%
had been achieved. In the event this HKT was exceeded, rHuEPO was
reduced by 25 U/kg. After 8 weeks of rHuEPO treatment HKT
increased from 22.9 3.1 to 32.1 4.2%, hemoglobin rose from 7.8
0.9 to 10.5 1.5 g/dl. During the following 4 months HKT and
hemoglobin did not change significantly. The rHuEPO-induced rise in
HKT was associated with increased peritoneal ultrafiltration (UF). UF
improved from 130 93 to 258 90ml/4 hr dwell time (P < 0.03) after
6 months of rHuEPO. A positive, linear correlation was observed
between HKT and UF (r = 0.6837, P < 0.001). Increased UF resulted
in an improved creatinine clearance (P < 0.05). Two patients required
an increased antihypertensive therapy. No change was observed in
body weight, pulse rate, cardiothoracic index, and serum chemistry.
The present data open new perspectives in the treatment of CAPD
patients: I.) Renal anemia can be corrected effectively without severe
side effects by SC administration of rHuEPO. 2.) Compared to recent
studies with intravenous administration of rHuEPO in hemodialysis
patients the SC rHuEPO dose per week could be reduced by about
one-third without loss of efficacy. 3.) The observed rise in UF after
rHuEPO-induced correction of anemia might improve dialysis effi-
ciency and fluid balance in CAPD patients.
Accelerated turnover of the alternative pathway of complement in renal
failure as determined by the quantitation of complement activation
products in plasma. M. Oppermann, C. Kurts, E. Quentin, M.H.
Weber, 0. GOtze, Abteilung Immunologie and Abteilung Nep/irologie
und Rheumatologie, Universitdt Gottingen, Federal Republic of Ger-
many. Evidence for the continuing activation of the alternative pathway
of complement (APC) in patients with chronic renal disease was
obtained by the quantitation of the APC components C3 and factor B,
the regulatory proteins factor D and factor H, as well as the activation
fragments Ba, Bb, C3a, activated C3 (C3b/iC3b/C3dg) and C5a in
EDTA-plasma with the aid of highly specific monoclonal antibody-
based ELISA procedures. Mean plasma levels of the Ba-fragment were
elevated 16-fold (16.0 6.0 tg Ba/ml) in patients with end-stage renal
disease (ESRD, N = 61) requiring hemodialysis compared to healthy
controls (N = 55, 1.01 0.30 g Ba/mi) and were shown to be
increased more than 5-fold (5.24 4.04 g Ba/mi) in patients with
chronic renal failure (CRF, N = 41). A similar trend was observed for
the larger C3-fragments C3b/iC3b/C3dg (17.9, 30.3, 30.6 g actC3/ml
in controls, CRF, ESRD, respectively) whereas plasma levels of the
anaphylatoxins C3a and C5a remained in normal ranges (10.5 to 86.6 ng
C3a/ml and 0.30 to 2.19 ng C5a/ml), possibly due to the rapid removal
via binding to cellular C3a- and C5a-receptors. The impaired elimina-
tion of factor D, the rate-limiting protease of the APC which is present
in plasma in active form and that was elevated in patients with CRF
(4.35 3.03 g factor D/ml) and with ESRD (12.1 3.53 tg/ml)
compared to controls (1.05 0.27 g/ml), and/or the retention of lower
molecular wt complement fragments in chronic renal disease are
considered as underlying causes for the increased levels of APC
activation products observed in these patients. As the detected com-
plement protein fragments are known to exert immune regulatory
functions in vitro, these findings may imply that these peptides are
involved in the maintenance of the immune suppressed state in renal
failure.
Expression of functional IL-2 receptors in the early stage of chronic
renal failure. H. Dumann, S.C. Meuer, K.H, Meyer zum Buschenfelde,
and H. KOhler, 1st Department of Internal Medicine, Mainz and
Department of Appl. Immunology, DKFZ Heidelberg, Federal Repub-
lic of Germany. About 40% of dialysis patients show nonresponsiveness
after hepatitis B vaccination. In vitro studies reveal a decrease of
monocyte dependent T cell proliferation, decreased IL-2 production
and increased IL-2 receptor expression of T cells in these patients.
Application of exogenous IL-2 normalizes immune responsiveness in
uremic patients. Even patients in the early stage of chronic renal failure
show decreased seroconversion rates after hepatitis B vaccination. In
the present study we examined IL-2 receptor expression of patients in
different stages of chronic renal failure. T cells were isolated from 44
patients with chronic renal failure and 57 control persons by E-
rosetting. Monocyte depletion was achieved by adhesion and treatment
with monoclonal antibodies. T cell proliferation was stimulated with
anti-CD3. lL-2 was added to a final concentration of 4 U/mI. After 4
days of incubation T cell proliferation was measured by 3H-thymidine
incorporation. Expression of functional IL-2 receptors was indicated by
a stimulation index: SI = cpm 3H-Thy (IL-2 + aCD3)/cpm 3H-Thy(IL-2). Thirty patients were immunized with 20 g of recombinant
hepatitis B vaccine at 0, 1 and 6 months. Patients who developed
antibody titers higher than 10 U/liter were regarded as nonresponders.
The expression of functional IL-2 receptors was elevated in patients
with renal insufficiency. In the control group IL-2 receptor expression
was 4.62 0.36 (SI), in patients with serum creatinine <3.5 mg/dl 10.32
2.36and in patients with serum creatinine >3.5 mg/dl 11.48 1.86.
After vaccination with hepatitis B vaccine, seroconversion was 42.7%
patients with creatinine <3.5 mg/dl and 52.2% in patients with creati-
nine >3.5 mg/dl. These results show that cellular immunodeficiency is
present already in the early stage of chronic renal failure. There is a
close relationship between IL-2 responsiveness of T cells and responder
state to hepatitis B vaccination. Addition of exogenous IL-2 may also
be successful in this patient group.
Immune response and biocompatibility in hemodialysis. U. T. Seyfert,
F. W. Albert, W. Gdmbel, W. Wdrmell, and E. Wenzel, Abt. f. KIm.
Haemostaseologie u. Transfusions medizin, D-6650 Homburg/Saar
and Med. Klinik III, Stadt. Kliniken, D-6750 Kaiserslautern, Federal
Republic of Germany. The purpose of this study was to examine the
course of IL-2 during long-term hemodialysis using different mem-
branes and to discuss the interactions between bioincompatibility of
membranes, clinical symptoms and IL-2 release. Patients and methods:
10 patients (6 females, 4 males, age ranging from 34 to 57 years)
undergoing maintenance hemodialysis (range 2 to 8 years). Different
membranes (cuprophane, polyacrilnitrile) were used. Blood samples
were taken at the same times: 0, 25, 240 (HD end) mm. Interleukin 2
was determined by a commercially available ELISA (Genzym,
München) in citrated samples. Then the results were compared with 35
transplantees under stable conditions and 26 patients undergoing ste-
roid-sensitive and steroid-refractory rejection episodes. Results: IL-2
levels in patients with end-stage renal failure are raised 1.37 +/— 1.1
U/mi compared to a normal collective (IL-2 < = 0.5 U/mI). In patients
undergoing acute rejection episodes there was a rise of IL-2 levels of
26.8 U/mI compared to IL-2 levels of <0.5 U/mI in transplantees under
stable conditions. Bioincompatibility of membranes could clearly be
related to clinical signs of pruritus and hypotension. We found a 3- to
8-fold increase in IL-2 levels. Conclusions: Further studies are required
to confirm our hypothesis that biocompatibility in clinical applications
of biomaterials can be compared with some of the mechanisms of
rejection episodes after kidney transplantation.
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Interactions of blood with artificial surfaces. U. T. Seyfert, U. Grothe-
Pfautsch, F.W. Albert, E. Wenzel, Abt. f. klinische Haemostaseologie
und Transfusionsmedizin, Universitätskliniken, D-6650 Horn burg/Saar,
and Med. Klinik III, Städt. Kliniken, D-6750 Kaiserslautern, Federal
Republic of Germany. The first interaction between blood and surface
is the adsorption of plasma proteins. Protein deposition on the surface
is quickly followed by the adsorption of blood cells such as platelets,
white and red cells. We could demonstrate this schematic follow-up in
characteristic scanning electron micrographs of dialyzers during hemo-
dialysis. Clotting within the dialyzer is one of the most significant
clinical bioincompatibility parameter, but the biocompatibility of dia-
lyzers is influenced by many factors (sterilization, housing design, flow
characteristics, potting material), only one of which is the membrane.
Typical scanning electron micrographic features of different membranes
(cuprophane, polyacrilnitrile) using different anticoagulant therapy (un-
fractionated, low molecular weight heparin, CG 4203-GrUnenthal
Aachen, prostacyclin-Wellcome) can be demonstrated. Effective inhi-
bition of platelet activation nevertheless does not guarantee a clot-free
hemodialysis. Thrombogenicity of dialysis membranes has not been
eliminated, although anticoagulant therapy has a good antithrombotic
effect in chronic hemodilaysis.
Increase of C-reactive protein (CRP) serum levels following hemodial-
ysis. M. Haubitz, M. Schulze, KM. Koch, Department of Nephrology,
University Hospitals, Hannover, Federal Republic of Germany. In-
creased plasma levels of interleukin- I (IL-i) have been detected follow-
ing hemodialysis (HD) with Cuprophan membranes. As IL-I stimulates
the synthesis of acute phase proteins, that is, CRP, increased serum
CRP levels could be expected. Elevated CRP levels have been detected
in one-third of the dialysis patients; however, no changes were ob-
served during or after dialysis procedure. As increases of serum levels
of CRP are reached after a time lag of 12 to 24 hr after stimulation, CRP
levels were measured before and 24 hr after HD with Cuprophan
membranes. CRP levels in 17 patients with end-stage renal disease
(chronic HD for 2 to 168 months) were measured using a sensitive
ELISA (detection limit 200 pg/mI) capable of detecting baseline CRP
levels in all serum samples. Values obtained 24 hr after HD were
corrected for hemoconcentration using serum albumin concentrations.
Serum CRP levels increased from 3240 1105 ng/ml ( SEM) before
HD to 5189 1716 ng/ml uncorrected and 4790 1448 ng/ml corrected
for hemoconcentration 24 hr after HD (P < 0.001, Wilcoxon-test for
paired differences). These results indicate that HD with Cuprophan
membranes leads to a stimulation of the acute phase response. The
influence of different stimuli for this increase like the dialysis procedure
itself, the membrane and the endotoxin content of the dialysate still has
to be elucidated.
Central register for side effects of biomaterials. U. T. Seyfert, G.
Pindur, F. Kettenbaum, G. Bohnert, G. Jutzler, R. Bambauer, E.
Wenzel, Abt.f. kim. Haemostaseologie u. Transfusionsmedizin, Abt.f.
Dialyse und Nephrologie, Universitätskliniken, D-6650 Homburg/Saar,
Federal Republic of Germany. The examination of the interaction
between biomaterials and tissues from a realistic clinical as well as
scientific viewpoint to complement the highly advanced experimental
and biochemical basic research is an undertaking that has suffered a
considerable amount of neglect in the past. Attempts to internationally
realize a Central Register for documenting clinically relevant side
effects will be reported on in detail. Implementation of the registry
involves the review of present literature by our data base. An incom-
patibility incident report has been developed according to the guidelines
of the report on pharmacological side effects of the 'Deutsche Arzne-
imittelkommission der Deutschen Arzteschaft." The aim of registering
and evaluating these reports will be demonstrated and discussed in
detail.
Incidence of Campylobacter pylon in patients with renal uinsufficiency
compared to patients with normal renal function. U. Giadziwa, G.
Haase, St. Handt, B. Oschowitzer, W.M. Glockner, H. Mann, H.-G.
Sieberth, Department of Internal Medicine, Technical University,
D-5100 Aachen, Federal Republic of Germany. Gastrointestinal symp-
toms, such as loss of appetite, nausea, and vomiting are frequent in
patients with various degrees of renal insufficiency (RI). The high urea
levels in RI may therefore be a factor favoring the colonization of the
gastric mucosa with Campylobacter pylon (C.p.). In our prospective
study we investigated the incidence of C.p. 128 patients were included:
in 63 patients with normal renal function (NRF) [29 , 34 9, mean age
(MA): 55 years] 62% had gastritis/14% peptic ulcer; in 65 RI (36 d, 29
9, MA: 56 years) 84% had gastritis/ 10% peptic ulcer. Biopsy speci-
mens were taken of the gastric antrum (A) and corpus (C) and were
examined histologically and microbiologically (CLO-test, Warthin-
Starry silver stain, and culture of C.p.). Total nitrogen in the gastric
juice was measured by the micromethod of Kjeldahl. Results:
Campylobacter pylori-incidence %
CLO-test Histology Culture
A C A C A C
Gastritis
Peptic ulcer
NRF
RI
NRF
RI
44 33
26 40
50 50
40 50
58 60
43 40
80 80
50 60
14
12
40
10
18
17
50
10
Nitrogen in gastric juice [mg/mI] NRF: 0.62 0.3/RI: 0.92 0.5
Conclusions: Our findings did not demonstrate any difference between
CLO-test, histology and culture independent of various degrees of renal
function. In spite of significantly higher nitrogen levels in uremic gastric
juice (P < 0.005) there is no difference in C.p. gastric colonization
between NRF and RI.
Ciprofloxacin kinetics in renal failure. H.J. Deuber, G. Ohrisch, A.
DOrfler, W. Schulz, G. Hopf, R. BOcker, III .Med.Clinics and Institute
of Nephrology, Bamberg, and Institute of Pharmacology, University of
Erlangen, Er/an gen, Federal Republic of Germany. Due to predomi-
nant renal excretion of ciprofloxacin (cip) in renal insufficiency a dose
adaptation is necessary. This study was done to determine appropriate
dosages in renal insufficient patients. Thirty-five patients with different
stages of renal insufficiency were treated with either 200 mg i.v. or 500
mg orally, cip once to twice daily during 5 days, followed by a wash-out
period of 3 days. Blood samples were taken throughout each day to
obtain kinetic data. Tissue samples were taken additionally. Cip and
merabolite concentrations were measured by HPLC.
Creatinine (mg/pidl)
Half life
Ciprofloxacin Metabolite
Below8 6hr —
Over 8, non-dialysis 11—14 hr 11 hr
Hemodialysis 7 hr 12 hr
Tissue concentrations were 1.3 0.6 mg/liter. A single hemodialysis
removes approximately 20 mg of cip, a single peritoneal dialysis
removes 0.2 mg of cip. Plasma concentrations of cip after and before
hemodialysis differ by 30 to 50%. Clearances of cip are approximately
60 mI/mm, regardless of dialyzer used. In patients with or without
moderate renal impairment and in patients on hemodialysis it is
recommended to apply 200 mg cip i.v. or 500mg cip orally twice a day.
If serum creatinine is higher than 8 mg/dl it is sufficient to apply 200 mg
cip i.v. or 500 mg cip orally once a day.
Pharmacokinetics of imipenem/cilastatin during continuous arteriove-
nous hemofiltration (CAVil). M. Przechera, D. Bengel, D. Friess, Th.
Kioss, T. Risler, Med.Klinik, Sektion Nephrologie, Universitdtsa-
potheke, Klinik für Anasthesiologie der Universität, D-7400 Tubingen,
Federal Republic of Germany. In patients with acute renal failure
undergoing CAVH, an antibiotic therapy of additional infections is
often required. Therefore we investigated the pharmacokinetic proper-
ties of the new 13-lactam antibiotic imipenem (N-Formimidoyl Thiena-
mycin) and the dehydropeptidase-inhibitors cilastatin under CAVH,
performed with a polyamid high-flux membrane. After infusion of 500
mg imipenem/500 mg cilastatin at 12 hour intervals, drug levels were
measured in blood and ultrafiltrate in 6 intensive care patients by the
HPLC-technique. Using a two compartment model we obtained the
following pharmacokinetic parameters for imipenem (cilastatin): the
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volume of distribution of the central compartment was 0.47 0.16
liter/kg/kg, (0.25 0.08 liter/kg/kg). The average filtration rate was
6.6 mI/mm and the mean clearances-CAVH were 6.49 1.2 mI/mm,
(4.71 0.9 mI/mm). Sieving coefficients were measured 2 hours after
the end of infusion: 0.97 0.11, (0.73 0.14). The terminal excretion
half-lives were 2.82 0.79 hr (14.58 5.31 hr). Therapeutic plasma
levels of imipenem (4 mg/liter) were observed for about 6 hr after
administration. Regarding these results, a new dosage schedule has to
be set up for the use of imipenem/cilastatin in patients treated with
CAVH. Compared to healthy volunteers we found a considerable
dissociation in the pharmacokinetic profile of the two compounds and
an accumulation of cilastatin.
Transitional cell carcinoma in adult polycystic kidney disease—Case
report and DNA analysis by polymorphic loci. R. Klingel, P.J.L,
Lagoda, E. Wandel, W.G. Dippold, H. Köhler, and K.-H. Meyer zum
Büschenfelde, 1st Dept. of Medicine University of Mainz and Institute
of Human Genetics University of Homburg, Federal Republic of
Germany. Adult polycystic kidney disease (APKD) is the third most
common cause of chronic renal failure in Europe and the United States,
accounting for 10% of all requirement for chronic renal replacement
therapy, APKD is linked to genetic markers on chromosome l6p.
Transitional cell carcinomas of the renal pelvis constitute 5 to 20% of all
renal tumors. In the DNA of transitional cell carcinomas the somatic
loss of DNA on chromosome lIp resulting in hemizygosity of the
non-deleted alleles in the tumor cells was detected. Micropapillary
hyperplasia of the tubular epithelium occurs in APKD-kidneys and may
impose an increased risk of malignancy. The case of a 59-year-old male
patient is reported who developed a multicentric transitional cell
carcinoma of the renal pelvis and the bladder. By Southern blot analysis
and with polymorphic markers we investigated the DNA of lympho-
cytes, the APKD-kidney and the tumor of the patient. DNA-probes
used were: c-Ha-ras (oncogene, chromosome lip); 3'HVR (chromo-
some i6p, adjacent APKD-locus); minisatellites 33.15, (GTG)5 and
coliphage M13 (repeat elements for DNA fingerprint). The case report
of the 59-year-old patient illustrates the difficulties of the diagnosis of a
renal pelvic tumor developing in APKD. Deletions or rearrangements in
the DNA of the DNA of the transitional cell carcinoma could not be
detected by the DNA fingerprints in general or by the 3'HVR probe
with regard to chromosome l6p. By c-Ha-ras we detected a DNA loss
of chromosome I Ip and a significant difference in the level of methyl-
ation of the gene in the tumor DNA. Further analysis especially of
chromosome l6p the putative APKD locus must assess the possible role
of the genetic defect of APKD for the malignant transformation of
transitional epithelium.
Serum levels of tumor markers in renal diseases. E. Quentin, A.
Ammon, M.H. Weber, H. Eiffert, J. Rummel, J. Niemann, F. Scheler,
Department of Internal Medicine, University of Gottingen, Gottingen,
Federal Republic of Germany. Serum levels of tumor markers are
influenced by malignant and non-malignant diseases. Alterations caused
by gastrointestinal diseases have been described frequently, but little is
known about tumor markers in renal diseases. We therefore determined
the serum levels of the antigens CEA, CA 15-3, CA 125, CA 19-9, and
MCA in 92 patients with non-malignant renal diseases at different
degree of renal insufficiency, 50 of these were on chronic hemodialysis
(ESRD). The control group consisted of 50 healthy blood donors.
Results: We found no difference between the levels of MCA and CA 125
as compared to the control group, however CEA and CA 15-3 levels,
and less CA 19-9, were elevated in patients undergoing hemodialysis.
We also found higher CA 15-3 and CA 19-9 levels in the group of the 42
patients with chronic renal diseases. CEA serum levels of these patients
did not differ from those of the control group. A relation between
underlying renal disease, level of tumor markers, or degree of renal
insufficiency could not be shown, therefore further investigations about
the mechanisms of elevation of tumor markers in renal diseases are
necessary.
Comparison of prophylactic filling of central venous hemodialysis
catheters with heparin or urokinase: Preliminary results in 21 patients.
H. Freudiger, Z. Glück, K. Meyer, Division of Nephrology, Regional-
spital, 2502 Biel, Switzerland. We assessed the efficiency and safety of
prophylactic central venous hemodialysis catheter filling with either
high dose heparin (5000 lU/mI) or combined urokinase (2500 lU/mI)
and high dose heparin. Twenty-one consecutive hemodialysis patients
were randomly assigned to receive either heparin alone after each
dialysis (9 pts) or in addition once weekly heparin and urokinase (12
pts). The total of treatment days was 268 days (30 24 days/patient;
mean I SD) for the heparin group and 613 days (51 45 days/patient)
for the urokinase group (NS; P < 0.22). There was 1 catheter failure due
to kinking (urokinase group) and 1 catheter had to be removed for a
staph, epidermidis septicemia (control group). In each treatment group
1 thrombotic occlusion occurred, which was easily lysed with uroki-
nase. Three hemorrhagic complications occurred in the urokinase
group: I transfusion demanding bleeding from the catheter insertion
site, I retinal bleeding in a diabetic patient and I upper gastrointestinal
bleeding in a highly uremic patient. Catheter flow conditions were
similar in both treatment groups, and coagulation parameters remained
within normal limits during the whole study duration. Conclusion:
Prophylactic central venous hemodialysis catheter filling with highly
concentrated heparin is safe and efficient in preventing thrombotic
occlusion. No beneficial effect could be demonstrated by a once weekly
addition of urokinase. Furthermore, use of the latter may increase the
risk of bleeding complications.
Verification of sodium modelling computation by sodium measure-
ments. J.A. Cerutti, A. Edward and B. Reinhardt, Ospedale Civico,
Lugano CH, Oberursel, D, Italy. Intradyalitic morbidity is common
during conventional dialysis. This phenomenon can be attributed in part
to an inadequate water and sodium removal which produce osmotic
imbalance and ipovolemia. The aim of each dialytic treatment is to
remove that amount of sodium and water which has been taken up by
the patient in the dialysis-free interval. It is easy to monitor the fluid
removal but not the sodium removal. To determine the sodium removal,
the mix of dialysate and ultrafiltrate has to be collected and sodium
concentration has to be correctly measured in particular in the case of
small concentration differences between the mix and the fresh dialysis
fluid. It is impossible to manage this necessary procedure of determi-
nation of sodium removal during each routine dialysis. To solve this
problem different authors like Gotch, Stiller and Mann and others
developed a mathematical model to calculate the sodium removal
instead of measuring. But the clinical application of sodium modelling is
depending on the correct correlation between the results of the com-
putation and the reality in the patient. In order to investigate this
correlation, we measured the kinetics and the total amount of sodium
removal and plasma sodium concentration and compared these mea-
sured values with the calculated values of sodium modelling computa-
tion of a commercial available computer, the CMS 08 of Fresenius.
Sodium concentrations are measured by flame photometer. For quan-
titative determination of the sodium removal the ultrafiltrate and
dialysate were collected every hour and every collection was weighted
and the sodium content was measured, so also with the total volume for
control. The use of the scale improved the exactness and accuracy
essentially. Hence it followed an average deviation of 6% between the
measured and calculated sodium removal. The difference between the
calculated and measured plasma sodium concentration (kinetics and
total amount) was in the range of 1 mmol beside the first hour of
treatment, where the difference was higher. Due to these good agree-
ments of calculated and measured values the sodium modelling com-
putation is believed to be suitable as an information and therapy
creation system.
Effect of computer-modulated profile hemodialysis on hemodynami-
cally relevant hormones. M. Keuchel, Ch. Laage, A. Dittmar, B. Saure,
H. Ebel, G. Himmelmann, K. Ehlenz, H. Kaffarnik, H. Lange, Dep.
Nephrology and Endocrinology, Inst. biomed. Statistics, Philipps-
University, Marburg, Federal Republic of Germany. Ultrafiltration
during extracorporal circulation may cause activation of hemodynami-
cally relevant hormones. The influence of computer-modulated profile
hemodialysis on the release of such hormones was investigated. Fifteen
patients with ESRD on regular hemodialysis were treated with 4
different bicarbonate hemodialysis profiles: A) constant ultrafiltration
(UF) and constant dialysis Na (138 mmol/liter), constant dialysate K (2
mmol/liter); B): decreasing UF, constant dialysate Na and K; C):
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decreasing UF and Na (starting 10% above serum Na), constant K; D):
as C, additionally adapted, decreasing K profile. Plasma-renin activity
(PRA), aldosterone, cortisole, adrenaline, noradrenalin and atrial natri-
uretic peptide (ANP) were measured before and after dialysis. PRA,
cortisole and adrenalin increased during standard dialysis, whereas a
reduction was seen during profiles C)—D). Postdialytic aldosterone and
noradrenalin levels were lower during all profiles. ANP increased
inconstantly after dialysis. These results suggest that a computer-
modulated profile hemodialysis leads to less hormone activation and is
hemodynamically better tolerated.
Protein loss in peritoneal dialysis: Significance for the elimination of
aluminum and zinc. H. Schmitt, T.H, Ittel, I. Berger, T.A. Bock, H.G.
Sieberth, Department of Internal Medicine II, Technical University,
5100 Aachen, Federal Republic of Germany. In peritoneal dialysis
protein losses differ considerably in quantity as well as in quality, thus
leading to a variable loss of carrier proteins of different trace elements.
However, it remains to be elucidated to what extent these variable
profiles in prote excretion are significant for the peritoneal clearance
of trace elements. During an 18 month period, we performed serial
measurements of the peritoneal loss of albumin, pre-albumin, transfer-
rin, ceruloplasmin, IgG and a2-microglobulin in 19 CAPD patients; we
also analyzed the corresponding concentrations of aluminum (Al) and
zinc (Zn) in serum and dialysate. The mean protein clearance correlated
inversely with the molecular weight and ranged from 0.57 mI/mm
(pre-albumin) to 0.16 mI/mm (a2-microglobulin). A clear cut significant
correlation was found between protein loss and ultrafiltration (P <
0.02), whereas no relationship was found between protein loss and
creatinine clearance (P < 0.07). The peritoneal removal of Al per day
correlated with the serum concentration of Al (P < 0.0001), the Al
clearance correlated with the creatinine clearance (P < 0.01). With a
dwell time of 4 to 5 hours there was a definite relationship between Al
clearance and ultrafiltration: using a dialysis solution with 1.36%
glucose Al clearance averaged 2.66 mI/mm, with 3.86% glucose there
was an increase to 4.38 mI/mm. A corresponding difference was not
observed for a longer dwell time of 8 to 10 hours (Al clearance 1.54 and
1.78 mI/mm, respectively), We found no correlation between Al
removal and protein loss into dialysate, in particular no relation to the
peritoneal excretion of the carrier protein transferrin. As regards the
elimination of Zn, however, we determined a definite relationship
between the total protein loss and the loss of each protein analyzed (P
<0.01) except of pre-albumin. On the other hand there was no relation
to creatinine clearance or ultrafiltration. We conclude that obviously
different mechanisms exist for the elimination of the clinically important
trace elements Al and Zn during CAPD. The peritoneal removal of Al is
determined by diffusion and ultrafiltration, for the transfer of Zn,
however, protein loss seems to be more important.
Protein pattern in PD-fluid and plasma of patients with peritonitis. H.J.
Deuber, G. Ohrisch, H. Heyn, W. Schulz, III .Med.Clinics and Institute
ofNephrology, Bamberg, Federal Republic of Germany. Nephelome-
try offers an excellent possibility of determining protein patterns and to
make quantitative analysis of single proteins in PD-fluid and in plasma.
Nephelometry depends on measurement of light scattering of antigen-
antibody complexes formed of specific proteins and their specific,
monoclonal antibodies. This study was done to investigate diurnal
alterations of protein pattern in patients with and without peritonitis. In
15 cases of CAPD patients with and without peritonitis nephelometric
analysis of protein pattern in PD-fluid as in plasma was done during the
day and was controlled during therapy period in those patients suffering
of peritonitis.
mg/liter 8.00 12.00 17.00 21.00
Total protein 1911/705 870/360 671/391 471/62
Albumin 1267/540 683/259 434/259 381/55
Transferrin 57/25 26/9 21/5 19/2
Alpha-I-Glycoprotein 88/66 47/24 31/7 31/4
IgG 211/121 123/25 90/18 79/14
IgA 116/98 30/9 23/10 19/8
1gM 9/2 7/I 7/1 6
The highest loss of protein occurs during night. During day there is a
decline of protein loss. The daily protein loss via PD-fluid in patients
with peritonitis is approximately 30 g. Protein pattern might be helpful
in diagnosis and following course of peritonitis. The best parameters for
estimating activity of peritonitis are seen in albumin and IgG concen-
trations. If possible, these parameters should be determined in noctur-
nal fluid.
Peritoneal function during long-term treatment with CAPD. J. Pass-
lick-Deetjen, H. Chlebowski, M. Koch, B. Grabensee, Department of
Nephrology, University of Düsseldorf, Düsseldorf, Federal Republic of
Germany. While treatment of end-stage renal failure with CAPD has
been established, there are not many investigations concerning perito-
neal function during long-term treatment. Method: 70 CAPD patients
underwent a peritoneal equilibration test. Mean age was 52.4 15.3
years, mean time of treatment with CAPD 12.3 mos, peritonitis rate
1/21.5 patient months. The equilibration test was performed during a 4
hr dwell time with 2 liters of a 1.36% glucose solution (gluc) at the
beginning (N 17), after 12 (N = 11)and after 20 mos (N = 4), or with
a 3.86% gluc at the beginning (N = 17), after 12 (N = 12) and after 30
mos (N = 17) of CAPD treatment. The following parameters have been
determined: D/P ratio of urea and creatinine (crea), glucose absorption
(Dt/D0-gluc) and ultrafiltration (UF). Six patients were compared
intraindividually at the beginning and after 12 mos (equilibration test
1.36% gluc). Results: (values are given: end of dwell time, SD;
significances: time t vs. 0): 1.36% gluc: D/P ratio, urea, crea, D/D0
gluc, UF: at the beginning, after 12 and 20 mos: no significant
differences. 3.86% gluc: at the beginning/after 12 mos/after 30 mos:
D/P ratio crea: 0.91 0.01/0.93 0.01 (P < 0.025)/0.98 0.04 (P <
0.01). D/P ratio crea: 0.71 0.03/0.75 0.03/0.86 0.08 (P < 0.005).
Dr/DO gluc: 27.4 0.3/25.6 4.9/17.4 5.0 (P < 0.005). UF: 1175
106/510 399/479 312 (P < 0.0005). Intraindividual comparison of 6
patients after 12 mos: D/P ratio, urea, crea: no change, D1/D0 gluc at
the beginning 0: 44.1 6.3, after 12 mos 35.3 7.5 (P <0.05), UF: at
beginning 126 98 ml, after 12 mos 100 126 (NS). As could be seen,
most of the patients show an augmentation of peritoneal permeability
with an increase of pore size of the peritoneal membrane, which could
not be correlated to the rate of peritonitis. Further investigations in a
greater number of patients with an intraindividual comparison are
necessary to confirm these preliminary data.
Physical exercise during hemodialysis (HD). R. Krause, H.-H. Abel,
Irmingard Bennhold, H.P. Koepchen, Moabit Hospital, Department
Internal Medicine III; Berlin (W), Federal Republic of Germany. The
study was designed to analyze the influence of training: I.) on the
pattern of cardiovascular control during hemodialysis, and 2.) on
long-term cardiovascular and metabolic adaptation. Over 6 months, 5
patients (60.8 1.7 yrs, 70.5 2.3 kg, HD 13.0 1.9 mo.) trained at
a bicycle ergometer during each hemodialysis with 50% VO2max for the
last 15 mm of each hour. Heart rate and blood pressure were measured
immediately before and after each exercise. At the beginning and at the
end of the training period, the patients were examined by spiroergom-
etry. During work, heart rate increased by 8% and systolic pressure by
7%. In the course of the months of training, heart rate and systolic
pressure decreased at rest by 10% and 12%, respectively. The training
achievement was raised by 25%. After 6 months, the maximum perfor-
mance at spiroergometry was increased by 20%. 02 uptake and lactate
accumulation at 50 watts diminished by 38% and 30%, respectively.
Continuous physical training with low intensity leads to a more econ-
omized muscular energy metabolism and likewise to an augmentation of
the physical performance diminished in hemodialysis patients. The
training-induced alteration of the pattern of cardiovascular control at
rest indicates a long-term reduction of cardiac work with the ensuing
positive consequences. Moreover, due to an increase in the general
activity level, work during hemodialysis reduces the occurrence of
hypotonic events.
Quality of life of elderly patients (>65 J.) on long-term hemodialysis
treatment. S. Schnack, J. Eigler, H. Schiffi, H.-J. Gurland, W. Segerer,
Department of Medicine "Innenstadt," University of Munich, I. De-
partment of Med.-GroJihadern, University of Munich, 2nd Department
of Med., Harlaching City Hospital, Munich, Federal Republic of
Germany. Questions concerning the quality of life of elderly, frequently
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polymorbid patients with end-stage renal disease subjected to renal
replacement therapy receive growing attention (Huseby, Kjellstrand, et
al: Psychological, social, and somatic prognostic indicators in old
patients undergoing long-term dialysis. Arch Intern Med 147(11): 1921—
1924, 1987). In April 1988 we encountered in three Munich dialysis
centers 107 patients with end-stage renal disease (60 f, 40 m) who were
65 years or older (73,2 5.3 yrs; 65 to 88 yrs) at the time long-term
hemodialysis (LTH) treatment was commenced; this is an increase of
almost 70% since 1983. One hundred of these patients (mean time on
LTH 35.6 28.3 mo.) responded to a questionnaire survey (30 items)
concerning somatic and psychosocial aspects of their "quality of life."
Comparative analysis of the answers showed high retest-reliability and
evidence of question validity. The question "Would you on the basis of
your own experience so far start long-term hemodialysis treatment
again?" was denied by 14 of 100 patients (10 f; 4 m). This group's
response was also indicative of depressive mood (P < 0.001) and
difficulties in coping with therapeutic measures in general (P < 0.005).
Responses for such behavior to be considered are: 1.) psychosocial
factors; 9 of 10 f lived alone and expressed signs of loneliness; 2.)
crippling disease in addition to chronic renal failure (all 4 m, 4 of 10 f).
On the other hand, the same degree of disability was found in 12 f and
8 m with positive response, respectively. Therefore, we conclude: I.)
the overall acceptance rate of LTH treatment in elderly patients is high
(89%); 2.) in those with evidence of denial (14%) psychosocial causes
seem to be of utmost importance.
High survival rate of cardiopulmonary resuscitation in dialysis patients.
M. Dreischer, W. Kreusser, Medic-Clinic II, Marien-Hospital, Duis-
burg, Federal Republic ofGermany. We studied retrospectively 17 of a
total of 110 dialysis patients who were resuscitated in our nephrological
department. The study period was January 1, 1986 through December
31, 1988. The average age was 61.7 years (age range 38 to 77). Three pts
were resuscitated during dialysis, 14 pts independently of dialysis. The
initial mechanism of arrest was hypotension and shock in 7 pts,
arrhythmias (ventricular fibrillation, asystole) in 6, myocardial infarc-
tion in 2, acute respiratory failure in 2. Five pts were not successfully
resuscitated. Two pts survived only for one day, 10 pts more than 30
days, 8 of them more than 180 days. These pts stayed in the hospital for
an average of 57.5 days (range 8 to 99). All the discharged pts were fully
rehabilitated and mentally intact. In this study, resuscitation was
defined as acute circulatory failure for which both closed-chest com-
pression and artificial ventilation were initiated. In addition, in 14 pts
(82%) an electrical countershock was necessary. High doses of cate-
cholamines, adrenaline and angiotensin were required. The pts who
survived for 24 hrs had to be artificially ventilated for a mean of 11 days
(range 0.5 to 21). None of the pts in whom resuscitation took longer
than 30 minutes survived to be discharged. Characteristics of 17 dialysis
pts with in-hospital arrests were analyzed within the last 3 years.
Forty-seven percent of these pts were discharged from the hospital. All
of those were mentally intact. Our data indicate that in dialysis pts
much higher doses of catecholamines are necessary than in other pts.
The reason for this may be catecholamine resistance in uremia, as
described by Kreusser et al (KI 24:83, 1983). Our results differ from
those obtained in an unselected group of pts in whom survival rate is
much lower: range from 14 to 24% (Bedell et al: NEJM 309:569, 1983;
George et al: AiM 87:28, 1989). The cause of these discrepancies is a
higher rate of myocardial infarction and congestive heart failure in
unselected pts and ventricular arrhythmias and hypotension in our pts.
Long-term follow-up of dialysis patients undergoing open heart sur-
gery. K. Ivens, A. Krian, R. Buhi, B. LOsse, H.D. Schulte, B.
Grabensee, und W. Bircks, Abteilung für Nephrologie, Kardiologie und
Abteilung fur Kardiochirurgie, Heinrich-Heine-Universitdt Düsseldorf,
FederalRepublic of Germany. A chronic disease with a diminished life
expectancy has been a limiting factor for elective (open) heart surgery
due to its high intra- and postoperative risks, as well as its poor
prognosis. Even nowadays patients with chronic renal failure have a
limited life expectancy due to secondary changes of the cardiovascular
system. To value the risks and benefits of open heart surgery in dialysis
patients, the following abstract will discuss the operative risks, fatal
complications and long-term prognosis of 72 dialysis patients. From
1979 until 1989, 72 dialysis patients (54 males, age 25 to 70, and 18
females, age 43 to 63) underwent a total of 75 open heart surgical
procedures, including coronary bypass surgery (46 times, 61.3%), valve
replacement (18 times, 24%), a combination of coronary artery bypass
surgery and valve replacement (4 times, 5.4%), simultaneous CABG
(coronary artery bypass graft) and carotid endarterectomy (2 times,
2.6%), as well as 5 other open heart surgical procedures, such as repair
of an ASD, removal of a foreign body of Myxoma (6.7%). Ten patients
(13%) died of postoperative complications, the highest mortality was
among patients with a combined surgical procedure (3 out of 4 died).
Three out of 18 patients with valve replacement (16%) and 3 out of 46
patients with CABG (6.5%) died. Considering the long-term follow-up,
another 6 patients died within 1 to 6 years after the operation.
Thirty-seven patients were significantly improved, 3 patients underwent
further open heart surgical procedures within 1 to 3 years, and 5
patients were able to receive a kidney transplant after open heart
surgery. In summary, the risk of coronary artery bypass surgery for
patients with dialysis is only slightly elevated due to technical problems
concerning heavily calcified vessels. Coronary artery bypass surgery
was shown to be efficient and justified to improve the long term
prognosis of dialysis patients and to prepare these patients for kidney
transplants.
Accelerated loss of glomerular filtration reserve in rat single kidneys
denervated by autotransplantation. K.H. Neumann, S. Menzel, B.
Peuschel, P. Vogt, Abt. Nephrologie and Klinik für Abdominal- und
Transplantations-chirurgie, Medizinische Hochschule Hannover, Han-
foyer, Federal Republic of Germany. Hemodynamic factors, in addi-
tion to immunologic and pharmacotoxic factors, are supposed to
contribute to the progressive loss of function of transplanted kidneys.
Since renal hemodynamics are influenced by renal nerves, we studied
the long-term effects of renal denervation on renal function in addition
to compensatory glomerular hyperfiltration. One kidney was hetero-
topically re-implanted into bilaterally nephrectomized Wistar rats
(ANX) at the age of 2 months. Creatinine clearance, proteinuria, body
weight and systolic blood pressure were measured monthly up to age 14
months. At 8 and 15 months glomerular filtration rate (GFR, inulin
clearance) and glomerular filtration reserve (AGFR, after infusion of
amino acids 0.9 g/kg body wt) were measured. Results were compared
to nephrectomized (NX) and unoperated control (CO) rats of the same
age. Development of body weight and blood pressure was similar in all
3 groups. Creatinine clearance began to decline and proteinuria was
elevated in 14-month-old ANX (36 6 mg/24 hr) and NX (50 19
mg/24 hr) compared to CO (13 2 mg/24 hr; SE). GFR and LGFR
(ml/min/g kidney wt; SE):
8Mo l5Mo
GFR GFR N GFR GFR N
ANX 0.74 0.08 0.26 0.10 6 0.60 0.03 0.19 0.02 10
NX 0.62 0.06 0.33 0.09 9 0.58 0.04 0.30 0.04 8
CO 0.74 0.05 0.36 0.07 7 0.73 0.03 0.39 0.08 7
GFR was not significantly different for all groups at both ages. Also,
zGFR was not significantly different for all groups at age 8 months.
However, at the age of 15 months LGFR of ANX was reduced
compared to NX (—37%) and KO (—49%, P 0.03). The accelerated
loss of glomerular filtration reserve of the transplanted kidneys com-
pared to remnant kidneys after unilateral nephrectomy indicates a
long-term detrimental effect of renal denervation, which might enhance
glomerular sclerosis by alterations of renal hemodynamics in addition to
the compensatory component of glomerular hyperfiltration.
Cytotoxicity of histidine in renal preservation. N. Klause, G. Gronow,
and W. Niedermayer, Physiologisches Institut der Universitdt und
Abt.Nephrologie, I.Med. Universitatsklinik, 2300 Kiel, Switzerland. Re-
cently histidine (HIS), a weak basic amino acid, has been used as a
buffer substance in high concentrations (up to 200 mmol/liter) in renal
preservation. We analyzed enzyme losses and intracellular K content
of isolated renal tubular cells at different HIS concentrations (Krebs-
Ringer medium, pH 7.4, 37°C). In anoxia, HIS had no effect on the
hypoxic tolerance of renal cells, the enzyme losses and intracellular K
were not different from control values. In contrast, during reoxygen-
ation, enzyme losses increased significantly and dose dependently in
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the presence of HIS. At 100 mmol HIS/liter, for example, the leakage
of cytoplasmatic LDH rose up to 375%, lysosomal ATPase up to 479%,
and mitochondrial GIDH up to 400%. Intracellular K content, how-
ever, decreased by 34%. Even at 1 mmol HIS/liter, enzyme losses
increased (LDH 110%, ATPase 177%, GIDH 147%). These cytotoxic
effects of HIS were observed only in the presence of oxygen, and were
suppressed in the reoxygenation period by the application of oxygen
radical scavenging enzymes (SOD and Catalase). Our results indicate
that HIS exerts in reoxygenated renal tubular cells (i.e., in flushed and
reperfused donor kidneys), even at los concentrations, cytotoxic effects
via lipid peroxidation, Thus, HIS should be substituted in preservation
solutions by a cytoprotective amino acid such as glycine.
Are high serum levels of PTH predictive for developing acute tubular
necrosis (ATN) after renal transplantation? 0. Traindl, W. Woloszczuk,
F. Ldngle, J. Kovarik, 2nd Dept. of Internal Medicine, University of
Vienna, Austria. A high level of serum PTH has been accused as a
causative factor in developing of ATN in renal grafts. We investigated
the correlation of serum PTH measured by various radioimmunoassay
techniques and the occurrence of ATN in 27 kidney allograft recipients.
Biological-active intact PTH (1-84), and levels of mid-regional and
c-terminal PTH fragments were measured immediately before grafting.
Comparing pts with primary graft function (N = 14) with pts with
biopsy proven ATN (N = 13) only the levels of PTH fragments were
significantly higher in the ATN group (mid-regional PTH: 2444
pmol/ml, SD = 1427 vs. 1221 pmol/ml, SD = 772, P < 0.05; c-terminal
PTH: 3.06 ng/ml, SD = 1.91 vs. 2.2 ng/ml, SD = 1.52, P < 0.05),
whereas intact PTH levels were only marginally higher in pts with ATN
(110 pg/mI, SD = 71 vs. 68 pg/mI, SD = 40, NS). In addition no
difference was found in cold ischemic time, missmatching and postop-
erative cyclosporine levels. This indicates, that biological active PTH is
not primary causative in the development of ATN, but the correlation
of the occurrence of ATN with high serum PTH fragments points at
their use as an "index" for accumulated uremic toxins and therefore for
quality of overall dialysis before transplantation. This is supported by a
significant difference found for calcitonin levels (156 pg/mI, SD = 92 vs.
80 pg/mI, SD = 40, P < 0.05) between the two groups.
Novel immunosuppressive drug, leflunomide, inhibits acute rejection of
kidney transplants in rats. G.H. Thoenes, C. Kuchle, K.H. Langer,
R.R. Bartlett, and R. Schleyerbach, Medizinische Klinik Innenstadt,
Universität MOnchen and Abt.Pathologie,Hoechst AG, Frankfurt,
Abt.Pharmakologie,Hoechst AG/Kalle-Albert, Wiesbaden, Federal Re-
public of Germany. Leflunomide, an isoxazol derivative, is a novel
immunosuppressive and antiphlogistic drug with proven protective
effects in experimental autoimmune diseases. For the first time, it is
reported here which influence is exerted on the rejection of kidney
grafts. Kidney donors were BN(Rt-ln)-, recipients Lewis(Rt-l 1)-rats
with a strong histocompatibility difference and a regular rejection on the
8th day. The operation was performed orthotopically at the right side
with ureter-anastomosis and bilateral nephrectomy. The treatment
commenced one day before transplantation and continued until the
32nd day. Thereafter the observation lasted without therapy until the
60th or the 100th day. Dosage: Lefiunomide 5 mg (A) and 10 mg (B),
cyclosporin A 10 mg (C), both orally; azathioprine 5 mg (D), pred-
nisolone 5 mg (E), both intravenously and all per kg body weight. 1.) All
animals of groups A, B and C survived the untreated controls and
arrived at the 32nd day with normal values of serum creatinine.
Azythioprine (D) and prednisolone (E) had no effect on the rejection
which occurred invariably on the 8th day. 2.) All animals of the groups
A, B, and C survived much longer despite of the discontinuance of the
medication. One part of the animals survived with normal serum
creatinine values for at least 60 days (killed for histological evaluation).
The other part of animals lived more than 100 days and up to 180 days.
The histology at 32 and 60 days: All kidneys after leflunomide (A, B)
and after cyclosporin A (C) showed very similar small penvascular
lymphocytic infiltrates deep in the cortex. The lack of efficacy of
azathioprine is surprising; however, it enforces the conclusion that
leflunomide is equally efficient as cyclosporin A in experimental kidney
transplantation. Both drugs leave behind a blockade of the rejection
process after discontinuence.
Molecular targets of Sandimmun in lymphoid and non-lymphoid cells.
B. Foxwell, C. Rodriguez, M.J. Mihatsch and B. Ryffel, SANDOZ AG
and Institute of Pathology, 4002 Basel, Switzerland. The molecular
targets of the immunosuppressant, Sandimmun (Cyclosporine, SIM)
was investigated on peripheral blood lymphocytes, erythrocytes and a
variety of lymphoid and non-lymphoid cell lines. Possible sites of SIM
action are membrane, cytosolic and nuclear proteins. By means of
photolabeling techniques using a photoactive SIM derivative, photo-
cross linked proteins have been analyzed from lysed cells by SDS gel
electrophoresis followed by fluorautoradiography. The only membrane
protein labeled with SIM was a 170 kD protein which is identical with
p-glycoprotein involved in multidrug resistance. This membrane protein
was only found in renal tubular and some endothelial cell lines. In the
cytosol the main protein labeled with the photoactive SIM derivative
was the 18 kD protein cyclophilin. Quantification by scanning of the
gels as well as ELISA measurements indicated that cyclophilin is
abundant (5 pg/mg total cellular protein) and equally distributed in
lymphoid and non-lymphoid tissues and cells. Besides its role in SIM
accumulation within the cell, cyclophilin may have an important role in
the proper folding of peptides, since a cis-transisomerase activity has
been recently found. SIM inhibits dose-dependently this enzyme activ-
ity and thus might alter specific, cellular substrates which are presently
unknown. The relationship of this new enzyme activity of cyclophilin
with both immunosuppression and adverse effects will be discussed. In
conclusion, the use of new techniques including photo-affinity labeling
allowed more insight in the cellular molecular targets of SIM action.
Cyclosporine should not be given on a "per kg" basis. H.A. Bock, V.
Kamber, B. Huser, J. Landmann, F.P. Brunner, G. Thiel, Division of
Nephrology, Kantonsspital, Basel, Switzerland. The initial prescription
of cyclosporine (CsA) after renal transplantation is usually made on a
"mg per kg" (body weight) basis. To evaluate this concept, we studied
the relation of CsA blood level and CsA dose using all CsA blood levels
taken at our clinic during January to April 1988 (1071 levels/164
patients). CsA whole blood trough levels were determined using a
specific monoclonal RIA for unmetabolized CsA (parent drug). In
patients with 3 CsA levels (N = 65), the relation of CsA level to CsA
dose was best fitted using an exponential curve, although simple linear
regression was nearly equivalent. Therefore, the mean ratio of CsA
level (ng/ml) and absolute CsA dose (mg CsA) was determined individ-
ually in all 164 patients. Although the average ratio increased with time
after transplantation (<10 days: 0.43/>3 years: 0.71), it was found to be
independent of age, sex, height and weight. It follows that at the same
"per kg" CsA dose, heavier patients had higher CsA levels than lighter
patients ( SEM, P < 0.05):
Weight
kg <55 55—65 65—75 75—85 >85
Level 30±3 37 47±3 53±3 51±4
mg
CsA/
kg
Level! 0.63 0.05 0.61 0.04 0.67 0.05 0.66 0.04 0.57 0.04
mg
CsA
N 18 48 46 35 17
The 1071 CsA levels correlated better with absolute dose (r = 0.47) than
with "per kg" dose (r = 0.42). To verify these findings, all patients
transplanted at our clinic in 1989 received a fixed oral dose of 100 mg
CsA b.i.d. from day I after transplantation. CsA levels on day 4 were in
the target range (40 to 80 ng/ml) in 7 of 13 patients, whereas they were
too high or too low in 3 patients each. The level/dose ratio averaged
0.31. We conclude that prescribing CsA "per kg" is unfounded and
carries the risk of underdosing lightweight and overdosing heavy
patients. A CsA dose of approximately 3 times the desired CsA target
level (ng/mI, parent drug) should provide a reasonable initial estimate.
Role of prostanoids in experimental Sandimmun nephrotoxicity. P.
Cooper, M.J. Mihatsch, B. Ryffel, SANDOZ Ltd., and Institute of
Pathology, Basel, Switzerland. The role of renal prostanoids (PG)
synthesis on experimental Sandimmun (Cyclosporin SIM) nephrotox-
icity was investigated in spontaneously hypertensive rats, which were
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given daily 20 or 50 mg/kg for 20 days p. os. Glomerular filtration rate
(GFR) measured by 51-Cr EDTA clearance after a single i.v. injection
was dose and time dependently reduced after SIM administration. A
significant decrease in GFR was measured after 24 hours. Urinary
prostanoid excretion (6 keto-F-l-alpha, TxB2, and PGE) increased time
and dose dependently, but significant changes in urinary PG excretion
only occurred after 6 days of drug administration. Renal prostaglandin
contents in the renal cortex and medulla were decreased after 10 and 20
days and did not reflect urinary PG excretion. In summary, SIM
induced complex changes on prostanoid synthesis and excretion. Since
GFR reduction preceded alterations of prostanoids, they represent
secondary events after SIM induced vasoconstriction.
Cyclosporine-induced tubular atrophy may be related to stimulation of
proteolytic enzymes in proximal tubules. C.J. Olbricht, C. Bossaller,
H-f. Gröne, E. Gutjahr, K. Burgwitz, K.M. Koch, Abteilung Nephrol-
ogie, Medizinische Hochschule Hannover, and Pat hologisches Inst itut,
Universität GOttingen, GOttingen, Federal Republic of Germany. Cy-
closporin A (CsA) is nephrotoxic and induces tubular atrophy. Cell
atrophy is a result of increased protein degradation and/or decreased
protein synthesis. The lysosoinal enzymes cathepsin B and L are key
enzymes in cellular protein breakdown. Therefore, the effect of CsA on
cathepsin B and L was evaluated. Three groups of Wistar rats were
studied: I.) six weeks treatment with CsA, 30mg/kg per day by gavage;
2.) controls received olive oil; 3.) left renal artery clipped by 0.2 mm clip
to reduce blood flow, since CsA reduces renal blood flow. The activity
of cathepsin B and L was measured in the microdissected segments SI,
S2, and S3 of the proximal tubule by a fluorometric assay. The enzyme
activity is expressed in pmol reaction product released per mm incuba-
tion time per mm tubule length. Creatinine clearance (Ccr) and left
kidney weight (KW) were measured. Values are mean SEM.
Cathepsin B and L, pmol/
Group N mg
'-'Cr
ml/min/IOOg
mm/mm
SI S2 S3
Control 8 800 30 0.62 0.03 20 2 9 1 5 I
CsA 8 720 20 0.49 0.OV 47 6 16 6 2
Clip 8 658 55 0.42 0.l2a 6 l 6 1.5 3 I
a p <0.05 vs. control. CsA reduced KW and Car. Cathepsin activities
were increased in SI and S2 (proximal convoluted).
P < 0.05 vs. control. CsA reduced KW and Cathepsin activities
were increased in Sl and S2 (proximal convoluted). The similar
reduction of Cr and KW by renal artery stenosis reduced cathepsin
activities. We conclude that CsA stimulates cathepsin in proximal
tubules independent of hemodynamic changes. Tubular atrophy in-
duced by CsA may be the result of increased cellular protein degrada-
tion.
Cyclosporin A nephrotoxicity in the rat: Lack of correlation between
the activities of N-acetyl-/3-D-glucosaminidase in proximal tubules and
urine. H. Schmid, I. Lindmeier, H. Schmitt, R. Eissele, G. Neuhaus,
M. Wehrmann, Institute of Pathology, University of Tubingen, D-7400
Tubingen, Federal Republic of Germany. We have recently reported
that the increased activity of N-acetyl-13-D-glucosaminidase (NAG) in
the majority of proximal convoluted tubules (PCT) of rats treated with
cyclosporin A (CsA) for 12 days may not account for increased
NAGuria (Nieren- und Hochdruckkrankheiten 17:338, 1988). To inves-
tigate this possibility further we administered CsA (15, 30 or 50
mg/kg. day) or olive oil (30 mg/kg . day) orally to 25 male Sprague-
Dawley rats for 24 days. Six animals were left untreated for a further 24
days. The catalytic activity of NAG was determined fluorometrically in
24-hour urine specimens (tmol/min mmol creatinine) and in micro-
dissected nephron segments (j.mol/min g dry weight) classified ac-
cording to their succinate dehydrogenase (SDH) activity, which was
determined histochemically in parallel sections. Changes in NAG
activities compared with the control values were found only in the
proximal tubules (PT) and were independent of CsA dosage: 160% in
PCT with normal SDH activity, 80% in PCT with reduced SDH activity,
and 130 to 240% in straight PT with reduced SDH activity, the activity
increasing along the medullary rays to the outer stripe of the outer
medulla. Urinary NAG activity was elevated to a maximum of 160%.
These changes were not present after discontinuation of CsA. NAG
activity in the urine specimens did not correlate with the activity in the
PCT with normal SDH activity which constitute the majority of the
cortical tubules. This finding supports our suggestion that the degree of
NAGuria is not determined by the renal NAG activity. Supported by
the Deutsche Forschungsgemeinschaft (Schm 418/2-1 and 418/2-2).
Dopamine metabolism of central nervous system after renal transplan-
tation. H. Kopsa, A. Lapin, 0. Janata, R. Osterode, First Medical
Clinic, Institute of Clinical Chemistry and Laboratory Diagnosis,
Chemotherapeutic University Clinic, University of Vienna, Austria.
One hundred and forty-four renal transplant recipients (80 male, 64
female) mean age at surgery 44.6 years (19 to 68), mean observation
period 42 months (3 to 90) were observed with regard to cyclosporin A
side effects on central neurotransmitters. Most frequent neurologic
disorders were cerebellar tremor, Parkinson's syndrome, hyp-par-
dysaesthesia and epilepsia. These complications occurred already in the
very early postoperative period; intensity and frequency were dose
dependent and disappeared when normal cyclosporin A levels were
achieved (100 to 200 ng/ml, RIA method with monoclonal specific
antibodies). All cases with Parkinson's disease were substituted with
dopamine followed by immediate therapeutic success. Two of them
showed Parkinson crisis 8 and 12 days, respectively, after transplanta-
tion. One renal transplant patient with recurrent grand mal epilepsia
needed intensive medical care and responded to dopamine. Psychiatric
symptoms were lethargy (N = 104), depression (N = 92) and confusion
(N = 32) and were mainly seen in the early postoperative period. In
contrast to patients under azathioprine medication disorders of mood
were more pronounced and frequent in recipients receiving cyclosporin
A. Psychiatric symptoms improved or disappeared when cyclosporin A
dosage was reduced or when a switch to azathioprine medication was
done. Additionally, low dose dopamine therapy was administered.
Sexual anamnesis revealed lack of potency in 18% and lack of libido in
11%. However, all relevant sexual hormones were normal. Experimen-
tal studies in rats were carried out during 4 weeks with a tenfold
cyclosporin A dose. Autopsy of the brain revealed decrease of dopa-
mine in the substantia nigra to 72%. Dopamine uptake mechanism,
however, was not influenced. We assume that central neurotransmitters
and immune system are linked. Side effects of cyclosporin A on central
nervous system are comparable with physiologic changes in advanced
age. The presented study shows that high doses of cyclosporin A are
possibly associated with diminution of dopamine in the central nervous
system.
Hypercalcemia following renal transplantation: Effect of cyclosporin A.
H. Schmidt, H.G. Kachel, E.H. Scheuermann, W. Schoeppe, Depart-
ment of Nephrology, University Hospital, Frankfurt, Federal Republic
of Germany. Elevated alkaline phosphatase (AP) levels were recently
reported in patients treated with cyclosporin A (CsA) following renal
transplantation (TX). To investigate the influence of CsA on posttrans-
plant hypercalcemia (HCA), we studied the case reports of 442 of our
transplanted patients. In 96 transplant recipients (22%) HCA (Ca >2.7
mmol/liter) were observed. Fifty-six of these 98 patients were treated
with CsA and 45 with azathioprine (Aza). To reduce the effect of GFR,
patients were divided according to their endogenous creatinine clear-
ances.
>80
CSA
mI/mm
AZA
<80 m
CSA
1/mm
AZA
N 17 31 36 14
Ca max mmol/liter 3.0 2.96 2.99 2.95
AP U/liter 153 191 164 117
PTH pmol/liter 742 1168 890 574
Steroid mg/Tag 36 40 36.7 39.5
Start of HCA 1.5 5.9 1.5 15
months after TX
In CsA treated patients HCA started much more earlier (during first 3
months p. TX) than in Aza treated group (6 to 20 months) among similar
steroid dosages. In patients with GFR of more than 80 mI/mm, mean
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maximum calcium was higher in the CsA group compared to Aza-
group, despite higher AP and PTH values in the Aza group. In patients
with GFR below 80 mI/mm AP, PTH and calcium levels were higher in
the CsA treated group. The earlier start of HCA and higher calcium
levels following renal transplantation under CsA compared to Aza
treatment despite similar GFR and steroid dosages seems to be due to
an effect of CsA on calcium metabolism.
Immunohistochemical investigations of transplantation vasculopathy.
A. Bosse, A. Roessner, J. BOgehoiz, E. Voilmer, G. Winde, H.
BrOndermann, W. Böcker, Gerhard-Domagk-Institut für Pathologie
Münster, Chirurgische Kiinik, and Poliklinik der WWU, Münster,
Federal Republic of Germany. The morphological features of arterial
alterations in transplanted kidneys resemble different stages of the
atherosclerotic plaque, which also shows apolipoprotein A1 and B
deposits. The present investigation tries to analyze the different cell
types in the arterial wall of rejected transplanted kidneys; it also aims at
comparing the conditions in the arteriosclerotic plaque as well as the
analysis of the lipoprotein metabolism. In order to do this, we analyzed
22 nephrectomy specimens with chronic rejection using immunohisto-
logic methods. We used antibodies directed against cells of the mono-
nuclear macrophage system, smooth muscle cells, against lymphocytes
and against lipoproteins A and B. The results show that the foam cell
areas consist of macrophages. Smooth muscle cells are found more
frequently at the stage of intima fibrosis. I lymphocytes form the
lymphatic infiltrate. Apolipoprotein A1 and B are found extracellularly
and in the cytoplasm of foam cells, These results demonstrate that,
apart from immunological factors, a disturbed lipoprotein metabolism
caused by endothelial dysfunction is of importance for the reaction in
the arterial wall in transplantation vasculopathy, similar to that found in
arteriosclerosis.
Urine cytology—A useful tool for the diagnosis of rejection and
cyclosporin (CsA) toxicity. M. Kyo, F. Gudat, P. Dalquen, G. Thiel,
M.J. Mihatsch, Institut für Pathologie, Universität Base!, Abi. für
Nephroiogie, Kantonsspital Base!, Base!, Switzerland. The introduc-
tion of CsA in a renal transplantation (tpl) made the diagnosis of
rejection (Rx) even more difficult. Therefore, new non-invasive objec-
tive techniques for the diagnosis of Rx and other causes of renal
dysfunction are necessary. Urine of 30 patients were investigated at 2
day intervals from day 0 up to day 40 after tpl. The freshly voided urine
samples (ca. 100 ml) were studied for the following parameters: total
cell count (n/mi), cell differentiation in Papanicolaou stained smears
(tubular cells, n/mi), lymphocytes and monocytes (n/mi) and immuno-
cytochemical staining of air-dried aceton fixed specimens for the
antigens: T 11 (pan-T cells), T4 (T helper cells), T8 (T suppressor cells),
lu-5 (epithelial cells), TAC (activated T cells), DR (class H antigen
bearing cells). Immediately after tpl there is a steep rise of the total
number of cells reaching peak values by the end of the first week after
tpl (m SD 6.6 5.7 x 10/mi) followed by a decrease reaching baseline
levels by days 10/11. Afterwards the total number of cells is on average
(m SD) below 1.5 1.5 x 10/mi. In case of Rx, obstruction or CsA
toxicity a dramatic cell increase is noted. Immunocytochemical differ-
entiation is essential for the diagnosis of Rx versus CsA toxicity.
Til
n
T4
X 10/mi
T8 TAC
n
lu-5
> 10/mi
DR
Control m 2.9 1.3 1.5 0.7 7.4 8.9
(N = 82) SD 3.2 1.8 1.8 1.6 10.7 12.1
Rejection 5/8 4/8 5/8 8/8 1/8 2/8(N = 8 pts)
CsA ++
toxicity 1/4 1/4 1/4 0/4 1/4 1/4(N = 4 pts)
Eighty-two samples taken during episodes without any signs of Rx, CsA
toxicity etc. + 8 (4) patients with biopsy proven Rx (CsA toxicity). The
table shows that only 4 out of 8 patients with Rx had T 4 cell counts
higher than control values (m SD) whereas all 8 patients with Rx had
TAC cell counts exceeding control values. In summary: Immunocyto-
chemical differentiation of spontaneously voided urine after tpl is a
simple non-invasive technique helpful in the diagnosis of Rx. The most
significant parameter is the number of activated T cells. The most
important parameter for the diagnosis of CsA toxicity is the predom-
inance of proximal tubular cells.
Early recognition of kidney graft rejection by urinary detection of renal
antigens using monoclonal antibodies in an nninuno-sandwich assay
design. G.A. Muller, E. Gege, W. Berg, T. Risier, W. Lauchart, H.
Holzer, D. Gassner, Medical Clinics and Department of Surgery,
University of Tubingen, 7400 Tubingen, Federal Republic of Germany.
During rejection crises early events in the kidneys take place on a
molecular level on cellular membranes, and antigens of tubular epithe-
hal cells are shed into the urine. Antigens of the different nephron
sections can be detected in the urine with the help of an immuno-
sandwich assay using the monoclonal antibodies TN14 (distal tubuli)
and TN15 (proximal tubuli). Serial 24-hr collection urines from three
healthy individuals and from 12 patients undergoing kidney transplan-
tation (day 0—25) were analyzed with the immuno-sandwich assay for
the presence of the TN14+ and TNI5+ antigens. The values of the
renal antigens in the urine of the healthy volunteers were very low.
During an uncomplicated follow-up the excretion rate of the relevant
antigens declined rapidly within a few days to a plateau and remained
stable. A rejection crises was signaled early by the increase of the
excretion rate of both markers. The increase of the antigen excretion
rate started 2 to 3 days prior to clinical and laboratory parameters
indicating a rejection crises. The clinical value of this new assay system
will be proven on a greater number of patients.
Original disease of the recipient and renal graft pathology: Report on
500 kidney transplantations. H. Nizze and S. Brockmöi!er, Institute of
Pathological Anatomy, Wilheim-Pieck-Universily, Rostock, German
Democratic Republic. Because the original renal disease of a kidney
transplant recipient may be mediated immunologically or non-immunolog-
ically, a possible pathogenetic connection could be supposed with subse-
quent rejection and non-rejection changes in the graft. This problem was
studied on a total of 500 Rostock kidney transplantations from 1976 to
1989, in which glomerulonephritis (53%), pyelonephritis (21%), diabetic
nephropathy (10%), and polycystic kidney disease (5%) were the four most
frequent underlying renal diseases. Of these, 457 pathomorphological
specimen (255 graft biopsies, 159 explanted grafts, 43 postmortem grafts)
of 348 renal transplant recipients were histologically examined and
correlated with the original kidney disease. The most striking findings were
a more frequent hyperacute rejection and an earlier loss of explanted grafts
as well as a higher incidence of relevant vascular rejection in graft biopsies
of glomerulonephritis versus pyeionephritis patients. The obtained results
suggest a possible disposition of recipients with glomerulonephritis to a
more rapid and intense graft rejection in comparison with transplant
patients with pyelonephritis as underlying renal disease.
Long-term effects of a CMV carrier status after kidney transplantation
(Tx). K. Bittner, J. Heymanns, A. Grüber, K. Havemann, H. Lange,
Departments of Nephroiogy, Hematology, and Ophthalmology, Phil-
ipps University of Marburg, FederaiRepublic of Germany. An effective
immunosuppressive therapy after Tx inevitably impairs T cell depend-
ing mechanisms in host defense against replicating viral infections.
CMV infection in healthy man is characterized by life long immunologic
stimulation. In the mean 48 months after Tx the long-term effects of
CMV infection were investigated in 59 infected in contrast to 17
non-infected patients. In addition to prednisolone 52 patients were
treated with cyclosporine (CsA), 14 with azathioprine (Aza) and 10 with
CsA and Aza. The following immunological and clinical parameters
were determined: CD8 and HNK1 (CD57)-lymphocyte subsets (two
color fiow-cytometry), neopterin excretion (RIA), serum myoglobin
(qualitative latex test) and conjunctival impression cytology. Results:
CMV N HNK1CD8 HNKICD8 Neopterin
CsA neg 12 58 41 146
pos 40 305C 155C 258C
Aza neg 5 45 30 117
05 9 190C 105C 206C
a p < 0.05
b P < 0.01
P < 0.001
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Myoglobin was elevated in 30 out of 56 CMV carriers compared to 3 out
of 17 non-CMV infected patients. CMV carriers more frequently
showed pathological changes of the conjunctival epithelial cells, such as
snake-like chromatin changes. These findings suggest a persistent
chronic active infection in transplanted CMV carriers.
Positive influence of sterile dialysate on fever during chronic chemodi-
alysis. K. Schaefer, D. von Herrath, A. Amir-Moazami, C.M. Erley, D.
Kutschera, K. Hartenstein, Sr. Joseph-Krankenhaus I, Med. Abt. I!,
Baumerplan 24, 1000 Berlin 42, Federal Republic of Germany. Febrile
episodes are observed in about 4% of all hemodialysis (HD). The assump-
tion is that bacteria and/or pyrogenic substances, which are regularly
found in dialysate (D), induce stimulation of monocytes that attach
themselves to the dialysis membrane. Activated monocytes are capable of
releasing interleukin I and other pyrogenic substances. We recently
reported on a simple method of producing sterile D (C.M. Erley et al.
ASAJO Transactions 34:209, 1988). We were interested in finding out if
sterile D would cut down on the occurrence of fever (37.5°C) during
chronic HD. Three hundred and thirty-three of 790 HD treatments were
carried out using D that had been passed through an ultrafilter (Ff1 88
Gambro, Lund, 2 m2 surface, polyamide membrane); the remaining 467
HDs were done in the conventional manner. The results show that the use
of sterile D clearly reduces the frequency of febrile episodes. Of the
patients who were treated using conventional HD, 3.6% showed a rise in
temperature, which was true of 1.9% of those treated with sterile D. The
reduction in febrile episodes corresponded to the reduction in bacterial and
pyrogenic contamination in the D. Summary: I) HD using sterile D is
readily feasible in a technical sense by interposing an ultrafllter. 2) The use
of sterile D results in a clear reduction in feverish episodes even in
conventional HD. 3) The use of sterile D would seem to be of particular
importance when bicarbonate HD is used with an open membrane, since
the D picks up considerable bacterial contamination quickly with this
method and the patient runs a higher bacterial and/or pyrogenic risk when
open membranes are also used.
Protein phosphorylation in platelets—Evidence for increased protein
kinase C activity in essential hypertension. H. Hailer, C. Lindschau, A.
Distler, Department of Internal Medicine, Klinikum Steglitz, Free
University Berlin, Federal Republic of Germany. We studied the
activity of the calcium/calmodulin branch and the protein kinase C
(PKC) branch of the phospholipase C-coupled second messenger sys-
tem in essential hypertension (EH) by measuring the phosphorylation of
I) myosin light-chain (20 kD) and 2) a 47 kD protein which is a specific
substrate of proteinkinase C in platelets of patients with essential
hypertension (EH; N = 18, mean age 47 6 yrs) and normotensives(NT; N = 20, mean age 40 5). Platelets were labelled with 32P and
incubated with thrombin (0.1 and 0.25 U/mI) and the phorbolester TPA
(10-v M) for 1, 5 and 10 mm. Proteins were isolated on SDS page.
Phosphorylation is expressed as % increase over basal. In addition we
measured intracellular free calcium [Ca2]1 in platelets with fura 2.
Results: ( + s) P < 0.01; EH vs. NT): BP in EH was 149/103 4/2
and in NT 122/75 6/2 mm Hg. [Ca2] was 122 11 in EH and 107
6 ni in NT (NS).
21 kD % control
thrombin (0.25U/ml) TPA
5mm1mm 5mm
EH
NT
145 6W 170 7°
120±2 138±3
159 9
133±6
47 kD % control
thrombin (0.25U/ml) TPA
I mm 5 mm I mm 5 mm
EH
NT
304
208
22W 417 31W lOS 2
8 301 16 102 2
159 9°
133 5
Stimulation with 0.1 U/m thrombin also showed increased phosphory-
lation of both proteins in EH. The results with thrombin indicate an
increased activity of both branches of the second messenger pathway in
platelets of EH. This could be due to changes in G-protein, phospholi-
pase C or [Ca2] in EH. The increased phosphorylation of the 47 kD
protein after stimulation of PKC with TPA in EH indicates an increased
activity of PKC in platelets of patients with EH. This increased PKC
activity is not correlated with the slightly elevated [Ca2] in EH.
Effects of cyclosporin A on intracellular free calcium in platelets. H.
Hailer, P. Quass, C. Lindschau, A. Distier, Department of Internal
Medicine, Kiinikum Stegiitz, Free University, Berlin, Federal Republic
of Germany. Cyclosporin A (CsA) increases platelet aggregation in vivo
and in vitro. The cellular mechanism of this effect is unclear. Intracel-
lular free calcium [Ca is an important second messenger in platelets,
and we therefore investigated the hypothesis that CsA leads to an
increased activation of this second messenger system. [Ca]1 was
measured with fura-2. Results ( SEM): Basal [Ca] was 181 10
nM (N = 8) and increased after stimulation with thrombin (0.18 U/mI)
to 393 17 nM. Preincubation with CsA (100 ng/ml for 30 mm) did not
alter the basal calcium concentration, but increased the thrombin-
induced calcium rise (393 17 nsi, P < 0.01). The subsequent decrease
to basal levels was slower after CsA. The effect of CsA on the
thrombin-induced calcium increase was abolished in calcium free
(EGTA) buffer (240 17 vs. 238 20, N = 9). The incubation with a
calcium antagonist (nitrendipine iO M) did not influence the effect of
CsA on the intracellular free calcium rise (384 20 vs. 388 19 nM).
However, incubation with an inhibitor of protein kinase C (H7, l0 M)
reduced the stimulating effect of CsA on [Ca]1 significantly (377 vs.
398 nM, P < 0.01, N = 8). The subsequent decrease of the intracellular
free calcium to basal levels was also enhanced after H7. Conclusions:
CsA increases the agonist-induced calcium mobilization in human
platelets. This effect seems to be dependent on the efflux of extracel-
lular calcium. The blockade of the L-type calcium channel does not
affect this effect of CsA. The antagonistic effect of an inhibitor of
protein kinase C may indicate that the effect of CsA is partly mediated
via this enzyme.
Does the idiopathic form of acute crescentic glomerulonephritis exist?
D. Bach, K. Hauser, P. Heering, U. Helmchen, B. Grabensee, Depart-
ment of Nephrology, Heinrich-Heine- University, Düsseldorf and Insti-
tute of Pathology, University of Hamburg, Hamburg, Federal Republic
of Germany. The clinical course of acute crescentic glomerulonephritis
is characterized by a rapid progressive renal failure. One differentiates
between secondary and idiopathic forms of this disease. According to
new results concerning the pathogenesis of this disease, the existence of
the so-called idiopathic form must be questioned. We investigated the
clinical course of 45 patients (27 m, 18 f, mean age 45 years) with
histologically-proven acute crescentic glomerulonephritis. In 38 cases,
an immunohistology was done; 21 were additionally investigated by
electron microscopy. Results: 29 patients (64.4%) had a secondary form
[5 patients with SLE (17.2%), 7 with Wegener'scher granulomatosis
(24.2%), 5 with Goodpasture syndrome (17.2%), 12 with different kinds
of vasculitis (41.4%)]. Sixteen patients (35.6%) were initially diagnosed
as idiopathic form (histologically type II and III). But 15 of them had, in
a critical review, features of a systemic disease. All patients were
treated with steroids and cyclophosphamide, 22 patients underwent
plasma separation. Twenty-two patients (49%) became free of chronic
dialysis treatment, in 8 of 10 patients with type III a good renal function
could be achieved permanently. Conclusions: 1.) Our results indicate
that the so-called idiopathic acute crescentic glomerulonephritis often
represents the renal involvement of a systemic disease. 2.) In using
improved serological investigations (e.g. ACPA), the basic disease can
be diagnosed more accurately. The histological type III has a relatively
good prognosis with early aggressive immunosuppressive therapy.
Correlations between active renin (AR) and inactive renin (IR) in
essential hypertension (EH). B. Kutkuhn, M. Hollenbeck, P. Heering, J.
Plum, B. Grabensee, Department of Nephrology, University of Düs-
seldorf, Düsseldorf, Federal Republic of Germany. The physiological
role of lR and its relation to active renin is uncertain. We investigated
the renin-aldosterone system in 10 patients with mild essential hyper-
tension in a sequential study without treatment and under treatment
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with the p-adrenergic blocking agent betaxolol (Bx). We analyzed the
RAA system under conditions of volume loading induced by 2000 ml
saline and volume depletion induced by 40 mg furosemide. Blood
samples were drawn every 30 minutes. Exercise testing was performed
by bicycle ergometer testing in 5 steps (4 mm each) from 25 to 125 watt
and 12 minutes rest. Active renin was determined as plasma renin
activity by radioimmunoassay, inactive renin was measured as PRA
following activation by trypsin. Following Bx, there was a decrease of
AR from 2.0 to 1.0 (P < 0,001) for all measuring points corresponding
to a more than proportionate increase of IR from 4.4 to 7.4 (P < 0.001).
Under furosemide, the AR increased from 1.2 to 3.8 (P < 0.001) before
application of Bx and after Bx from 0.6 to 2.6 (P <0.01). There was no
effect on IR (4.6 vs. 4.2 before Bx and 7.6 vs. 8.0 after Bx). Under
sodium chloride the AR decreased from 2.2 to 0.7 (P < 0.001) before
Bx, and after Bx from 1.4 to 0.3 (P < 0.001). There was no effect on IR
(4.7 vs. 4.9 before Bx and 8.4 vs. 7.4 after Bx). There was no change of
AR during ergometer exercise (4.4 vs. 4.7 before, and 7.0 vs. 6.7 after
Bx). Conclusions: 1.) Volume depletion and volume loading induced
stimulation and suppression of the AR in patients with essential
hypertension. 2.) Changes of AR were maintained during treatment
with betaxolol. 3.) Volume depletion and volume loading did not in-
duce any change of IR renin. 4.) Bicycle exercise testing did not show
to be an adequate stimulus for AR and IR. 5.) Different clinical
conditions known to influence AR were not able to induce any acute
changes of inactive renin in men; we were not able to prove any acute
conversion.
Regulation of blood pressure and hANP during treatment with cyclos-
porin A. P. Heering, J. Plum, M. Hollenbeck, B. Grabensee, Depart-
ment of Nephrology, Heinrich Heine University, 4000 Duesseldotf,
Federal Republic of Germany. The predominant side effect of CsA are
an impairment of renal function and an increased blood pressure. To
analyze blood pressure regulation we performed exercise studies in
patients without renal disease during administration of CsA and two
control groups. We studied 10 patients with mild essential hypertension
EH (WHO 1) (group A), 10 healthy controls (group B) and 10 patients
during treatment with CsA due to liver or corneal transplantation (group
C). Investigations performed were inulin and PAH clearance. Exercise
studies were performed by bicycle ergometer in five steps (4 minutes
each) from 25 to 125 watts and 12 minutes rest. We monitored plasma
renin activity (pra), aldosterone (al) and hANP. Heart rate and mean
blood pressure were monitored automatically. Results showed: 1.)
Patients from all groups showed an increase of hANP during exercise
and a decrease during rest (Table). There was a correlation between
exercise and hANP levels, but none between exercise and plasma renin
activity and aldosterone. Basal hANP levels were increased in patients
from group C.
hANP levels ( SD) during exercise
Group rest 50 w 125 w rest I rest 3
A 39 32 80 63 192 177 142 117 84 44
B 57 31 77 45 174 73 181 69 124 39
C 84±14 97±13 199±31 171±36 137±24
2.) Mean arterial blood pressure rose during exercise from 88.9 4.6 to
114.5 8.6 mm Hg in healthy controls, in patients with EH from 113
4.9 to 133 14.6 mm Hg and from 88.9 4.6 to 114.5 8.6mm Hg in
patients of group C. Conclusion: There was no difference of the
renin-angiotensin-aldosterone (RAA) system during exercise between
patients treated with CsA and two control groups. The increase of mean
blood pressure during treatment with CsA was not mediated by the
RAA system. Increased hANP levels during treatment with CsA may
be an indicator of volume retention induced by CsA.
Renal function during administration of cyclosporin A P. Heering, D.
Bach, G. Kreuzpaintner, B. Grabensee, Department of Nephrology,
Heinrich Heine University, D-4000 Düsseldorf, Federal Republic of
Germany. The predominant side effect of CsA is CsA induced nephro-
toxicity. We performed renal function studies in patients without renal
disease during administration of CsA and healthy controls. We inves-
tigated whether creatinine <1.3 mg/dl and CsA trough levels within the
therapeutic range exclude CsA induced nephrotoxicity. We studied 20
patients during treatment with CsA due to liver or corneal transplanta-
tion (group 1) and 15 healthy controls (group 2). We tried to achieve
CsA trough levels between 100 and 150 ng/ml in the monoclonal assay.
Investigations performed were inulin and PAH clearance, sodium
sulfateloading, sodium bicarbonate loading. Plasma renin activity (pra)
and aldosterone (al) were measured basally and after stimulation with
40 mg furosemide i.v. Results: 1.) Clearances of inulin and PAH were
significantly impaired during the administration of CsA. Group 1: C1
94.4 7.2ml/min/1.73 m2, CPAH 378.9 23.5 ml/min/1.73 m2. Group
2: C10 121 5.3 ml/min/1.73 m2 (P < 0.001); CPAH 605 39
ml/min/l.73 m2 (P < 0.001). Renovascular resistance (RVR) was
significantly increased during administration of CsA. 2.) Basal pra was
not different between both groups, after stimulation with furosemide;
there was only blunted response in group 1 (2.7 1.4 ng/ml/hr) as
compared to 7.7 1.9 ng/ml/hr in group 2 (P < 0.05). Aldosterone was
decreased during administration of CsA (NS). 3.) Incomplete distal
tubular acidosis with impairment of net acid excretion could be dem-
onstrated in 3 patients from group 1, but none of group 2. Conclusion:
I.) Close monitoring of serum creatinine and CsA trough levels does not
prevent from functional impairment induced by CsA. Impairment of
renal perfusion, gel filtration and increased renovascular resistance
could be demonstrated. PRA is suppressed. In 3 of 20 patients incom-
plete distal tubular acidosis could be demonstrated.
